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The investigation of complex interactions and the multitude of influencing parameters in
biotechnological processes requires a huge number of single experiments. To increase the
amount of information gained from the available sample volume, approaches of miniaturizing
the investigated unit operations are developed. Also the time invested in experimentation is
reduced by parallelized procedures and the manual effort is drastically decreased by the ap-
plication of robotic instrumentation such as liquid-handling stations (LHS). LHS are widely
used tools in the field of bioprocess development. Their ability of automated handling of
liquids and miniaturized reaction vessels (e.g. multiwell plates) enables high-throughput
screening of a variety of experimental conditions. These miniaturized, parallelized and
automated investigations are a central element of high-throughput process development
(HTPD) and are well-established in biotechnological research in academia as well as in
industry.
Only recently the established process development has been further improved by new
concepts. These include e.g. in silico approaches for the automated data handling and
the modeling of processes as well as the reorganization of workflows and unit operations.
However, for the generation of innovative approaches and their fast integration into process
development, novel technologies are to be implemented in HTPD.
The scope of this thesis is to broaden the ambit of LHS as toolbox for process develop-
ment. For this purpose, new technological strategies are to be combined and integrated
in automated experimental workflows on LHS. A key element in this work is the ap-
plication of 3D-printing techniques. 3D-printing is defined as the layerwise built-up of
three dimensional objects. Currently, multiple printing techniques are available with a
huge amount of different printing materials. The availability of 3D-printer in the entry-
level segment and furthermore the possibility of ordering 3D-printed parts from service
providers opens a broad circle of users access to 3D-printing. The simple usability in
comparison with conventional fabrication methods allows also laypersons the fast realiza-
tion of technical concepts. This strategy is most commonly referred to as rapid prototyping.
In this thesis, rapid prototyping was used to develop new approaches for the implementa-
tion of microfluidics an bioprinting in LHS-based high-throughput experimentation. In the
first part, the applicability of the ’microfluidics-on-liquid handling station’ (𝜇F-on-LHS)
system for different biotechnological areas was investigated. This system has been developed
as a preparatory work for this dissertation. It combines the advantages of experiments
c
executed in microfluidic channels with the automated workflow of a LHS.
The 𝜇F-on-LHS system was further developed and now covers an analytic bottleneck in
the biopharmaceutical development. In LHS-based experimentation, the method of choice
for qualitative and quantitative analysis of samples are absorption measurements. Due to
the detection limits of the integrated spectrophotometers, the sample concentration has
to be adapted which demands error-prone dilution steps. To overcome this issue of error
and to simplify the measurement, a disposable microfluidic device was designed allowing
the absorption measurements of protein solutions in a concentration range from 0.1 to
100 mg/mL in a high-throughput format. Each of the 96 channels of one device consists of
four measurement chambers with distinct channel height, increasing from 100 to 1500 𝜇m.
This setup enables a four point measurement of 36 𝜇L samples with various optical path
lengths for the direct calculation of calibration curves and the determination of protein
concentrations. The device was validated according to ICH-guidelines and the applicability
was demonstrated by its integration in a microscale chromatography screening performed
on a LHS. The developed microfluidic device will simplify process development and increase
the process robustness.
The second example for the application of the 𝜇F-on-LHS system covers the field of chemical
synthesis. Here, the advantageous application of microfluidic flow-through experiments
performed on LHS was shown for the fabrication of polymer nanoparticles. The photopoly-
merization of miniemulsions is a promising approach for the production of nanoparticles and
nanocapsules from biofunctional polymers. Miniemulsions provide mild reaction conditions
for sensitive biomaterials and monomer droplets of a miniemulsion behave as separate
reaction compartments. However, the targeted total monomer conversion depends on many
influencing factors. The developed microfluidic device allows the screening of these factors
in an automated screening procedure. In a design of experiments approach, the influence
on the monomer conversion was investigated by varying miniemulsion compositions and
irradiation conditions. This resulted in the classification of cause variables in a large
parameter space with only small sample consumption.
The connectivity of the 𝜇F-on-LHS system with other microfluidic approaches was demon-
strated by the integration of microfluidic biofilm flowcells in a fully automated procedure.
This platform was applied for the execution of fluorescence in situ hybridization (FISH)
as well as catalyzed reporter deposition fluorescence in situ hybridization (CARD-FISH).
These methods are powerful tools for the identification of single species in complex microbial
communities as is present in biofilms. Custom made cartridges enabled the processing of
up to nine flowcells in parallel. Besides the automated execution of every process step of
the CARD-FISH protocol, also a semi-quantitative read-out of the fluorescence signal of
the stained species was established. The procedure was successfully applied to single- and
mixed-species biofilms of E. coli and B. subtilis. The repeatability and reproducibility
was enhanced and the required manual work was significantly reduced which increases the
possible throughput of cultivation flowcells in one working day.
The second part of this work describes the linkage of the three dimensional printing
of biomaterials and biocompatible materials, referred to as bioprinting, and automated
screening procedures on LHS. For this, different printing techniques were investigated
regarding their applicability in the production of multiwell plate compatible three dimen-
sional hydrogel structures. The integration of these structures in multiwell plates enables
their implementation in automated experiments executed by LHS. This strategy allows
for high-throughput investigations of various printing materials and their effect on the
interactions between the different components of the bioinks with the liquid surroundings.
The driving force behind bioprinting is the vision of printing spare parts for the human
body which is referred to as tissue engineering. The research in this field demands strict
requirements to the printing devices applied. For example, the devices have to be operated
in sterile conditions and simple first printing trials are mostly hard to execute due to
stringent operation regimentation. These circumstances hamper the application spectrum
of bioprinting techniques in research areas besides tissue engineering. To overcome this
shortcoming, entry-level bioprinting devices are a promising approach. As such devices are
not commercially available, one aim of this thesis was the construction and establishment
of an entry-level device capable of extrusion-based bioprinting. This was achieved by the
modification of a conventional fused filament fabrication printer. The open source pedigree
of this printer allowed the fast adaption of customized extension parts which were partly
fabricated by the printer itself. Besides the construction of a syringe extrusion unit and the
replacement of the original wooden housing parts with custom-fit acrylic glass parts, an user
friendly user interface was established to simplify the control of the printer and the printing
process. This setup is capable of printing simple geometrical structures into the wells of
multiwell plates and, furthermore, the fabrication of more complex 3D-structures. Printing
in multiwell plates is a prerequisite for the implementation of bioprinted structures in
HTPD. The feasibility of the concept was demonstrated by the execution of a biocatalysis
case study on a LHS. For this purpose, a two step printing procedure was applied to
encapsulate the enzyme 𝛽-galactosidase in hollow hydrogel cylinders which were directly
fabricated in multiwell plates. Subsequently, an activity assay of the encapsulated enzyme
was executed and analyzed on a LHS. Thus, optimal parameters for a hydrogel-based
𝛽-galactosidase process could be determined, which is an important step towards the use
of functional hybrid materials in biocatalysis. It was shown that the presented device
allows a simple first access to bioprinting and bioprinting materials and opens new ways in
process development by the implementation of bioprinted structures in high-throughput
approaches.
Bioprinted structures are also applied as carrier modules for controlled drug-delivery.
Thereby, the uptake and release kinetics of the drug molecule is affected by the physical
and chemical properties of the printed structures,the utilized materials and the condi-
tion of the surrounding liquid. To investigate these interrelations, a screening procedure
was established. For the fabrication of multiwell compatible bioprinted structures, a
stereolithography-based 3D-printer was applied. Stereolithography is the spatially con-
trolled photopolymerization of low viscous precursor solutions. To establish bioprinting
with an entry-level stereolithography printer, the ideal adjustment of bioink composition
and printing parameters have been investigated. This allowed the fabrication of hollow
hydrogel cylinders of various compositions which could be placed in the wells of a 48 well
plate. These structures were examined with regard to their uptake and release behavior
under varying buffer conditions in a LHS-based screening procedure. Lysozyme was used
as model substance. The resulting pH and salt dependent uptake and release profiles
showed the successful application of this concept. The presented setup provides another
beneficial approach for the implementation of bioprinted structures in automated screening
procedures for the support of bioprinting material development.
In summary, it can be said that technological approaches for the advantageous combi-
nation of microfluidics and bioprinting with LHS have been established and thoroughly
investigated in this work. The 𝜇F-on-LHS system has been successfully integrated into
automated procedures for various applications. A microfluidic chip has been developed
that eliminates a bottleneck in the concentration determination in bioprocess development.
Furthermore, the performance of flow-through polymerization experiments in combination
with statistical experimental design in the field of chemical synthesis has been established.
In addition, the 𝜇F-on-LHS system has been further developed and expanded and now
allows the automated analysis of biofilms by FISH. Besides that, structures fabricated
using bioprinting techniques were successfully integrated into HTPD. Two different printing
techniques have been established for the production of these structures. The suitability of
this concept has been demonstrated for biocatalysis and drug-delivery case studies.
The technologies developed offer new powerful approaches to extend the range of applica-
tions for the development of future-proof LHS-based high-throughput processes.
CHAPTER 2
German Abstract - Zusammenfassung
Die Untersuchung komplexer Wechselwirkungen und einer Vielzahl von Einflussgrößen
in biotechnologischen Prozessen erfordert zahlreiche Einzelversuchen. Durch Miniatur-
isierung der gängigen einzelnen Prozessschritte wird die Menge an Informationen die
aus dem verfügbaren Probenvolumen gewonnen werden kann gesteigert. Mit dem Ein-
satz von Robotertechnik wie z. B. Liquid-Handling Stationen (LHS) wird der manuelle
Aufwand drastisch reduziert. Der Einsatz von LHS ist in der Bioprozessentwicklung
weit verbreitet. Sie ermöglichen die automatisierte Handhabung von Flüssigkeiten und
miniaturisierten Reaktionsgefäßen (wie z. B. Multiwell-Platten) und erlauben somit das
Hochdurchsatz-Screening einer Vielzahl experimenteller Bedingungen. Diese miniatur-
isierten, parallelisierten und automatisierten Untersuchungen sind ein zentrales Element
der Hochdurchsatz-Prozessentwicklung (High-Throughput Process Development, HTPD)
und sind in der biotechnologischen Forschung sowohl im akademischen Bereich als auch in
der Industrie etabliert.
Erst in jüngster Zeit wird die bestehende Prozessentwicklung durch neue Konzepte weiter
verbessert. Dazu gehören z. B. in silico Ansätze für die automatisierte Datenverarbeitung
und die Prozessmodellierung sowie die Reorganisation von Arbeitsabläufen und Prozess-
schritten. Um innovative Ansätze und deren schnelle Einbindung in die Prozessentwicklung
zu verwirklichen sollen neuartige Technologien in HTPD integriert und angewendet werden.
Der Fokus dieser Arbeit liegt daher in der Erweiterung des Anwendungsbereichs von
LHS als Basis für die Prozessentwicklung. Dazu sollen neue technologische Strategien
kombiniert und in automatisierte experimentelle Arbeitsabläufe auf LHS integriert werden.
Ein Schlüsselelement dieses Ansatzes ist die Anwendung von 3D-Drucktechniken. 3D-Druck
ist definiert als der schichtweise Aufbau dreidimensionaler Objekte. Gegenwärtig stehen
mehrere Drucktechniken mit einer Vielzahl von unterschiedlichen Druckmaterialien zur
Verfügung. Die Verfügbarkeit von 3D-Druckern im Einstiegssegment und die Möglichkeit
3D-Druckteilen bei Dienstleistern zu bestellen ermöglicht einem breiten Nutzerkreis den
Zugang zum 3D-Drucken. Die im Vergleich zu herkömmlichen Fertigungsmethoden einfache
Bedienbarkeit von 3D-Druckern ermöglicht zudem auch Laien die schnelle Umsetzung von
technischen Konzepten. Diese Strategie wird häufig als Rapid Prototyping bezeichnet.
In dieser Arbeit wird Rapid Prototyping verwendet, um neuen Ansätze zu entwickeln,
welche die Einbindung von Mikrofluidik und Bioprinting in LHS-gestützte Hochdurchsatz-
Experimente ermöglichen soll. Im ersten Teil dieser Arbeit wurde die Anwendbarkeit des
g
’microfluidics-on-liquid handling station’ (𝜇F-on-LHS) Konzepts für verschiedene biotech-
nologische Bereiche untersucht. Dieses System wurde als Vorarbeit für diese Dissertation
entwickelt. Es verbindet die Vorteile von Experimenten in mikrofluidischen Kanälen mit
dem automatisierten Workflow von LHS.
Eine Weiterentwicklung des 𝜇F-on-LHS Konzepts schließt eine analytische Lücke in
der biopharmazeutischen Prozessentwicklung. In auf LHS durchgeführten Experimenten
sind Absorptionsmessungen die Methode der Wahl für die qualitative und quantitative
Analyse von Proben. Aufgrund der Detektionsgrenzen der integrierten Spektralphotometer
muss die Probenkonzentration angepasst werden, was fehleranfällige Verdünnungsschritte
erfordert. Um diese Fehlerquelle zu beseitigen und die Messung zu vereinfachen, wurde ein
Einweg-Mikrofluidikchip entwickelt. Dieser Chip ermöglicht Absorptionsmessungen von
Proteinlösungen in einem Konzentrationsbereich von 0.1 bis 100 mg/mL im Hochdurch-
satzformat. Jeder der 96 Kanäle eines Chips besteht aus vier Messkammern mit unter-
schiedlicher Kanalhöhe, die zwischen 100 und 1500 𝜇m variieren. Dieser Aufbau ermöglicht
eine Vier-Punkt-Messung einer Probe von 36 𝜇L mit mehreren optischen Weglängen für die
direkte Erstellung von Kalibrierkurven und die Bestimmung von Proteinkonzentrationen.
Der Chip wurde nach ICH-Richtlinien validiert und seine Anwendbarkeit wurde in einem
miniaturisierten Chromatographie-Screening auf einer LHS nachgewiesen. Der entwickelte
mikrofluidische Chip wird die Prozessentwicklung vereinfachen und die Robustheit der
Prozesse erhöhen.
Das zweite Beispiel für die Anwendung des 𝜇F-on-LHS Systems betrifft den Bereich der
chemischen Synthese. Hier zeigte sich die vorteilhafte Anwendung der mikrofluidischen
Experimente im Durchfluss auf LHS zur Herstellung von Polymer-Nanopartikeln. Die
Photopolymerisation von Miniemulsionen ist für die Herstellung von Nanopartikeln und
Nanokapseln aus biofunktionellen Polymeren ein vielversprechender Ansatz. Miniemulsio-
nen bieten milde Reaktionsbedingungen für empfindliche Biomaterialien und die Monomer-
tröpfchen einer Miniemulsion verhalten sich als separate Reaktionskompartimente. Die
angestrebte vollständige Umwandlung des Monomers hängt jedoch von vielen Einflussfak-
toren ab. Der entwickelte mikrofluidische experimentelle Aufbau ermöglicht das Screening
dieser Faktoren in einem automatisierten Verfahren. Mit Hilfe statistischer Versuchs-
planung wurde der Einfluss von unterschiedlichen Miniemulsionszusammensetzungen und
Bestrahlungsbedingungen auf die Monomerumwandlung untersucht. Dieses Vorgehen
erlaubte die Klassifizierung von Einflussgrößen in einem großen Parameterraum bei nur
geringem Probenverbrauch.
Die Kompatibilität des 𝜇F-on-LHS Systems mit anderen mikrofluidischen Methoden wurde
durch die Integration von mikrofluidischen Biofilm-Flusszellen in ein vollautomatisches
Verfahren gezeigt. Diese Kombination ermöglichte die automatisierte Durchführung der
Fluoreszenz in situ Hybridisierung (FISH) sowie der ’catalyzed reporter’ Fluoreszenz in
situ Hybridisierung (CARD-FISH). Beide Methoden sind leistungsfähige Werkzeuge zur
Identifizierung einzelner mikrobieller Spezies in komplexen Gemeinschaften, wie sie in
Biofilmen vorkommen. Speziell angefertigte Transportkassetten ermöglichen die parallele
Prozessierung von bis zu neun Flusszellen. Neben der automatisierten Ausführung aller
Prozessschritte des (CARD)-FISH Protokolls wurde auch ein semi-quantitatives Auslesen
des Fluoreszenzsignals der angefärbten Proben etabliert. Das Verfahren wurde durch die au-
tomatisierte Durchführung von FISH-Experimenten mit Biofilmen bestehend aus nur einer
oder mehrerer Spezies und anschließender Analyse mittels Fluoreszenzspektroskopie im inte-
grierten Plattenleser validiert. Die Wiederholbarkeit und Reproduzierbarkeit wurde durch
die Automatisierung gesteigert, gleichzeitig wurde der nötige manuelle Arbeitsaufwand
stark reduziert.
Der zweite Teil dieser Arbeit beschreibt die Verknüpfung des dreidimensionalen Drucks
von Biomaterialien und biokompatiblen Materialien, das so genannte Bioprinting, und
automatisierte Screeningverfahren auf LHS. Hierzu werden verschiedene Drucktechniken auf
ihre Anwendbarkeit bei der Herstellung von Multiwellplatten-kompatiblen dreidimension-
alen Hydrogelstrukturen untersucht. Die Integration solcher Strukturen in Multiwellplatten
ermöglicht deren Einbindung in automatisierte, von LHS durchgeführte Experimente. Diese
Strategie ermöglicht die Hochdurchsatzuntersuchung von variablen Zusammensetzungen
der Druckmaterialien als auch der umgebenden Flüssigkeit und die Auswirkungen dieser
Variationen auf die Interaktionen zwischen den verschiedenen Komponenten der Biotinten.
Die treibende Innavationskraft hinter Bioprinting ist die Vision, Ersatzteile für den
menschlichen Körper zu drucken, das so genannte Tissue Engineering. Die Forschung auf
diesem Gebiet stellt hohe Anforderungen an die eingesetzten Druckgeräte. So müssen die
Geräte z.B. steril betrieben werden und einfache Druckversuche sind aufgrund der strengen
Betriebsvorschriften meist nur schwer durchführbar. Diese Umstände erschweren das
Anwendungsspektrum von Bioprinting-Techniken in Forschungsgebieten neben dem Tissue
Engineering. Bioprinting-Geräte im Einstiegssegment sind ein vielversprechender Ansatz
um diesen Nachteil auszugleichen. Da solche Geräte nicht kommerziell erhältlich sind,
waren der Aufbau und die Etablierung eines Einstiegsgerätes für den extrusionsgestützten
Biodruck ein Ziel dieser Arbeit. Dies wurde durch den Umbau eines konventionellen Fused-
Filament-Fabrication-Druckers erreicht. Der Open Source Gedanke auf dem der Drucker
beruht ermöglichte die schnelle Adaption von speziell angefertigten Erweiterungsteilen, die
zum Teil vom Drucker selbst hergestellt wurden. Neben dem Bau einer Extrusionseinheit
und dem Austausch der originalen Holzgehäuseteile durch passgenaue Acrylglasteile wurde
auch eine benutzerfreundliche Bedienoberfläche etabliert, um die Steuerung des Druckers
und des Druckprozesses zu vereinfachen. Mit diesem Aufbau ist es möglich, einfache
geometrische Strukturen in die Wells von Multiwellplatten zu drucken und auch komplexere
3D-Strukturen herzustellen. Durch den Druck in Multiwellplatten ist die Implementierung
von Bio-3D-Strukturen in HTPD möglich. Die Umsetzbarkeit des Konzepts wurde durch
die Durchführung einer Biokatalyse-Fallstudie auf einer LHS nachgewiesen. Zu diesem
Zweck wurde ein zweistufiges Druckverfahren angewendet, um das Enzym 𝛽-Galactosidase
in hohlen, direkt in Multiwellplatten hergestellten, Hydrogelzylindern zu verkapseln. An-
schließend wurde ein Aktivitätsassay des verkapselten Enzyms auf einer LHS durchgeführt
und analysiert. So konnten optimale Prozessparameter für einen Hydrogel basierten 𝛽-
Galactosidase Prozess bestimmt werden. Dies ist ein wichtiger Schritt in Richtung der
Verwendung von funktionellen Hybridmaterialien in der Biokatalyse. Somit wurde gezeigt,
dass der entwickelte Drucker einen einfachen ersten Einstieg in Bioprinting und Biodruck-
materialien ermöglicht und durch die Implementierung von mit Bioprinting-Techniken
gedruckte Strukturen in Hochdurchsatz-Experimente neue Wege in der Prozessentwicklung
eröffnet.
Diese Bio-3D-Strukturen werden auch als Trägermatrizen für die kontrollierte Wirkstoff-
abgabe eingesetzt. Dabei wird die Aufnahme- und Freisetzungskinetik des Wirkstoff-
moleküls durch die physikalischen und chemischen Eigenschaften der gedruckten Strukturen
und die in der umgebenden Flüssigkeit herrschenden Bedingungen beeinflusst. Um diese
Zusammenhänge genauer zu untersuchen wurde ein Screeningverfahren etabliert. Für
die Herstellung von Multiwell-kompatiblen Hydrogel-Strukturen wurde bei dieser zweiten
Studie ein Stereolithographiedrucker eingesetzt. Die Stereolithographie ist die räumlich
gesteuerte Photopolymerisation niederviskoser Monomerlösungen. Um das Bioprinting mit
einem Stereolithographiedrucker der Einstiegsklasse zu etablieren, wurde die ideale Abstim-
mung der Biotintenzusammensetzung und Druckparametern untersucht. Dies ermöglichte
die Herstellung von hohlen Hydrogelzylindern, die in Wells einer 48 Well-Platte eingesetzt
werden konnten. Diese Strukturen wurden in einem LHS-basierten Screeningverfahren
auf ihr Aufnahme- und Freisetzungsverhalten unter unterschiedlichen Pufferbedingungen
untersucht. Dabei diente Lysozym als Modellmolekül. Die resultierenden pH- und salz-
abhängigen Aufnahme- und Freisetzungsprofile zeigten die erfolgreiche Anwendung des
entwickelten Verfahrens. Die hier vorgestellte Studie zeigt einen weiteren vorteilhaften
Ansatz auf, welcher die Implementierung von mit Bioprinting-Techniken gedruckter Struk-
turen in automatisierte Screeningverfahren ermöglicht.
Zusammenfassend kann gesagt werden, dass in dieser Arbeit technologische Ansätze
für die vorteilhafte Verknüpfung von Mikrofluidik und Bioprinting mit automatisierten
LHS-Experimenten etabliert und eingehend untersucht wurden. Das 𝜇F-on-LHS Sys-
tem wurde erfolgreich in automatisierte Verfahren für verschiedene Anwendungsbereiche
integriert. Es wurde ein mikrofluidischer Chip entwickelt der den Engpass der Konzen-
trationsbestimmung in der Hochdurchsatz-Bioprozessentwicklung beseitigt. Weiterhin
wurde die Durchführung von Polymerisationsexperimenten im Durchfluss in Kombina-
tion mit statistischer Versuchsplanung im Bereich der chemischen Synthese etabliert.
Darüber hinaus wurde das System weiterentwickelt und erweitert und erlaubt nun die
automatisierte Analyse von Biofilmen in mikrofluidischen Kultivierungschips durch FISH.
Außerdem wurden mit Bioprinting-Techniken hergestellte Strukturen erfolgreich in die
Hochdurchsatz-Prozessentwicklung integriert. Für die Herstellung dieser Strukturen wur-
den zwei verschiedene Drucktechniken etabliert. Die Eignung dieses Konzepts wurde für
Biokatalyse- und Drug-Delivery-Fallstudien gezeigt.
Die entwickelten Technologien bieten neue leistungsfähige Ansätze, um das Anwendungsspek-
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The human urge to understand the processes in nature has always driven researchers and
explorers to new findings. Universal scholars and specialists have accumulated a broad
knowledge which nowadays can be imparted in schools and universities to educate the
young scientists. This allows the training of specialized professionals with sound expertise.
The research of these professionals lead to a deeper understanding and a high information
density in their specific area. To increase the creativity and for the recognition of scientific
gaps to bridge, a scientific exchange has to take place between the several disciplines. This
interdisciplinary communication is able to address new challenges implied by scientific
progress [1].
An example for a interdisciplinary research area is biotechnology. This area combines
life sciences, like biology and chemistry, and the engineering principles like mathematics,
material science and technical processes [2]. The aim of biotechnological research is not
only to fully understand the processes of nature, but to make them technically feasible and
usable. The adaptions of these processes are made on the macroscopic and microscopic
level. The adapted processes are applied for the controlled production of specific molecules.
These target molecules range from simple molecules [3–5] as well as complex biomolecules
such as antibodies for biopharmaceutical use [6, 7]. An optimization of the production of
these molecules can be achieved by the determination of ideal environmental growth and
process conditions or by specific manipulations of lifelike processes and organisms [8]. The
large multiplicity of possible conditions, variations and combinations engendered challenges
hardly to be mastered with conventional lab work. In order to cope with increasing exper-
imental effort, methods and technologies have been adapted and developed. Promising
approaches to increase the throughput of samples and reactions have been found in the
automation and parallelization of experiments and the reduction of the needed sample
volume through miniaturization [9]. For this purpose, new devices have been developed
which enable the implementation of these features in the experimental workflow.
In the following sections, the devices and techniques applied in this doctoral thesis for
the execution of experiments are described. Besides the microwell plates, liquid-handling
stations and microfluidics which allow automated and miniaturized experimentation also
the combinatorial concept of 𝜇F-on-LHS is introduced.
The lead time for the implementation of novel scientific concepts and their application is
mostly long due to constructive effort. By adapting rapid prototyping technologies for the
manufacturing of lab equipment, the time to application was signifficantly reduced [10,
11]. Rapid prototyping methods have contributed to the fast optimization and adaption of
1
3.1 High-Throughput Experimentation
laboratory equipment [12, 13]. By including biological or biocompatible materials in rapid
prototyping production processes, new areas of biotechnology are explored. This approach
was taken in biomedical research for the additive fabrication of hybrid materials and
functional 3D-tissues [14]. The technological advances in bioprinting for tissue engineering
in terms of methods, materials and devices have also inspired further biotechnological
sectors to new, innovative applications. This includes the incorporation of algae [15] and
bacterial cells [16] in bioprinting processes.
At the end of this chapter, an overview about 3D-printing and bioprinting is given. The
application of these technologies is set into the context of this work.
3.1 High-Throughput Experimentation
In Hungary of the early 1950s, laboratory equipment was scarce and influenza broke out,
which motivated Gyula Takácsy to develop novel laboratory tools. As reported by the
Hungarian National Center for Epidemiology, the hungarian microbiologist Takácsy devel-
oped one of the first approaches on the replacement of separate reaction tubes. One of his
developments is the first prototype of what will be known as multiwell plate or microplate.
He prepared a piece of acrylic glass with 8 x 12 cavities for the simplified preparation of
multiple simultaneous serial dilutions.[17] This invention was soon be adapted from other
researchers and further developed [18]. With the production of disposable plates containing
up to 96 cavities, the multiwell plate was available for researchers in large quantities. The
possibility of parallel experimentation with a scaled-down sample volume accelerated the
investigation and execution of various experiments. With the standardization of the well
and plate dimensions promoted by the Society for Biomolecular Sciences (ANSI/SBS 1-2004
to ANSI/SBS 4-2004) the automated handling of theses plates became possible [19].
The transfer and merging of liquids is one of the most essential tasks in life science research.
In order to increase the throughput of experiments and minimize the manual effort, the
handling of the microplates and further the handling of liquids had to be automated. To
accomplish this purpose, liquid-handling stations (LHS) were developed which are able
to process several thousands of samples. Such extensive test series are referred to as
high-throughput screening (HTS) or high-throughput experimentation (HTE).[20]
The automated sample handling and the ability to mix and dilute liquid reagents in a
broad volume range with a high reproducibility led to an intensified utilization of these
LHS in various industrial and scientific procedures. The application of the LHS support
rapid scientific progress for labour-intensive research projects, such as the human genome
project [21, 22] or drug discovery [23]. In order to meet the increasingly complex require-
ments, the LHS can be expanded modularly. Robotic liquid handling arms with options
up to 384 pipetting tips facilitate the integration of microplates with 384 and 1536 wells
in automated processes. Various lab devices were implemented to enable more process
steps to be automated and novel scale-down approaches have been developed to take
advantage of the available potential offered by the LHS. The properties described here
and the successful implementation of many process steps make the LHS a workhorse in
bioprocess development and biotechnological research [20, 24]. In the following section,
selected examples of HTE applications on LHS are described.
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Applications of HTE in Bioprocess Development
The higher laboratory efficiency which was achieved by the execution of LHS-based high-
throughput experimentation has led to the establishment of LHS as integral part in various
research areas. Technical extensions which allow the manipulation of samples beyond
the transfer of liquids extended the spectrum of applications. The sample preparation
and processing was further automated by the integration of e.g. centrifuges, shaker plat-
forms, tempering conditioning systems and filtration units in the automated workflows [20].
Furtermore, the integration of spectrophotometric plate readers allowed the simple and fast
sample UV/Vis absorption based sample analysis. The benefits of automated sample pro-
cessing were employed e.g. in biocatalysis research [25] and genomics [26]. One of the major
application areas of LHS-based biochemical experimentation is in the high-throughput
process development (HTPD) of the biopharmaceutical research. The flexibility of the
LHS allowed the miniaturization of various process steps of pharmaceutical production
including upstream, downstream and formulation operations [23, 27]. Huber et al. in-
tegrated a microscale cultivation device in a robotic platform to generate high-content
data for biological production systems [28]. Furthermore, a combination with small-scale
downstream procedures is possible. Such scale-down approaches have been developed for a
variety of process steps. The published applications range from protein crystallization [29],
precipitation [30] and refolding studies [31] to the investigation of alternative purification
procedures like aqueous two-phase systems in microplate format [32, 33]. Investigations for
chromatography-based purification were made in terms of resin screening studies [34, 35]
and miniaturized chromatography procedures [36–38] as can bee seen in figure 3.1. The
reduced volume of samples required for a miniaturized experimental approach is ideal for
the small amount of target molecules available in the early phase of drug discovery.




Microfluidics is described as the manipulation of small volumes of liquid in the range from
few microliters to even nanoliters. Comparable with the development and application of
microplates, the technological development of microfluidics has also been driven by the
need of an increased throughput with decreased sample consumption [39]. The assembly
of microfluidic channels is called microfluidic chip or device. Through networks of these
small channels, liquids are transported by active or passive pumping. The throughput of
samples is increased by multiplexing or parallelization of channel systems. Thus, various
assays and complex flows can be realized in microfluidic devices on compact space. The
applications range from simple flow-through experiments to elaborate mixing tasks and
single cell investigations.[40–42] The small scale of the channels implies changes in the
fluid dynamics compared to the macro scale. In microfluidic systems a laminar flow is
established. Due to the small channel diameters, turbulences which are difficult to control
are avoided. The laminar flow also has the effect that the mixing of liquids is driven
exclusively by diffusion. Additionally, it enables the generation of multiphase streams
and droplets.[43] Operations like mixing or sorting are accomplished by the integration of
special fluidic elements [44–46], microvalves and micropumps [47, 48].
For the fabrication of sophisticated microfluidic devices, a range of production techniques
and materials are in use.[49, 50] The production techniques for theses channel systems
originally derived from the semiconductor industry and micro-electromechanical devices.
With methods like etching and photolithography microfluidic channels were produced in
glass and silicon parts.[51] With the rising demand of disposable devices, the fabrication
in glass and silicon got too expensive. This lead to the implementation of new materials
and designs in the microfluidic device fabrication process [52–54]. Nowadays, silicone and
other polymers are applied for the fabrication of microfluidic devices. The selection of
techniques for the production include one-step and two-step manufacturing methods [49].
Also micromilling [55] and 3D-printing are applied for the production of casting molds as
well as the direct fabrication of microfluidic devices [13, 56].
Microfluidic Applications in Life Science and Biotechnology
In the past, various microfluidic applications have been developed for biomedical and
biological research and diagnostics [40, 41, 57]. The ability of precise fluid handling and
flow-through applications have made microfluidics an alternative to conventional experi-
mentation [58].
As already mentioned, the microfluidic research was driven by application in genomics like
DNA synthesis [59] or flow-through PCR [60]. The size of microfluidic structures allows
single cell investigations in stem cell research [61] just as studies of cell communities as in
biofilms [62, 63]. The integration of cross-sections in the microfluidic networks allows the
specific generation of droplets [64], which are used as microreactors [65] or cell vehicles [66].
Further, this droplet generation devices are applied for polymerization studies [67, 68]. The
laminar flow behavior of fluids in microfluidic channels comes into effect by the generation
of aqueous two-phase systems for the separation of cells [69–71] and proteins [72, 73].
Further protein separation approaches are investigated by the implementation of liquid
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chromatography procedures on microfluidic devices [74].
Despite the great number of scientific publications on microfluidics, only a few microfluidic
approaches have been developed beyond the proof-of-concept status and toward market-
ability [58, 75]. This commercialized approaches are for example lab-on-disk devices where
transport and distribution of the liquids is controlled by centrifugal forces (Gyros xPlore™)
and microfluidic capillary electrophoresis systems (PerkinElmer LabChip®).
3.3 The Microfluidics on Liquid-Handling Station System
Although few microfluidic-based applications have been commercialized, the breakthrough
as standard method in industry and academia is still lacking. The available devices are
designed for specific applications and microfluidic channel layouts. A common standard for
an easy transfer and application of microfluidic methods is an ongoing topic of discussion [75–
77]. Besides the standardization of connectivities, the integration in automated workflows
is also a desireable feature [76, 78].
In preliminary works of this thesis, an approach of combining liquid-handling stations and
microfluidic devices was developed [79]. This ’microfluidics on liquid-handling stations’
system (𝜇F-on-LHS) enables the execution of microfluidic experiments by a LHS compatible
interface (see figure 3.2).
Figure 3.2: Photograph of 𝜇F-on-LHS devices in an automated procedure on a liquid-handling
station.
The peripheral equipment needed for microfluidic experiments like pumps, valves and
control units is provided by the LHS. The dimensions of the used microfluidic devices are
in agreement with the standard dimensions of microwell plates. Therefore, the chips can
be transferred by the robotic manipulator arm and integrated functional devices such as
integrated spectrophotermeter can be part of the workflow. The microfluidic chips are
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fabricated using silicone molding procedure [49]. The shape of the channel structures is
defined by an replication master which can be freely adapted to the intended application.
The connection of the LHS tips to the microfluidic channels is reversible, which allows the
fully automated handling of the chips on the LHS.
3.4 3D-Printing
With the invention of the printing press by Johannes Gutenberg in 1440, a rapid and precise
reproduction of letters, words and pictures became possible. For his invention, Gutenberg
misused the already existing screwpress and adapted this machine to a new purpose. In
the process of time, the printing press was continuously improved, modified and further
adaptions to new emerging needs and developments were carried out. With the rising
popularity of personal computers and inkjet printers since the middle of the 20th century,
the creation and reproduction of texts and pictures could be accessed by the population at
large. In the 1980s, similar to the approach of Gutenberg, scientists rededicated the known
method of photopolymerization to an new application. They developed an apparatus for
the build up of three-dimensional objects based on photopolymerization. With the patent
of this apparatus filed by Chuck Hull in 1986, the era of additive manufacturing (AM),
mostly referred as 3D-Printing, began [80]. AM describes manufacturing technologies
which build up objects by layer-wise addition of material. On the contrary, traditional
methods like milling, turning and drilling are now described as subtractive manufacturing.
Within the umbrella term of additive manufacturing, in addition to stereolithography
further techniques have been developed in the following years (see overview in section
3.4.1). In the case of 3D-printing, the expiry of patents and subsequently the dropping
prices of 3D-printing machines drastically increased the popularity and number of employed
3D-printers in industrial, academic or private workshops.[81, 82]
At the moment, rapid prototyping is the most widely used application of 3D-printing.
Thus, 3D-printed prototypes accelerate the development of the final product compared to
conventional production or prototyping methods, like machining and injection molding.
Furthermore, for small-batch production, customer-specific adjustments and manufacturing
of functional pre-serial parts 3D-printing provides as an ideal fabrication technology,
particularly because of the elimination of investments for tooling.[83, 84]
Due to these advantages of 3D-printing in comparison with other techniques a variety
of industrial fields make use of 3D-printing [83, 85]. In medium-sized companies or in
scientific laboratories 3D-printing is applied to supplement mechanical workshops.
The application of 3D-Printers for rapid prototyping tasks in the academic research has
lead to improvements of existing technologies or methods (e.g. syringe pumps [86], custom
bottle caps and multiwell plates [87], culture systems [88]). Furthermore, the production
methods offered through 3D-printing support the development of novel scientific tools
which are tough to realize with conventional methods [89, 90]. Through the free availability
of computer-aided design (CAD) software and databases with 3D-files, online tutorials, the
ever-growing 3D-printing community and the numerous specialized 3D-printing providers,
everyone has access to 3D-printing.
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3.4.1 Conventional 3D-printing techniques
In preparation for all printing techniques, a digital, three-dimensional file of the object to
build has to be designed and further processed into thin layers. The thickness of the layers
depends on the possible resolution of the 3D-printer. Theses layers are then translated in a
command set which can be interpreted by the 3D-printer for the layer-by-layer conversion
of the digital into a haptic model.
The first patented 3D-printing technology was stereolithography (SLA, see figure 3.3 mid-
dle). This technique is based on the light-induced polymerization of monomers. The light
source for this applied photopolymerization can either be a laser (laser-based SLA) or a so
called digital light processing unit like a projector (DLP-based SLA). Both systems have
in common, that the directed light induces a spatial controlled polymerization of liquid
photopolymer resin. This resin is provided in a vat in which a build platform is immersed.
The resin-filled gap between the bottom of the vat and the build platform or the last build
layer defines the layer height. The laser beam scans the image of the current layer to build
and solidifies the shape of the model. [91]
A variation of this technique is the multi-jet modeling as depicted in figure 3.3 (bottom).
Here, a print-head distributes the resin comparable to an inkjet process. The resin is
UV-polymerized by passing light sources mounted on the print-head. [92, 93] In case of the
binder jetting technology, not the material itself but a binder liquid is distributed by the
print head. The defined application of binder onto layer-wise provided powder material
generates the models [94].
Another fabrication technology for three-dimensional objects is selective laser sintering
(SLS) [95]. Powder material is layer-wise piled up and melted by a laser. With this
technique, also metal containing powders can be processed which enables the print of metal
parts [96].
The most popular 3D-printing technique is the fused deposition modeling (FDM) or fused
filament fabrication (FFF). With this method, melted thermoplastic material is extruded in
several lines to build up every layer (see 3.3, top). The popularity of this technique is based
upon the low prices for the printers and the printing material, but also the open-source
pedigree and support through user-communities are a big advantage of FFF. As the concept
printing procedure is very straightforward and allows a lot of tuning possibilities, a huge
amount of various materials is available, including flexible, carbon fiber reinforced and
metal or wood infused materials [97, 98].
3.4.2 Bioprinting
A particular application of 3D-printing techniques can be found in the field of bioprinting.
The concept of bioprinting describes the coating or printing of biomaterials like cells or
proteins, biocompatible materials or other biological relevant materials [99]. The bioprint-
ing development was originally driven by the visionary idea of reproducing organs by
3D-printing techniques [100]. First steps were made by the modification of inkjet printers
for the two dimensional patterning of biologically active components [101]. The build-up
of three dimensional structures could be achieved by the modification of stereolithographic
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Figure 3.3: Schematic representation of the 3D-printing techniques fused filament fabrica-




methods and the development of extrusion-based bioprinters. Most of the bioprinting
research has been made in the fields of tissue engineering and regenerative medicine. The
focus lies on the coordination of printing material and printing techniques for the production
of complex structures able to mimic living tissues. The printed structures are applied for
bone regeneration, transplantable tissues or as models for drug testing. The biological
components are implemented directly in the printing material or are seeded afterwards on
printed matrices. The challenge of a successful integration of sensitive biological material
in the printing process is the preservation of the biological integrity of the components.
This requires the provision of mild printing conditions with regard to material, printing
environment and printing technique. Therefore, physical and chemical parameters like
printing temperature, occurring shear stress and toxicity have to be considered. Malda et al.
emphasized the adjustment of the printing parameters in the so called ’biofabrication
window’ to balance shape fidelity, stiffness and cell culture abilities [102].
The most applied techniques for bioprinting processes are deposition-based methods like
inkjet and extrusion printing. The inkjet bioprinting techniques are adopted from conven-
tional thermal or piezoelectric print heads. The printing material is forced through small
orifices and low volume droplets are generated and deposited. [103, 104] The extrusion-
based printing techniques were derived from paste extrusion instrumentation. Compressed
air or piston generated pressure pushes the printing material through dispensing tips of
varying geometrical dimensions [105]. An schematic representation of these techniques is
shown in figure 3.4.
Figure 3.4: Deposition-based bioprinting methods for the fabrication of three dimensional
structers of bioinks. Illustration adapted with permission. [102]
Commercially available bioprinter are most commonly equipped with several options
for cell bioprinting like special print heads and cell-friendly environments. Since the
variety of devices currently on the market is very small and these are in a very high price
segment, there is an urgent need for flexible and inexpensive entry-level devices [106]. The
beneficial application of these devices is seen in biotechnological research areas beyond
tissue engineering. The reduced costs and comprehensible operational sequences eases the
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access and lower the hurdle of device manipulation in comparison to costly commercial
devices. Furthermore, by the reduction or even renunciation of the implementation of
living cells in printing processes, entry-level bioprinting devices are a promising tool for an
easy first access to bioprinting in research and education.
The materials used in bioprinting processes are mostly referred to as bioinks. The base
component of bioinks are polymers or their precursors, some of which have already shown
their suitability in other biotechnological applications like for example enzyme encapsulation
or DNA and protein release studies [107–110]. Besides the basic material also biological
components and auxiliary materials for the optimization of the printing process and the
print results are added. For the incorporation of biological components in polymeric
networks a high content of water is preferable to maintain biological activity by mimicking
native environements. [102]
In the case of extrusion-based bioprinting, the use of hydrogels as printing material is
well established. Hydrogels are biocompatible polymers that show the ability to absorb
and retain large quantities of water within the network structures. Hydrogel networks
generate a mechanical supportive environement [102]. Hydrogels are therefore suitable for
providing mild conditions for encapsulated biological components whilst protecting them
from harmful surroundings. The polymers used for the fabrication of hydrogels are either
of natural or synthetic origin. The state of network stability is related to the cross-linking
strategy. This allows the generation of reversible or covalently bonded networks structures,
dependent on physical or chemical cross-linking.[110] Through the variation of bioink
components and cross-linking strategies, the characteristics of precursor solutions and
resulting polymeric networks are tuned [102, 107, 111]. Further porosity, swelling behavoir
and therfore diffusity of the hydrogels can be tuned [110]. Setting up the right combination
of printing device, bioink formulation and overall printing process is one of the major




The process development in the biotechnological and chemical sector often requires labor
intensive screening studies to optimize relevant parameters. Numerous independent experi-
ments are needed to determine the optimal conditions for the individual process. However,
the required manual work and time decreases the possible experimental throughput on a
working day. Therefore, suitable automation of such operations is worthwhile to achieve
in order to increase experimental throughput. Furthermore, the outcome of the methods,
particularly of sensitive assays, would benefit from a good repeatability and comparability.
To date, the automation of multiwell plate based assays can be readily accomplished by the
use of commercially available and widely used liquid handling stations. However, beyond
these well-established methods the degree of automation in biotechnological labs is still
low.
Within the scope of this doctoral thesis, the implementation of applications from the
interdisciplinary area of biotechnology into automated experimental workflows is investi-
gated. The focus hereby lies on the development of techniques and processes by integrating
the fields of microfluidics as well as 3D bioprinting to industrial relevant instrumentation.
The first goal, the automation of microfluidic experiments, should be achieved by adapt-
ing the concept of microfluidics on liquid handling stations (𝜇F-on-LHS). This 𝜇F-on-LHS
concept was developed in preliminary works to this thesis. The presented interface between
microfluidic channels and the tips of a liquid handling station combines the advantages
of both systems for flow through investigations in an automated experimental workflows.
In order to demonstrate the broad applicability of this concept, examples from the field
of material synthesis, microbiology and analysis in bioprocess development are to be
investigated.
For various approaches in the biological or biochemical area biocompatible polymer
networks are applied. The polymers provide functional surfaces or serve as encapsulation
material for biological components. The size of the polymer structures range from mono-
liths in the range of few centimeters to particles in the nanometer range. One applied
method for the generation of polymer nanoparticles is the photoinitiated polymerization
of miniemulsions. The outcome of a polymerization process depends on the influence of
several cause variables. The knowledge of the effects of these variables is essential for
the production of tailor-made particles. A strategy for the systematical investigation of
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these interdependencies is highly desirable. For the execution of the variables screening
an automated process management and low sample consumption is beneficial. To enable
reliable experimental workflows and the gaining of a large information quantity from one
single batch of miniemulsion the concept of 𝜇F-on-LHS is to be applied.
The study of complex multi-species biofilms is of interest not only in terms of caused
issues in everyday life but also in terms of the potential benefits that may arise from their
targeted integration in bioprocesses. For the deeper understanding of the interactions
and processes taking place in biofilms, the identification of the species involved is a key
factor. For this task, fluorescence in situ hybridization (FISH) is the method of choice
in microbiological research. The FISH-procedure as well as the subsequent microscopic
imaging are time- and work-consuming. The automation of this workflow is a worthwhile
development towards better comparability of individual experiments with the additional
benefit of less manual effort. The adaption of cultivation flowcells to the 𝜇F-on-LHS
interface is to perform to enable automated experimentation. Besides the automation
of the diverse protocol steps also the quantitative fluorescence analysis of the processed
flowcells in the integrated plate reader is to be investigated.
UV/Vis spectroscopy in plate readers plays a central role in bioprocess development.
Here, the key factors of process control are the yield of the target molecule and the concen-
tration of potential contaminants. The assessment of the performance of respective process
steps is dependent on the quality of the analysis. The method of choice for qualification
and quantification of theses performance indicators is the spectrophotometric absorption
measurement. The raising challenge for the employed device is the wide concentration
range to be covered. Increasing titers in purification processes exceed the detection limits
of conventional photometers. The available devices capable of this concentration range
are either not high throughput compatible or need extra space for the implementation
in automated workflows. Therefore, a tool is supposed to be developed which allows the
absorption measurements of samples with reduced volumes and increased concentration
range compared to microplate based measurements. Ideally, this tool is suitable for manual
use as well as fully integratable in automated workflows with standard LHS equipment.
Besides the investigation of beneficial applications of the 𝜇F-on-LHS in biotechnological
context it is the aim of this work to investigate the integration of bioprinting techniques in
automated screening procedures. Bioprinting is of increasing interest in the field of tissue
engineering and regenerative medicine. However, the available bioprinter are cost intensive
and complex which reduces the acceptance and their integration in other biotechnological
areas. Beyond tissue engineering, 3D bioprinting offers the potential of enabling completely
new approaches for biotechnology. By the systematical use of "nature’s toolbox", novel
application possibilities may be established beyond natural systems. The addressed topics
are the integration of biocatalysts for artificial reaction cascades and the investigation of
interactions between printed hydrogels and their liquid surrounding. Therefore, to access
the possibilities of printable biology for the next generation of biotechnology new approaches
have to be explored to adapt and modify conventional 3D printers for bioprinting. These
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approaches shall enable entry-level access in bioprinting research. Furthermore strategies
to integrate 3D-printed structures in automated screening studies in order to optimize
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Abstract
Nowadays the performance of experiments in automated microliter scale
format are common practice in the biopharmaceutical process develop-
ment. The increased number of experiments, reduced sample volumes
and usage of robotic platforms require the adjustment of photometric
measurements to determine the protein concentration. This work presents
the qualification and usage of a disposable measurement device which
can be used with conventional microplate photometers. The application
of the microfluidic device (𝜇F-device) allows absorption measurements of
protein concentrations from around 0.1 to 100 mg/mL with an accuracy
of 99.2 % dependent on given protein extinction coefficients. The inte-
grated four measurement chambers of increasing height (100 – 1500 𝜇m)
allow the direct calculation of calibration curves and the determination
of protein concentrations independent of used optical path lengths with
a sample volume of 36 𝜇L. This study contains the validation of the
analytical 𝜇F-device according to ICH Guidelines as well as a representa-
tive case study. A salt gradient screening with chromatography columns
in microliter scale performed on a liquid-handling station presents the
usability of the 𝜇F-device. It is shown that an improvement of the
repeatability and accuracy of the chromatograms could be achieved by
𝜇F-device implementation in comparison to photometric measurements
performed in microtiter plates.
Keywords: absorption measurement; high protein concentration; high-throughput experi-
mentation; microfluidic
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Introduction
The market of biopharmaceuticals is steadily growing especially the commercialization
of monoclonal antibody drug substances [112]. This trend requires the development
of new process steps as well as the optimization of established ones. The purification
development of the complex molecules is regarded as the most cost and time intensive
step due to high investment and material costs [113]. To face these disadvantages the
downstream development focusses on statistically based design of experiments [114] as well
as automated sample handling and analysis [23] at an early phase. At this early phase of
product development only a low amount of target molecules are available. To gain the
highest amount of information out of the given low sample volume the execution of high
throughput screening procedures in microliter scale is the method of choice [24, 115]. Many
process steps are already established in an automated microscale format, like microliter
scale chromatography [36] or precipitation screenings [116]. Unfortunately they are not
used to their full potential due to limited integrated analytical methods. Implemented
analytical methods are often time consuming, do need high sample volumes and are not
specialized to the extended determination range tested in the high throughput format.
One of the most important parameters to be tested is the product yield and the impurity
concentration. The method of choice to determine these parameters are photometric
measurements. Dependent on the tested process step, the concentrations to be determined
vary from around 0.01 mg/mL to more than 100 mg/mL. Thus, the analytical method
has to cover a wide concentration range. Since conventional photometric methods do not
cover this range the samples have to be diluted. The dilution of the samples increase the
inaccuracy of the measurement and requires a rough knowledge of the initial concentration
of the molecule to be measured. Aggravating this situation in some cases, not only one
specific type of molecule has to be quantified but also samples with different types of
molecules, with varying extinction coefficients and concentrations. One example is the
determination of target molecule and impurity concentrations of fractions collected from
chromatography runs. The selection of the optimal dilution requires previous knowledge of
expected protein content to avoid measurement inaccuracy for one type of the molecules
to be determined. Every photometric detector has a specific absorption limit depending on
given device properties. Based on the Lambert Beer Law (equation 5.1), the absorption A
and therefore the maximum measureable protein concentration c is linearly dependent on
the extinction coefficient 𝜀𝜆 and the path length d of the measurement cell.
𝐴 = 𝑐 * 𝜀𝜆 * 𝑑 (5.1)
The extinction coefficient 𝜀𝜆 is dependent on the amino acids on the protein surface which
absorb light at the set wave length and therefore specific for every protein. The parameter
which can be manipulated by the developers is the path length d. The linear relation of d
to A led to the implementation of novel instruments with lower or flexible path lengths.
One example therefore is the Nanodrop spectrophotometer series from Thermo Scientific
(Waltham, USA) [117]. With these tools one to eight sample drops with a volume of 2 𝜇L
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are contained by surface tension between two planar surfaces. The instruments can generate
path lengths between 1 and 0.05 mm. The low sample consumption, easy usage and the
relatively high protein concentration which can be measured directly, explain the sales
volume of these instruments. The Solo VPE from C. Technologies Inc. (Bridgewater, USA)
is able to change the optical path length from 0.01 mm to 15 mm via a movable optical
fiber (FibretteTM). From the variable path length data the slope m can be calculated
(𝑚 = 𝛥𝐴/𝛥𝑑). With m and known 𝜀𝜆 the protein concentration can be determined. Due to
many measurement points over a wide path length range the tool is very precise and covers
a huge protein concentration range [118]. Disadvantages of described tools are the manual
operation and the limited number of samples which can be measured simultaneously (one
sample (Nanodrop 2000c and Solo VPE) to eight samples (Nanodrop 8000). Thus they are
hardly automatable nor high throughput compatible. An instrument which meets the high
throughput needs of the biopharmaceutical process development is the DropSenseTM 96
UV/VIS droplet reader from Trinean (Gentbrugge, Belgium). This instrument also has a
very small sample consumption of 2 𝜇L and is equipped with 96-well robotic compatible
measurement units. Here the protein absorption is measured in two chambers of differing
heights. This two point measurement does not allow the application of the slope technique
implemented with the SoloVPE. The microfluidic device (𝜇F-device) presented in the
current study is an approach to combine the advantages of the instruments described above.
The 𝜇F-device and its channel structures are constructed according to the microplate
format. The specific design of the channel structures, each with four measurement chambers
of different height, allow the application of the slope method for an increased measurement
accuracy and a direct four-point calibration of every measured sample. Especially to be
emphasized is the accurate measurement in a wide protein concentration range enabled by
the provided path lengths. Furthermore, microplate photometers already implemented in
the lab can be used so that no investment in a new instrument has to be done.
Materials and Methods
Design and manufacturing of the 𝜇F-device
Materials The two component curing silicone Elastosil®RT 601 (Wacker Chemie, Burg-
hausen, Germany), a polydimethysiloxane (PDMS), was used for manufacturing the 𝜇F-
device. The replication master for the 𝜇F-device was designed in-house and manufactured
by Proform AG (Marly, Switzerland). This master served as inverted structure in the
molding cavity and therefore defined the channels of the molded 𝜇F-device. The master
was designed according to the microwell plate standard. A total of 96 channel structures
are evenly distributed on the master. The inlets of the channel structures are vertical
cylinders which are aligned such as wells of a 96-well plate (see figure 5.1).
Connected to the inlet, a circular channel with four oval chambers and a vertical outlet
on the end was designed. The four chambers have different heights (100, 600, 1000 and
1500 𝜇m) and are arranged in the pattern of the wells of a 384-well plate. This allows a
simple read out of the chambers in the microplate photometer. To improve the stability
and the automated handling of the 𝜇F-device on the liquid handling station (LHS), the
silicone 𝜇F-device was placed inside a specially designed, 3D printed cartridge (Sculpteo,
Villejuif, France). This cartridge allowed the handling by the robotic manipulator arm
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(A) (C)
(D)(B)
Figure 5.1: (A) CAD model of the replication master for the manufacturing of the 𝜇F-device.
(B) Magnified channel structure with the four measuring chambers of varying channel height
(100, 600, 1000, and 1500 𝜇m) (C) Photograph of the assembled device on the deck of the liquid
handling station. The LHS-tips dispense the samples directly into the channel structures eight
at a time. (D) Visualization of the absorption data gained in the four measuring chambers of
one channel structure to illustrate the absorption gradient due to the differing channel heights.
of the LHS. The measurement in the microplate photometer was possible through 384
perforations which were arranged evenly according to the microplate standard.
Methods The molding process of the 𝜇F-device was executed as described by Wald-
baur et al. [79]. Only the spacer part of the molding tool was replaced. To obtain a clear
and plain surface, a flat piece of polished stainless steel was employed instead.
Qualification of the 𝜇F-device
Materials Lysozyme from Chicken egg white was purchased in solid form from Hampton
Research (Aliso Viejo, USA). Acetic acid and sodium acetate for buffer preparation were
purchased from Merck KGaA (Darmstadt, Germany). Ultrapure water (ISO 3696) was
used to prepare all solutions. Protein solutions for 𝜇F-device qualification were prepared
in 20 mM acetate buffer at pH 5 with a nominal mass concentration of 50 mg/mL.
A buffer exchange of the protein solution with Sephadex media from GE Healthcare
(Buckinghamshire, Great Britain) was performed to remove buffer salts or other components
present in the purchased protein preparations. The size exclusion chromatography (SEC)
column was manually packed with a diameter of 2.5 cm and a bed height of 23 cm. The
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fractions were concentrated to a protein concentration of 100 mg/mL with the help of
20 mL Vivaspin ultra filtration spin columns (Sartorius, Goettingen, Germany) with a
molecular weight cut off of 3000 Da. For liquid handling a Tecan Freedom Evo 200 (Tecan,
Crailsheim, Germany) LHS equipped with 1 mL syringes was used. The LHS was equipped
with an Infinite® M200 pro plate reader (Tecan, Crailsheim, Germany) and controlled
by Magellan 7.1, both provided by Tecan. The LHS was controlled by Evoware 2.5 also
provided by Tecan. To compare the absorption results of the 𝜇F-device with an established
method, measurements of protein absorption at 280 nm in the Nanodrop 2000 (Thermo
Scientific, Waltham, USA) were performed.
Methods The buffer exchange of the lysozyme solution was conducted at an ÄktaPrime
plus system from GE Healthcare. A total of 5 mL of lysozyme solution with a concentration
of 50 mg/mL was purified. The protein was fractionated in 10 mL Falcon tubes and the
concentration measured with an extinction coefficient of 22 L/(g*cm) with the Nanodrop
2000. The concentration of the dilute protein concentration was performed with Vivaspins
and a rotational speed of 8000 rad/sec. A protein dilution series from 100 mg/mL to 0.1
mg/mL with acetate buffer was prepared. The 𝜇F-device was automatically handled and
filled on the robotic platform. The absorption at 280 nm of protein solutions and buffer
blanks were measured in the 𝜇F-device in quadruplicate. For the calculation of protein




With the absorption A, the concentration c [mg/mL], the extinction coefficient
𝜀𝜆 [mL/mg*cm] and the path length d [cm]. Additionally the slope m, which results of the
absorptions plotted against the four given path lengths was determined. With this slope





The evaluation of gained results and consequently the validation of the 𝜇F-device followed
the International Conference on Harmonisation (ICH) harmonized tripartite guideline
Q2(R1) (Validation of analytical procedures: text and methodology) [119]. Following these
guidelines the accuracy, repeatability and measuring range of absorption results gained with
the developed analytical 𝜇F-device were studied. To prove the precision of the analytical
device lysozyme solution with a concentration of 5 mg/mL was prepared and measured in
four measurement units of the 𝜇F-device. The deviation of the absorption measurements
were calculated. To determine the absorption range of the 𝜇F-device, lysozyme solutions in
a concentration range of 0.1 and 100 mg/mL were prepared and measured in quadruplicate.
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Case Study
Materials For the chromatography runs the buffer described in section 2.1 was used
(Buffer A). By adding 1.25 M sodium chloride (NaCl) (Merck, Darmstadt, Germany) to
Buffer A the high salt buffer (Buffer B) was prepared. Purified monoclonal antibody (mAb)
solution was provided by Synthon (Nijmegen, Netherlands). Cytochrome C (CytC) was
purchased as lyophilized powder from Sigma-Aldrich (St. Louis, USA). The mAb stock
solution was buffer exchanged and concentrated to 65 mg/mL by 20 mL Vivaspins with a
molecular weight cut off of 50000 Da. For fraction collection, fraction volume determination
and UV absorption measurements, half area UV-MTPs were used. For the preparation of
high salt buffers and the dilution of elution fractions two 96 deep well square plates (DWP)
(VWR, Germany) with a volumetric capacity of 2 mL were used. RoboColumns® prepacked
with 200 𝜇L SP Sepharose FF were purchased from Atoll GmbH (Weingarten, Germany).
Column chromatography in high throughput experimental mode using RoboColumns® was
performed on a Tecan Freedom Evo 200 LHS, additionally equipped with a Te-Chrom
column carrier.
Methods To prepare the elution buffers, two different troughs with Buffer A and Buffer B
were assigned to the robotic platform. These components were mixed automatically in a
DWP to achieve four salt gradients with respectively 10 salt steps resulting in different
end concentrations. The gained end salt concentrations were 1.25 M, 1 M, 0.75 M and
0.5 M NaCl. CytC was dissolved in acetate buffer and transferred to the mAb solution
to reach a starting protein concentration of 60 mg/mL mAb and 3 mg/mL CytC. This
solution was transferred to eight Eppendorf Tubes (Eppendorf, Hamburg, Germany) and
also placed in designated carriers on the robotic platform. A detailed description of
parallelized chromatography performed automated on an LHS has been published by
Wiendahl et al. [37]. In this case study an exemplary salt gradient screening was performed.
Therefore, four gradients of varying slopes were tested to separate mAb molecules from
CytC via cation-exchange chromatography (CEX). The salt gradients had a length of ten
column volumes respectively 2 mL with different end salt concentrations which resulted in
four different salt gradient slopes. For every tested salt gradient twenty elution fractions
with a set volume of 100 𝜇L were collected in half area UV-MTP. After measuring the
absorption at 900 and 990 nm to gain information of the precise fraction volumes following
the method published by McGown et al. [120] and Lampinen et al. [121], 38 𝜇L of the
samples were transferred to the presented analytical 𝜇F-device. A volume of 20 𝜇L of the
samples for the 1:50 dilution and 33 𝜇L for the 1:15 dilution were transferred to DWPs. To
reach the respective dilution low salt buffer was added to every sample (980 𝜇L respectively
467 𝜇L), mixed and transferred to a full area UV-MTP. Afterwards the absorption at
280 nm and 410 nm was measured of undiluted samples transferred to the 𝜇F-device and
diluted samples transferred to the UV-MTPs. Every cation-exchange run was executed
and analyzed in duplicate.
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Results
Qualification of the 𝜇F-device
According to the ICH Q2 guidelines the 𝜇F-device has been tested in regard to accuracy,
precision (repeatability), linearity and range. For the qualification a lysozyme solution
series from 0.1 – 100 mg/mL was prepared. After the preparation the theoretical lysozyme
concentration was verified by fourfold absorption measurements with the Nanodrop 2000.
The determined concentration values can be found in figure 5.2.
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100 75 50 25 10 5 2.5 1 0.5 0.1 
c-nanodrop 
[mg/ml] 
98.5 77.5 53 24.5 9.8 4.9 2.4 0.9 0.49 0.1 
STD [%] 0.75 1.24 2.78 0.55 1.67 0.78 3.26 2.11 4.11 7.89
c-chip  
[mg/mL] 
98.29 78.15 53.15 24.2 9.73 4.79 2.38 0.89 0.485 0.1 
STD [%] 0.22 1.64 6.15 4.32 0.87 4.88 4.29 1.45 2.98 3.2 
(c)
Figure 5.2: (a) Lysozyme absorption values measured in the 𝜇F-device plotted against the
channel height. Exemplarily determination of the slope m of the regression line. The reference
concentration of this sample measured in Nanodrop 2000 was 4.9 mg/mL. (b) Calculated
lysozyme concentrations based on 𝜇F-device absorption data plotted against set concentration
values with corresponding standard deviations. (c) Tabular listing of theoretical lysozyme
concentrations, concentrations based on Nanodrop measurements and concentrations based on
𝜇F-device measurements with corresponding standard deviations.
For qualification the absorption of every sample was determined in four channel structures.
Additionally a buffer blank was measured and subtracted from the protein absorption
values. The absorption values were plotted against the height of the four measuring
chambers synonymous to the optical path length. The resulting values and the zero value
were fitted with a linear regression. Values deviating from the regression line by more
than 3 % were excluded from the regression of the second fit calculation. Thereupon, the
slope m of the optimized regression was calculated for every measured sample. With m
and 𝜀280 (equation 5.3) the concentration could be calculated. In figure 5.2a the described
method is exemplarily shown for a protein sample containing 4.9 mg/mL lysozyme. For
23
5.1 Implementation of a Microfluidic Device for the quatification of protein concentrations
this measurement the slope m with a value of 10.71 1/cm was calculated which resulted
in a protein concentration of 4.87 mg/ml (see equation 5.3). For measurements in the
areas of the upper and lower detection limits the concentration can directly be calculated
with the application of the Lambert-Beer law (equation 5.2). Here only the highest or
lowest channel height was suitable for the exact absorption measurement. For the used
photometer the range of detection was between 0.001 and 2.3 OD. Calculated lysozyme
concentrations can be found in the tabular listing in figure 5.2c. For the visualization of
the gained results, the lysozyme concentrations and related standard deviations determined
with the 𝜇F-device are plotted against set concentration values determined by Nanodrop
measurements in figure 5.2b.
Case Study
The presented analytical 𝜇F-device enables direct protein absorption measurements in a
wide concentration range implementable on a liquid handling station. In order to demon-
strate the applicability of the 𝜇F-device it was implemented in a HTE (high throughput
experimentation) process development step. For this, HTE chromatography was performed
with a binary protein solution containing mAb with a starting concentration of 65 mg/mL
and CytC with a starting concentration of 3 mg/mL. The actual aim of the chromatogra-
phy screening was to find the optimal salt gradient to separate these two proteins. For
this, four gradients of varying slope and end salt concentration were tested in duplicate.
Important for the selection of the best suited gradient was the proper determination of
protein concentration in the collected elution fractions. The elution fractions were analyzed
directly in the channel structures of the 𝜇F-device respectively in four chambers of differing
heights and after dilution of the fractions in MTPs for comparison. The absorption values
of every single fraction are displayed as round symbols in figure 5.3 and figure 5.4. The
absorption values of the mAb and CytC molecules were separated with the help of the
also measured absorption at 410 nm wavelength. At this wavelength CytC has a second
absorption maximum whereas mAb does not absorb light. With the known absorption
ratio of 280 nm and 410 nm of CytC (0.24, data not shown) the detected 280 nm sum
signal could be divided in mAb and CytC specific absorption. The absorption values of
the 20 elution fractions formed the basis of a nonlinear Gaussian fit for the preparation of
chromatograms describing the elution of the molecules. In figure 5.3 the absorption values
at 280 nm from mAb and CytC are plotted against the elution volume.
The fitted chromatogram represents the run with the steepest salt gradient with absorp-
tion values measured in the measuring chambers from 100 𝜇m to 1500 𝜇m path length
in the 𝜇F-device. With decreasing channel height the absorption values decreased. The
mAb represented by the blue symbols eluted first over an elution volume of 1000 𝜇L. CytC,
represented by the red symbols, starts to elute at around 650 𝜇L and over an elution
volume of 850 𝜇L. No baseline separation could be achieved. Independent on the chamber
height the curve progression was similar. Only the absorption signals of CytC measured
with a path length of 100 𝜇m did not show a significant absorption peak. Depending on
the salt gradient slope the chromatograms showed varying resolutions. The plot set in
figure 5.4 a-d illustrates the influence of the varying salt gradients on the resolution of the
chromatographic runs.
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volume [µl]





















































Figure 5.3: Elution profiles of mAb and CytC with a gradient from 0–1.25 mM NaCl in 10
CV. Plotted are absorption values at 280 nm measured in the µF-device in the four respective
measuring chambers with a height of 100, 600, 1000 and 1500 𝜇m. Absorption values of mAb
are plotted as blue circles, absorption values of CytC are plotted as red circles. The absorption
values were fitted with a nonlinear Gaussian fit (blue and red lines).
The graphs contain the absorption values measured in the channels at a path length
of 1000 𝜇m and absorption values measured in a UV MTP. For the measurement in the
MTP the fractions had to be diluted. Depending on the expected protein content the
samples were diluted in a ratio of 1:50 (fraction 1-12) respectively in a ratio of 1:15 (fraction
13-20). The shown absorption values of the MTP are standardized to a dilution of 1:50.
With decreasing slope of the salt gradient the detected elution peaks of both protein
types widened. Additionally the elution points were shifted to higher volumes and the
resolution of the separation declined. In figure 5.4d the run with the lowest gradient is
depicted. Here the elution peak of the mAb overlays the CytC elution peak. The absolute
absorption values of the MTP were lower in the order of magnitude of around 75 % in
comparison to absorption values measured in the 1000 𝜇m chamber of the 𝜇F-device.
With decreasing slope of the salt gradient the chosen nonlinear Gaussian fit did get less
precise independent on measurement device. In figure 5.4a fraction 4, 9 and 13 (F4, F9
and F13) are highlighted in yellow. For these fractions the approach to calculate protein
concentrations from 𝜇F-device absorption data is shown for both proteins (figures 5.5a and
5.5b) and compared to the calculated protein concentrations based on MTP absorption
data (figure 5.5a).
In figure 5.5a and 5.5b the mAb respectively CytC absorption values of F4, F9 and
F13 are plotted against the path lengths of the measuring chambers of the 𝜇F-device.
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Figure 5.4: Chromatograms of the four screened elution gradients of mAb and CytC
absorption values. Illustrated are absorption values with related standard deviations measured
in the 𝜇F-device in a measuring chamber height of 1000 µm and absorption values measured in
MTP after dilution. (a) Gradient from 0 – 1.25 mM NaCl in 10 CV, highlighted are fraction 4,
9 and 13 which have been further investigated; (b) gradient from 0 – 1 mM NaCl in 10 CV; (c)
gradient from 0 – 0.75 mM NaCl in 10 CV; (d) gradient from 0 – 0.5 mM NaCl in 10 CV.
The regression lines were calculated based on at least 3 measured values of one channel
structure in duplicate. Measurement values which deviated from this regression by more
than 3 % were not included in the calculation of the slope m. The mAb absorption value
for F4 determined with a path length of 1500 𝜇m was eliminated from further calculations
due to this deviation as well as the CytC absorption value of F9 which was determined
with a chamber height of 1500 𝜇m and F13 which was determined with a chamber height
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Figure 5.5: Absorption values with related standard deviations of fraction 4, 9 and 13
from mAb (a) and CytC (b) measured in the 𝜇F-device plotted against channel height with
regression lines and related slope values m. The grey area depicts the allowed deviation of 3 %.
(c, d) Protein concentrations with related standard deviations of F4, F9 and F13 calculated
based on 𝜇F-device absorption values (dark colored) and based on MTP absorption values
(light colored). The concentrations based on absorption values measured in the 𝜇F-device were
calculated with the slope method (equation 5.3).
of 100 𝜇m. This exclusion criteria is illustrated by the grey area in figures 5.5a and 5.5b.
The calculated regression coefficients (R2) for shown data all had a value above 0.996. The
corresponding protein concentrations were determined following equation 5.3. The protein
concentrations of similar fractions were also determined based on absorption measurements
conducted in MTPs. The so calculated mAb and CytC concentrations are compared to
𝜇F-device results in figure 5.5c. To display the wide protein concentration range of chosen
fractions in one plot, a logarithmic scale was selected. The highest mAb concentration
could be found in F4 with a value of 140 mg/mL based on data of the 𝜇F-device and
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a standard deviation of 0.04 % and 210 mg/mL based on MTP data with a standard
deviation of 30.1 %. In F9 both molecules were present at a comparable concentration. In
F13 the lowest mAb concentration was detected with in a value of 0.02 – 0.03 mg/mL. All
calculated protein concentrations with associated standard deviations can be found in a
tabular listing in figure 5.5d.
Discussion
Qualification of the 𝜇F-device
In this section the validation of the presented analytical tool according to accuracy,
repeatability, linearity and range as prescribed by the ICH guideline Q2 (R1) is discussed.
The comparison between measured protein concentrations determined with the µF-device
and the reference concentration values determined with the Nanodrop 2000 (see figure
5.2) illustrates an excellent consistency. In accordance to ICH guidelines this complies the
validation criterion of accuracy. The determined accuracy was 99.02 % in a concentration
range of 0.5 – 10 mg/mL (equation 5.3) and 99.92 % in a range of 0.1 – 0.5 mg/mL and
10 – 100 mg/mL Lysozyme. The obtained measurement deviations can be explained by
the manual manufacturing of the 𝜇F-device and the used silicone material with relatively
low stiffness. With known protein concentration the applied slope method and so fitted
calibration curve can be used to calculate the extinction coefficient with only one protein
sample respectively one starting concentration. Nonetheless, with the fourfold measurement
of ten different lysozyme concentrations an excellent repeatability could be determined
expressed by an average standard deviation of 3.1 %. The linearity of gained results
could be shown both for plotting the absorption values over path length (𝑅2 = 0.988) and
plotting calculated concentration over reference concentration values (𝑅2 = 0.9998) (see
figure 5.2).
Case Study
The aim of the executed case study was to separate the mAb molecules with a relatively
high starting concentration of 65 mg/mL from CytC molecules with a starting concentration
of 3 mg/mL. To find an optimal separation with CEX a screening of four salt gradients
differing in slope and end salt concentration were performed in microliter scale on a LHS.
As assumed the mAb molecules with an isoelectric point (pI) of 7.9 eluted prior to CytC
molecules with a pI of 10.4 for all performed runs with the exception of the run presented in
figure 5.4d (this phenomenon will be discussed within the next paragraph). The explanation
for this elution order can be found in the stronger electrostatic interaction of CytC with
negatively charged ligands in comparison with weaker adsorption of mAb molecules on
the resin. Thus, a higher salt concentration is necessary to desorb the CytC molecules
from the resin what implies a later elution. With decreasing gradient slope the peaks were
shifted to later elution volumes. In figure 5.4d it seems that CytC is eluting with the mAb
molecules but taking the mass balance of CytC molecules into account, it can be expected
that the main peak of CytC elutes outside the set fraction range. The elution of CytC at
comparatively low salt concentrations are potentially caused by a specific interaction with
the mAb and thus a co-elution of CytC molecules. The best chromatographic resolution
could be found with the steepest gradient and an end salt concentration of 1.25 mM NaCl.
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To further optimize the run with the aim of a baseline separation, a step elution with
a step height of 0.4 mM NaCl hold for 5 CV for mAb elution and a second step with
1.25 mM NaCl hold for 4 CV to elute CytC from the column is recommended, based
on the results of the gradient screening. In the next paragraph the absorption values of
𝜇F-device measurements will be discussed and compared to MTP absorption measurements.
Fractions analyzed with the analytical device have a mean standard deviation of 3.5 %
compared to MTP measurements with a mean standard deviation of 8.2 % (see figure 5.3
and 5.4). The higher accuracy of absorption measurements executed with the 𝜇F-device
can be explained by direct analysis of all fractioned samples without the need of dilution.
In figure 5.3 the absorption measurements of every measuring chamber is plotted. The
decrease of absorption values with decreasing path length respectively height of measuring
chamber is in good agreement with the Lambert Beer law (equation 5.1). The selected
nonlinear Gaussian fit represents the absorption values very precise. This not only implies
that the absorption values can be fitted with a characteristic chromatographic elution curve
but also that the absorption values actually represents the eluting protein amount. The
CytC peak cannot be depicted well by the fit of results of the 100 𝜇m measuring chamber.
Here, the measured absorption values of CytC are close to the buffer blank absorption
what may explain the weak fit results. In figure 5.4 the influence of the salt gradient on
the elution profile measured in the 𝜇F-device and in the MTP is shown. The absolute
absorption values of the MTP and the 𝜇F-device varied due to divergent path length and
the dilution of the fractions for MTP measurements. In principal the curve progressions of
chromatograms obtained by absorption results of the 𝜇F-device and MTP are comparable
as well as elution starting points, absorption maxima and elution end points. Deviations
traceable to the measurement system are obtained with CytC peaks and were especially
significant at the flattest tested gradient (see figure 5.4d). One explanation may be the
chosen dilution rate of 1:50 for the fractions F1-F12. Due to the low amount of CytC in
these fractions the error caused by dilution had a higher impact. Contributing to this
assumption the comparability of CytC peaks was better for a flatter gradient depicted in
figure 5.4c. Here, CytC molecules elute where the fractions have been diluted in a ratio
of 1:15 what gives a better precision of the results. In all displayed graphs the measured
absorption values oscillate around the fit curve for measurements executed in 𝜇F-device
and MTP. The oscillatory movement is periodical and due to the practical implementation
of the chromatographic run on the LHS. The dispensing of the buffers is not continuous
as in common chromatographic runs but subsequently. This potentially cause a longer
holding time of the proteins on the column. This phenomenon had an increased impact
on fit results with decreasing salt gradient slope. To increase fit accuracy the step size as
well as the fraction size should be decreased. To depict the dependencies of specific path
length of the measuring chambers on the absorption values the linear relation is shown
in figure 5.5a and 5.5b for three exemplarily chosen fractions (F4, F9, and F13). The
regression coefficient of 0.996 proves the linearity of the adsorption values gained with
different chamber heights. The mAb absorption value of F4 measured in the chamber
with a height of 1500 𝜇m was excluded from further calculations due to the exceedance
of the determined absorption limit of 2.3 OD. The same reasoning applies to the CytC
absorption value of F13 measured in a chamber of 100 𝜇m height. At this point the
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quantification limit was reached. This explanation does not hold true for the deviation
of the CytC absorption value of F9 measured in the 1500 𝜇m chamber height. Here
the deviation is potentially due to a measurement error in the channel structure caused
by small air bubbles. With the help of the slope of the discussed regression lines the
concentrations of mAb and CytC in the respective fractions could be calculated. These
calculated concentrations were compared to the concentrations determined with MTP
absorption values and are displayed in figure 5.5c. The calculated values represent the
expected concentrations of mAb and CytC when taking the related chromatograms of
figure 5.4a into account. In direct comparison, deviations between MTP and 𝜇F-device
results of more than 60 % were detected for both protein species. One explanation of
these high discrepancies can be found in the extent of calculated standard deviations. The
standard deviations of determined mean protein concentrations measured in the microfluidic
channels had a maximum value of 0.06 mg/mL. The comparatively low standard deviations
of these measurements prove the reliability of the developed 𝜇F-device. In contrast, the
standard deviations of protein concentrations determined with MTP were between 1.08 and
64.71 mg/mL (20 – >100 %). These standard deviations were so high that the standard
deviation error also covered concentrations calculated with 𝜇F-device absorption results.
The high standard deviations of the concentrations calculated based on MTP results
could be explained with dilution errors, additional required liquid handling steps and the
potential formation of a meniscus in the wells of the MTP. The angle of this meniscus is
highly dependent on protein concentration and buffer compositions. The consideration of
this phenomenon is complex especially when measuring varying concentrations at varying
liquid levels during one screening, such as occurred in this case study. The deviations
potentially caused by meniscus can be excluded by application of the 𝜇F-device due to
the completely filled channel structures. Including the discussed standard deviations the
calculated concentrations based on 𝜇F-device and MTP results are comparable and support
the statement that the presented 𝜇F-device is applicable for absorption measurements.
In the discussed case study the target molecule (mAb) and the impurity (CytC) could
be quantified due to the second absorption maximum of Cytochrome C at 410 nm. To
distinguish between target molecule and impurities having similar absorption characteristics
the spectral method published by Hansen et al. [38, 122] may be transferred to the presented
𝜇F-device. This possible application will be part of future investigations.
Concluding Remarks
The presented analytical 𝜇F-device could be validated according to ICH guidelines. In
the course of this validation the accuracy, repeatability and linearity was proven for
a concentration range from 0.1 – 100 mg/mL, with lysozyme as model protein. This
qualification permits the application of the 𝜇F- device for protein absorption measurements
in the biopharmaceutical process development. The case study demonstrated a successful
application of the µF-device on a liquid handling station. The analytical 𝜇F-device
was simple to implement in an existing automated development step. Furthermore,
the absorption of elution fractions measured with the presented µF-device resulted in
comprehensible characteristic elution profiles. Consequently, the 𝜇F-device presented in
this study is a promising alternative or supplement to existing devices combining a wide
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measurement range with high throughput compatibility.
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Abstract
Photoinitiated polymerization is usually applied in the area of specialty
chemicals and UV curing but can also be employed in the production
of biofunctional polymers and nanocapsules. A promising approach for
the preparation of those polymers is the photoinitiated polymerization
of miniemulsions. Here, the mild reaction conditions are beneficial for
the integration of sensitive biomaterials into the process. The optimal
combination of different varied cause variables like irradiance, irradiation
time, and height of the irradiated volume is crucial for an appropriate
polymerization result. For the presented proof of concept study, a
microfluidic tool was established to screen these cause variables in an
automated high throughput manner on a liquid handling station (LHS).
The experiments are planned and executed by means of a design of
experiments (DoE) approach to investigate the effect of the variables on
the residual monomer content (RMC) within the stated design space.
As the RMC is considered as crucial for bioapplications, the optimal
parameter combinations for the complete monomer conversion have been
determined. The model-based evaluation of the executed experiments
resulted a channel height respectively optical path of 200–400 𝜇m, an
irradiance of 65% (equals 44.2 mW/cm2) and an irradiation time of 30 s
for complete styrene conversion.
Keywords: DoE; liquid-handling station; microfluidics; miniemulsion; photopolymeriza-
tion
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Introduction
The employment of polymer networks for applications in the biological, biomedical, or
biochemical field is common standard [123]. Most of these biomaterial-based networks can
be prepared by photoinitiated polymerization [124]. The huge potential of the photopoly-
merization of bio compatible materials is exploited for a broad range of applications, for
instance tissue engineering [125, 126], dental applications [127], drug delivery [107, 108],
cell encapsulation [128, 129], biomimetic coatings [130], and nano-patterned surfaces [131].
The selected biomaterials can be directly implemented into polymer networks, e.g.
by stereolithographic methods to build functional 3D structures as reported by Ar-
caute et al. [132]. Biofunctionalized polymers can also be achieved by subsequent modi-
fication. Pierre et al. presented a method to immobilize enzymes on photopolymerized
monoliths [133]. In addition, the employment of click-chemistry was shown to be an efficient
method to generate biofunctional polymers [134].
Applying these methods the integrity of the bioactive materials has to be preserved
throughout the whole process. Therefore, the photoinitiated polymerization provides a
good technology for the generation of polymer networks under mild reaction conditions.
Photopolymerization can be executed at room temperature that is preferable for biological
material. One of the main advantages of the photopolymerization is the spatial and
temporal control of the reaction by turning on the light for defined time spans and at
specified locations to produce radicals at this particular spot [135]. Also the irradiation
condition of the reaction system can be varied by employing different monochromatic light
sources that allows specific excitation of the dedicated photoinitiator and optimization of
the initiation rate, respectively [136].
To produce nanoparticles for coatings or for the encapsulation of drugs and biomaterials,
the (photo-) polymerization of miniemulsions is the method of choice [137]. Miniemulsions
consist of small, homogeneous, and stable monomer droplets that behave as autonomous
reaction compartments [138]. The photopolymerization of miniemulsions takes place in an
aqueous environment, avoiding the use of organic solvents, which is another benefit for the
processing of biomaterials.
Due to the opaque appearance of those miniemulsions, the limiting parameter of the
photopolymerization process is the limited penetration depth of the photons into the
reaction volume. Light attenuation (extinction) in heterogeneous systems arises not only
from absorption of photons but also from scattering effects. Monomer miniemulsions
are highly scattering media, the optical properties are known to be strongly dependent
on the droplet size and the chemical nature of the oil phase [139]. In case of diluted
miniemulsions, a droplet size increase causes a progressive increase of the scattering
coefficient, but without affecting the absorption coefficient of the miniemulsion and the
photoinitiator itself. The use of concentrated miniemulsions may give rise to significant
loss of photons by multiple scattering due to the high density of droplets. The increased
scattering contribution increases extinction and reduces light penetration depth. However,
photons can be scattered several times by the monomer droplets and be subsequently
absorbed by the photoinitiator that may compensate the consequences of considerably
shorter optical path length [140]. Nevertheless, the effective extent of the loss of photons due
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to out-scattering and its impact on photopolymerization of monomer miniemulsions remain
to be investigated. One strategy to overcome possible limitations of the photochemical
reaction system is to optimize the reactor layer thickness with respect to the penetration
depth of the UV light in the dispersed media.
This approach was adopted regarding the development of continuous operating pho-
topolymerization reactors for the polymerization of miniemulsions in tubular reactors and
microfluidic devices. To identify the influence of different parameters on the polymerization
result, a number of parameters like residence time or droplet size have been varied [67,
136]. These studies revealed that reactors with an optical path of 1 mm are suitable for
continuous flow photopolymerization with a high polymer yield. Another conclusion is
that a systematic investigation of the different influencing parameters is needed to obtain
optimal reaction conditions for the intended application.
Nevertheless, preserving the functionality of biomaterials in photopolymerization pro-
cesses is still a challenging task and requires further understanding and optimization of the
technology [124]. The application of high energy photons due to UV radiation recommends
the control and dosing of irradiance and irradiation time. Likewise, a crucial parameter
is the almost complete monomer conversion to minimize toxic contaminants without the
need of complex and expensive purification steps [141].
To investigate several cause variables of the photoinitiated miniemulsion photopolymer-
ization and their impact on the monomer conversion, a method has to be established
that allows a fast screening procedure with low sample consumption in a preferably large
parameter space.
The presented screening study provides versatile methods for the characterization of
photopolymerization processes that will contribute to an improved understanding of these
processes. It combines established techniques for high throughput experimentation with a
newly developed microfluidic platform for photopolymerization. As a proof of concept study
the Design of Experiments (DoE) methodology was selected for a systematic examination
of different and mutual-dependent parameters like irradiance, irradiation time, and channel
height (optical path) regarding to their impact on the monomer conversion. The DoE
permits to detect the correlation and impact of the cause variables on the target value
in the selected design space [142]. To accelerate and simplify the exploration within the
design space a strategy to increase the sample throughput was developed by adopting a
microfluidic (𝜇F) device on a liquid handling station (LHS), which has been introduced by
Waldbaur et al. [79]. This approach allows a high throughput screening process with low
sample consumption and less manual operation due to automation. The use of microfluidic
chips that can be designed highly variable permits, e.g. the study of the effect of various
channel heights respectively reactor layer thickness or optical path on the monomer
conversion. In addition to the optical path, the concentration of photoinitiator, the time of
irradiation and the irradiance was varied to explore the impact of these parameters on the
photoinitiated polymerization in regard to minimize the residual monomer content (RMC).
In practice, for the miniemulsion photopolymerization styrene was selected as model
monomer for various reasons. A particular feature is the ability to form copolymers with
a high variability of other monomers that permits the adjustment of different polymer
properties. A further advantage is the implementation of chemical substitution on the
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aromatic core (nucleus) allowing simple introduction of additional chemical functionali-
ties during homo- or copolymerization. Further, employing styrene as a comonomer the
synthesized polymer can be easily secondary functionalized, for example introducing ion
exchange capabilities by sulfonation. In addition, using alkyne styrene as a comonomer,
which is chemically easily accessible, the obtained polymer can be (bio-) functionalized by
click chemistry [143]. Bis(acylphosphine) oxide (Irgacure 819, BAPO) has been selected as
photoinitiator for several reasons, in particular due to the excellent absorption properties
in the near UV region and fast photolysis under bleaching, combined with high initiation
quantum yields [144]. Thereby it was possible to excite the photoinitiator efficiently employ-
ing quasi monochromatic LEDs without appreciable absorption by the monomer styrene,
permitting fast, and deep-through initiation of frontal polymerization. In addition, BAPO
is capable of multiple photo-induced decomposition (“snowballing” radical generation),
leading to multiple growing radicals within a polymerizing chain, and is attributed to the
formation of ultrahigh molecular weight polymers [145].
Materials and Methods
Chemicals
For the presented proof of concept study styrene was chosen as monomer and used as
received (≥99 %, Sigma-Aldrich, St. Lois, USA). The miniemulsions were stabilized with the
nonionic surfactant Lutensol® AT 50, obtained from BASF SE (Ludwigshafen, Germany),
and the hydrophobic n-hexadecane (Alfa Aesar, Ward Hill, USA) against coalescence and
Ostwald ripening. Bis(2,4,6-trimethylbenzoyl)-phenylphosphineoxide (Irgacure® 819) from
BASF SE (Ludwigshafen, Germany) was employed as oil-soluble photoinitiator without
any further purification. Ethanol (≥99.9 %, Carl Roth, Karlsruhe, Germany) was applied
for the sample preparation for GC analysis of RMC. Ultrapure water was used throughout
all experiments (Elga LabWater, Celle, Germany). The two component curing PDMS
Elastosil 601 RT (Wacker Chemie, Burghausen, Germany) was employed for molding the
microfluidic chips.
Preparation of miniemulsions
The miniemulsions in this study are composed of 10 wt% styrene as dispersed phase in
the continuous phase water. The content of Lutensol® AT 50 (1.4 wt%) and hexadecane
(4 wt%) remained constant for all miniemulsions while weight percentage of Irgacure® 819
(photoinitiator) was adjusted according to the experimental design between 0.5 and 3 wt%
with respect to the dispersed phase. The two phases were preemulsified under mechanical
stirring at 1800 rpm (Ultra Turrax®Tube Drive, IKA-Werke, Staufen im Breisgau, Germany)
for 30 min followed by ultrasonication (Branson Sonifier S-450D, Branson Ultrasonics
Corp., USA) over 4 min at 90 % amplitude to prepare the miniemulsions.
Manufacturing of microfluidic devices
The fabrication of the microfluidic replication master, the molding and the manufacturing
of the microfluidic chip was executed as described by Waldbaur et al. [79]. The replication
master for the introduced application was designed with seven inlet channels and one
outlet channel (see figure 5.6). The seven channels differed in width and heights of their
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individual sections. For the presented proof of concept study, inlet channel No. 2 (IN-2)
and the outlet channel (OUT) were utilized. The width of the channel between the inlet
and the outlet port is kept constant with 1 mm. The bottom plate of the chip was made of
silicone with a thickness of 1.5 mm. The used inlet channel has three sections with different
heights (1000, 500, and 200 𝜇m) and each about 29 mm long. By irradiating the channel
from the bottom up, the irradiated volume could be varied by these different optical path
lengths to evaluate the effect of the penetration depth of irradiation in miniemulsions.
Figure 5.6: Part (A) of this figure shows the replication master for the molding of the
microfluidic chips used for the presented experiments. The channel system consists of one
outlet channel (OUT) and seven inlet channels (IN 1–7) that differ in width and are decreasing
in height. Part (B) of the picture, this step-wise decrease is shown at the example of the
channel 2 that allows experiments with different optical path length.
The microfluidic chip setup
A conventional disposable tip (DiTi) carrier from Tecan (Crailsheim, Germany) provides
as base-module for the chip system. A custom made insert was placed in the carrier that
serves as positioning site for the chip. The insert was designed with a gap, which allows
the mounting of the monochromatic UV LED-spot (NVSU233A, 365 nm, Nichia, Japan)
with a maximum irradiance of 68 mW/cm2 under the microfluidic chip and thereby a
irradiation from below. This LED-based irradiation system was equipped with a condenser
and power supply by macrolenses (Dr.-Ing. Klaus Schmitt, Weinheim, Germany). An
overview photograph of the setup on the liquid handling station is shown in figure 5.7. To
control the irradiated reaction volume, a mask with a 7 mm × 1 mm slit in direction of
the channel was placed between the chip and the diode to create a defined irradiation slot.
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The UV radiation coming out of the chip was weakened by mounting a piece of acrylic
glass on top of the chip. With additional equipment from Tecan-like carriers for centrifuge
tubes, microtiter plates, and troughs placed on the desk of the LHS an integration of the
microfluidic chip in an automated screening procedure was possible. The liquid handling
station used in this work was a Freedom EVO 200 (Tecan, Crailsheim, Germany) equipped
with 1000 𝜇L syringes and controlled by EVOware Standard (provided with the LHS).
Figure 5.7: Photograph of the experimental setup on the liquid handling station. Shown
here are troughs for the reagents (A), centrifugal tubes (B), and deep-well plate (C) for the
storage and processing of the polymer samples. The modified carrier (D) for the microfluidic
chip that allows the fixation of the LED-spot underneath the chip and a reversible connection
between the channel system and the pipetting needles of the liquid handling arm (E). The
magnified detail shows the irradiated channel section.
Design of experiments
The experimental design was created by the use of MODDE (Version 10.1, Umetrics,
Umeå, Sweden). Thus, four parameters with a critical influence on the miniemulsion
photopolymerization in microfluidic channels were identified and set as factors with de-
fined variation ranges. The considered variation ranges of the factors irradiation time t,
irradiance I, initiator concentration c, and height of the microfluidic channel h (optical
path) are presented in table 5.1.
Based on a D-optimal design a fractional factorial experimental matrix with 26 experi-
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Table 5.1: Variation of the cause variables for the photopolymerization of styrene in microflu-
idic channels with irradiation at 365 nm (I = 100 % equals 68 mW/cm2)
Cause variable Variation range
Irradiation time (t) 10-60 s
Irradiance (I ) 25, 50, 75, 100 %
Initiator concentration (c) 0.5-3.0 wt%
Channel height (h) 20, 500, 1000 𝜇m
ments was obtained. The experimental design included a threefold determination of the
center point to affirm the experimental repeatability. The produced polymer lattices have
been analyzed regarding the residual monomer content (RMC in %), their particle size
distribution and the morphology of the polymer particles. The experimental results for the
RMC were fitted with a quadratic model using the response-surface-method in MODDE
consisting of 14 coefficients (including four linear, six interaction, and four quadratic terms).
To discuss the influence of the factors on the RMC a model discrimination was performed
to identify nonsignificant coefficients. The remaining coefficients are shown in figure 5.8
and the modeling results for RMC are depicted as contour plots.
Figure 5.8: Coefficient plot to illustrate the impact of irradiation time t, irradiance I, channel
height h (optical path), and combined factors on the residual monomer content (RMC in %)
for the 26 executed experiments of photoinitiated miniemulsion polymerization in microfluidic
channels. The error bars represent the ± 95 % confidence interval.
Automated screening procedure
To explore the impact of different variable factors on the photopolymerization of miniemul-
sions in microfluidic channels a screening in the variation range of the cause variables was
executed in an automated manner on a liquid handling station. Therefore, the chip setup
was placed on the deck of the LHS and troughs with 25 mL miniemulsion of different
compositions were put next to the chip carrier. For the sample preparation, a deep-well
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microtiter plate and 15 mL centrifugal tubes, each with 100 mL ultrapure water, and a
trough with Ethanol were provided on the platform (see figure 5.7). The mounting and
irradiance of the LED-spot was adjusted manually.
For the polymerization runs, an amount of 800 𝜇L of the prepared miniemulsion was
aspirated by a pipetting needle. After the liquid handling arm (LiHa) was reversibly
connected to the channel system, the miniemulsion was pumped semicontinuously in steps
of 7 𝜇L, which correlates with the irradiated volume through the mask. The pause between
two steps allowed the control of the irradiation time. The time needed for the volume
exchange was negligible. As soon as the complete volume of the irradiated miniemulsion
was aspirated by the pipetting needle in the outlet port, the needles were elevated to
unplug the connection and the sample was then dispensed in the microwell plate provided.
A part of the sample was used to prepare a dilution with ethanol for GC-analysis. To
protect the samples in the wells from light, the plate was wrapped in aluminum foil and
covered with a lightproof lid. The dilution for the PCCS analysis (photon cross-correlation
spectroscopy) was achieved by mixing 100 𝜇L of the sample with 100 mL of ultrapure
water in a centrifugal tube.
Before the following polymerization experiment could be executed, the channel was purged
with water and dried with streaming air pumped by the LHS. After every polymerization
cycle, the diluted samples could be taken off the LHS and were transferred to the subsequent
analytics.
Analytics
For the determination of the residual monomer content, processed samples were analyzed
via gas chromatography (Agilent 6890 plus, Agilent Technologies, Santa Clara, USA). The
samples were mixed with ethanol (ratio of 1:4) in a microwell plate, followed by filtration
through Nylon filter (0.2 𝜇m pore size). The samples were analyzed at 200°C on a highly
polar capillary column (Agilent INNOWax, 30 m length, 0.32 mm inner diameter, 0.25 𝜇m
film thickness). The chromatograms of the individual analyses were evaluated with the
ChemStation Software (Agilent, REV. A10.02).
The samples for the determination of the particle size distribution via photon cross-
correlation spectroscopy (PCCS) and for the study of the morphology of the polymer
particles via SEM have been diluted with ultrapure water (ratio of 1:100). The photon
cross-correlation spectroscopy was conducted in the NANOPHOX sensor system (Sympatec,
Clausthal-Zellerfeld, Germany) and evaluated with the corresponding software (WINDOX,
Version 5.6, Sympatec, Germany). The scanning electron microscope LEO1530 (LEO/Zeiss,




To validate the concept of screening photopolymerization in miniemulsions by employing
the 𝜇F-on-LHS concept, styrene miniemulsions with varying Irgacure® 819 content were
polymerized under the conditions brought out by the experimental design. These 26 experi-
ments carried out within the stated factor ranges resulted in residual styrene concentrations
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between 0 and 74 % with respect to the initial monomer concentration. Thus a wide
range of response values could be discussed as model output. A response surface modeling
approach was employed to identify sensitive process parameters to the residual monomer
concentration and to identify the optimal parameter set leading to a complete conversion
of styrene miniemulsions. The response surface methodology including all 14 coefficients of
the four residual styrene concentration (RMC) defining factors predicted the experimental
data very well with a coefficient of determination (R2) of about 0.99, a model validity of
0.84 and a reproducibility of 0.98. Analyzing the significance of each factor to the response
showed that the initial concentration of Irgacure® 819 had no perceptible impact on the
residual styrene concentration after polymerization within the stated factor ranges. The
selected range of photoinitiator variation might be too small for a noticeable impact, in
connection with an overestimated minimum concentration. Figure 3 shows the coefficient
plot with scaled and centered coefficients comparable with confidence intervals. In this
plot the Irgacure® 819 concentration and its interaction terms have been excluded due
to their nonsignificant influence on the model. The seven remaining coefficients simplify
the response surface model with no lack of fit (R2 = 0.98, model validity 0.83). The
values of the coefficients (see figure 5.8) are indicators for the significance of the factors
and interaction terms and their impact on the response. Thereby, factors with positive
coefficient values make a contribution to higher residual styrene concentrations, while
factors with negative ones are indicative for enhanced styrene conversion. Especially the
coefficient of the irradiance itself is negative and nonsignificant, but the term of I * I will
lead to a remarkable effect at higher irradiance in the direction of higher residual styrene
concentrations. This may be explained by depolymerization that becomes dominant at
higher irradiance especially with increasing irradiation time. The comparatively limited
effect of the irradiance can be explained in connection with the small impact of the interac-
tion term I * t, which can be attributed to the fast bleaching of the photoinitiator even for
the lowest investigated irradiance and highest investigated photoinitiator concentration
(c.f. ongoing discussion in the following section). Keeping all other factors constant, the
residual styrene concentration increases if the polymerization is carried out in higher
channels. This dependency depicts that the influence of the penetration depth of the
photons has to be considered even in photoreactors with optical path lengths between 200
and 1000 𝜇m. Furthermore, the term h * t predicts a positive interaction to the styrene
conversion, thus a certain combination of channel height and irradiation time could enhance
the polymerization results in regard to high monomer conversion. In addition, the factor
time is represented in the negative factor t and in the positive term t * t, meaning that
the longer the styrene miniemulsion is irradiated the smaller the residual styrene content
after polymerization is. This effect will be counterbalanced at higher irradiation times by
the positive term of I * I that predicts higher residual styrene concentrations.
Response surface modeling
The results of the four-dimensional response surface modeling will be discussed on the basis
of two sets of contour plots (figure 5.9). The negative values for the residual monomer
content RMC at the limits of the response surfaces are extrapolated of the empiric modeling
approach and are therefore taken as full conversion.
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Figure 5.9: Contour plot set to illustrate the predicted development of the residual monomer
content (RMC). (A–C) depending on the irradiance (25–100 %) and the channel height
(200–1000 𝜇m) for three different irradiation times (from left to right: t = 10, 35, 60 s). (D–F)
Depending on the irradiation time (10–60 s) and the irradiance (25–100 % for three different
channel heights (from left to right: h = 200, 500, 1000 𝜇m).
Figure 5.9A–C shows the RMC as a function of irradiance and channel height after 10, 35,
and 60 s of irradiation. This sequence of subplots demonstrates that the monomer conversion
increases with irradiation time from 10 to 60 s as expected for free radical polymerization
mechanism among ongoing initiation steps and subsequent monomer addition to growing
polymer radicals. For short irradiation times a RMC from 10 to 70 % can be achieved,
in comparison with 0–30 % for intermediate and 0–15 % for the highest irradiation time.
The negative influence of increasing channel height to the RMC is particularly distinctive
for 10 s of irradiation and becomes much smaller in the case of 35 and 60 s. After
irradiation with 50 % irradiance over 10 s, an increase in the optical path from 200 to
400 𝜇m has more than doubled the RMC from 11 to 24 %, whereas for t = 60 s, the
RMC is only increased by about 2 %. These results must be linked to the heterogeneity
of the photochemical reactions system. The penetration depth of photons in monomer
miniemulsions can by highly restricted due to scattering. According to Lobry et al. [146],
droplets in the front layers have a higher probability of being nucleated than those in the
rear. At high optical attenuation, initiation is highly localized leading to low conversion
rates. The smaller the channel height and thus the optical path is, the more miniemulsion
droplets are penetrated by incident photons and thus the polymerization reaction can be
initiated within the whole reaction volume more equally. The penetration of photons in
every droplet is a requirement in miniemulsion photopolymerization to achieve complete
monomer conversion. Consequently, controlling the height with respect to the penetration
depth of irradiation in a reactor for photopolymerization of miniemulsions, allows to reach
quasi homogeneous reaction conditions for a rather heterogeneous system. This could be
critical especially for continuous reactors in which turbulent flow is negligible. According to
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figure 5.9A–C, a reduced effect of the channel height is predicted for 35 s of irradiation and
is hardly present for 60 s. In summary, a positive interaction between channel height and
irradiation time causes low RMC that means in effect that an increasing channel height
demands an extension of the irradiation time simultaneously. The styrene concentration
drops to less than 15 % after 60 s of irradiation in all channels up to 1000 𝜇m. This
appears surprisingly, since the expected penetration of UV radiation into photoinitiator-
free monomer miniemulsions would not exceed 100 𝜇m, with the consequence that only
in a small fraction of droplets close to the irradiated surface polymerization could be
initiated [147]. In addition, the presence of a photoinitiator will be further reduce the
penetration depth of photons, leading to an enhanced heterogeneity between irradiated
and nonirradiated volume. Nevertheless, employing a bleachable photoinitiator like BAPO,
with longer irradiation times more photons are penetrating deeper into the reaction volume,
as long as the “shielding” effect due to scattering phenomena becomes dominant. In fact,
the observed transmission through the microfluidic chips increases with time for all channels
heights and photoinitiator concentrations, in particular within the first 20 s for channel
heights of 200 and 500 𝜇m, which we attribute to the bleaching of the photoinitiator. This
would imply that within this period the photoinitiator is completely consumed in the
volume penetrated well with photons when scattering determine the optical properties of
the miniemulsions only. As a consequence, for increasing optical path lengths, especially
for the 1000 𝜇m channel, other effects must be considered to explain the strong positive
impact of the irradiation time on monomer conversion. On the basis of “shielding” due
to scattering, only mixing effects by convection can cause that all the droplets of the
miniemulsion are being nucleated within moderate time periods. This positive interaction
can be exploited to enhance the photopolymerization performance by choosing maximal
channel height and minimal irradiation time for complete monomer conversion. According
to the subplots in figure 5.9A–C, the best performance regarding the throughput and
monomer conversion with 0 % RMC would be achieved in a 200–400 𝜇m channel, after 35
s of irradiation and 65 % irradiance. The curved contour levels depict that the irradiance
passes through an optimum at a constant irradiation time. Moderate irradiance around
65 % result in a minimal RMC at channel heights up to 400 𝜇m.
Tomovska et al. [148] discussed a comparable correlation between irradiance and the
maximum conversion of styrene/butyl acrylate miniemulsions using irradiances of 2, 4,
and 6 mW/cm2 in a continuous photoreactor with 1 mm inner diameter after 30 min of
irradiation. They explain the occurrence of a maximum in the monomer conversion in
dependence of the irradiance with faster photoinitiator decomposition for higher irradiance
and argue that the polymerization reaction stops after photoinitiator consumption. Taking
this under consideration, an optimum for irradiance should be recognized in the modeling
results for time and channel height dependency, because a complete exhaustion of the
photoinitiator becomes unlikely for short irradiation times in combination with increased
channel height. However, none of these dependencies can be recognized in the contour plots
shown in figure 5.9. The course of the contour levels is similar within the subplots and only
the absolute value of the RMC changes with irradiation time. Increasing the irradiance
from 25 to about 65 % minimizes the RMC by approximately 7 % for all combinations of
channel height and irradiation time, followed by a renewed increase of the RMC to a value
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insignificantly lower at 100 % irradiance than at 25 %. According to the fundamentals of free
radical polymerization mechanism, the active polymer chains (macro radicals) propagate
further even if the photoinitiator is exhausted. This postpolymerization is attributed to
the polymer radicals that continue to grow until bimolecular termination [149]. A more
reasonable explanation for the occurrence of an optimum in irradiance refers to the primary
radical generation and the competing recombination of primary with macro radicals. With
increasing irradiance from 25 to 65 % more photoinitiator radicals (primary radicals)
per time and volume are formed, because higher photon flux densities accelerate the
initiation rate. Thus, the RMC decreases due to multiple chain initiation and propagation
reactions running in parallel. If the irradiance is increased over 65 %, the concentration of
photoinitiator radicals reached such a high level that the recombination of radicals becomes
the dominating reaction, so either the reverse photolysis or the termination of chains by
radicals are more likely to happen. Altogether, the polymerization rate decelerates at
higher irradiances, because less primary radicals survive to be able to start the chain
mechanism that results in higher RMC values. In conclusion, the contour plots depict that
the RMC is basically controlled by factors time, channel height, and its interdependence
with the irradiance, which appears to be optimal at about 65 %. The contour plots in
figure 5.9D–F reveal additional information about the dependency of the predicted RMC
on the irradiation time, which is plotted against irradiance for the three experimental
channel heights in subplots, respectively. The RMC ranges from 17 to 0 % in 200 𝜇m
channels, for channels of 500 𝜇m a RMC from 37 % up to complete conversion can be
achieved and in 1000 𝜇m channels values between 70 and 8 % are depicted for the RMC.
The most remarkable characteristic shown in figure 5.9D–F is the occurrence of a minimum
in the RMC with progressing irradiation time from 10 to 60 s. For a set combination
of channel height and irradiance the RMC decreases with increasing irradiation time,
since the ongoing decomposition of the photoinitiator leads to the formation of primary
radicals able to initiate chain starts until exhaust of the photoinitiator. Subsequent and
continuing propagation steps result into further consumption of monomer molecules. For
the polymerization within 200 and 500 𝜇m channels and intermediate irradiances, the
values of the RMC are located in the dark plotted area of complete conversion. The
shown subplots illustrate the shift of the RMC minimum with longer irradiation time and
increasing channel height toward longer times of irradiation. The subplot on the right for
the 1000 𝜇m channel (figure 5.9F) gives reason to expect that the correspondent minimum
will appear at irradiation times longer than 60 s, considering that an extrapolation beyond
the limits of the design space is subject to considerable uncertainty. Nevertheless, under
consideration of the heterogeneity of the reaction system again, one can assume/expect,
that an irradiation time of 60 s is not sufficient in the 1000 𝜇m channel to nucleate all
miniemulsion droplets. It seems a matter of time that all droplets are able to reach
the front layers, which are sufficient penetrated by photons. The negative influence on
the RMC for longer irradiation times can be explained with depolymerization reactions
leading to the reappearance of monomer molecules. The photodegradation and especially
the photooxidation of polystyrene under UV irradiation are intensively discussed in the
literature, e.g. in the review of Yousif et al. [150]. Depending on the chromophore groups
existing in the reaction mixture and the irradiation conditions the absorption of photons
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produce low molecular weight radicals and polymeric macro radicals that are able to
accomplish chain scission leading to the reduction of the molecular weight of the polymer
even in the absence of oxygen. In the presence of oxygen, which cannot be completely
excluded in the conducted experiments, different photoproducts maybe formed during
the photooxidation of polystyrene starting with the primary formation of hydroperoxides
followed by several types of secondary reactions [151, 152]. Nevertheless, it is expected
that for the employed microfluidic system oxygen contribution is very limited. Kaczmarek
et al. [153] reported that small amounts (0.1–0.5 wt%) of photoinitiators like benzophenone
accelerate photodestruction in polystyrene with breaking up of fragments from end chains
under irradiation. The photolysis of benzophenone and Irgacure® 819 is characterized
by the generation of benzoyl radicals, another potential species that could participate
in depolymerization reactions at longer irradiation times. According to Kwant [154],
depolymerization as the reverse reaction of chain propagation in styrene polymerization
becomes significant in the range of rather high conversion, because diffusion limitations
lower the rate constant of the propagation reaction significantly. These above-mentioned
mechanistic aspects support the appearance of the RMC minimum in figure 5.9D–F due to
depolymerization reactions that are effective at longer irradiation times.
REM analysis
The shape of the generated polymer particles were analyzed regarding the question if
high monomer conversion has necessarily resulted in spherical polymer particles with a
narrow particle size distribution as expected from miniemulsion polymerization mechanism.
Conflicting this postulated narrow and monomodal polymer particle size distributions,
PCCS measurements show broad monomodal or bimodal distributions (see figure 5.12).
Nevertheless, the SEM images and PCCS measurements provide some information to
support the discussed dependencies. The observed surface structures in the SEM images
(see figure 5.10) vary from sharp spheres and half-shells over spherical particles covered with
a cloudy layer of network-like polymer structures. In some experiments, usually in 1000 𝜇m
channels and with short irradiation times, no regular polymer structures are detected
by SEM analysis. An interpretation of the images in correlation with corresponding
RMC values illustrates that experimental conditions resulting in a low RMC do not
necessarily result in spherical, equal-sized polymer particles consequently. Figure 5.10
shows exemplarily the differences in the surface appearances of generated polymer particles
out of three experiments with 0 % RMC in each case. The spherical and hemispherical
polymer particles as shown in the right image of figure 5.10 most closely correspond to the
expected polymer structure and moreover to the optimal experimental conditions predicted
by the response surface modeling. The deviation from the ideal spherical polymer structure
in figure 5.10, thus the occurrence of half-shell particles, cloudy layer formation (figure
5.10, center image) and the sticking in network-like structures (figure 5.10, left image), can
be explained by the formation of styrene dimers up to short oligomers in dependency of
the selected polymerization conditions. For example, the cloudy layer in the center image
indicates that 100 % irradiance compared with 75 % in the right image may be indicative
for an excess of photons in channels with 200 𝜇m height, so concurrently propagating
chains are terminated to yield a high amount of small molecular weight polymers. As
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possible explanation for the appearance of cloudy layers and different polymer particle
shapes, the preparation conditions of the samples for SEM imaging and the formation of
gel-type polymer structures has to be taken into account.
Figure 5.10: SEM images of the resulting polystyrene particles from experiments in the 200
𝜇m channel with a RMC of 0 % but different configurations ((A): I = 50 %, t=60 s, 2.2wt%
Irgacure® 819; (B): I = 100 %, t = 35 s, 1.8 wt% Irgacure® 819; (C): I = 75%, t = 60 s, 3.0
wt%) Irgacure® 819). Scale on the left image: 2000 nm, on the middle and right image: 1000
nm.
The polymer surface structures presented in figure 5.11 show considerable differences,
although the shown particles were generated in experiments resulting in a RMC of around
17 %. The differences can be connected to different initial photoinitiator concentrations. The
resulting particles shown in the left image clarify, that using a Irgacure® 819 concentration
of 0.5 % is not sufficient in 1000 𝜇m channels to form sharp, spherical polymer particles
during 60 s of irradiation even at 100 % irradiance, whereas 3 % Irgacure® 819 provide
well-defined structures like shown in the right image of figure 5.11.
Figure 5.11: SEM images of the resulting polystyrene particles from experiments in the 1000
𝜇m channel with an irradiation time of 60 s and an irradiance of 100 and 17 % RMC. The
concentration of the initiator varies from 0.5 wt% on the (A) to 3.0 wt% on the (B). Scale:
1000 nm.
Particle size distribution
The measured particle size distributions of the polymer particles range from bimodal
distributions to broad monomodal behavior (see figure 5.12). The main polymer fraction
is located between 300 and 400 nm in diameter. This particle size is consistent with
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the dominated particle size observed in SEM images for the well-defined spherical and
hemispherical polymer structures. The second size is for all experiments either smaller
than 120 nm or around 160 nm or not obvious. Particle sizes beneath 120 nm seem to be
an artifact in these PCCS measurements, because correspondent polymer particles could
not be confirmed by SEM image analysis. However, it should be noticed that polymer
structures from these experiments were strongly sticking together and had no well-defined
spherical shape. It can be assumed that PCCS analysis only provides reliable information
for nearly spherical polymer particles and should not be applied if a sticky network of
oligomers contributes to the scattered light signal as well.













 1000 µm, 100% I, 0,5 wt% Initiator
 1000 µm, 100% I, 3,0 wt% Initiator
Figure 5.12: Particle size distribution of the resulting polystyrene particles from experiments
in the 1000 𝜇m channel with 100 % irradiance and a photoinitiator concentration of 0.5 wt%
(black squares) respectively 3.0 wt% (red squares).
Concluding remarks
The reported combination of microfluidics and liquid handling stations (𝜇F-on-LHS) was
successfully adapted to the screening of photoinitiated miniemulsion polymerization. The
concept was validated by styrene miniemulsion photopolymerization under variation of
the cause variables like irradiance, irradiation time, and optical pathway. Employing
statistical methods (DoE) this concept is a promising tool for the investigation of complex
interdependencies with automated execution and low sample consumption.
It was shown that complete monomer conversion as required for bioapplications can be
reached in channels with an optical path length smaller than 1000 𝜇m. An increase in
irradiation time led to a decrease of the residual monomer content. A linkage of complete
monomer conversion to spherical particles in principle could not be deduced by the analysis
of SEM images.
Probably, the molecular weight distribution of the formed polymers is another topic
49
5.2 Photoinitiated Miniemulsion Polymerization in Microfluidic Chips
for the comprehensive understanding of the photoinitiated miniemulsion polymerization,
which has to be the subject of further investigations. In this context, a reconsideration of
the impact of the photoinitiator concentration on the molecular weight has to be taken
into account. Thus, the design space will be expanded for the consideration of the impact
of the cause variables on the polymer shape and characteristics. To conduct the required
experiments the presented strategy is expected to be very suitable.
Acknowledgments
This research work is part of the project “Molecular Interaction Engineering: From Nature’s
Toolbox to Hybrid Technical Systems,” which is funded by the German Federal Ministry of
Education and Research (BMBF), funding code 031A095B. The authors bear the complete
responsibility for the content of this publication. Special thanks go to Volker Zibat from
the Laboratory for Electron Microscopy at the Karlsruhe Institute of Technology (LEM –
KIT) for recording the SEM images.
50
5.2 Photoinitiated Miniemulsion Polymerization in Microfluidic Chips
References
67. Lobry, E., Jasinski, F., Penconi, M., Chemtob, A., Croutxé-Barghorn, C., Oliveros,
E., Braun, A. M., and Criqui, A. ‘Continuous-flow synthesis of polymer nanoparticles
in a microreactor via miniemulsion photopolymerization’. RSC Advances, vol. 4(82)
(2014), pp. 43756–43759 (cit. on pp. 4, 37).
79. Waldbaur, A., Kittelmann, J., Radtke, C. P., Hubbuch, J., and Rapp, B. E. ‘Mi-
crofluidics on liquid handling stations (𝜇F-on-LHS): an industry compatible chip
interface between microfluidics and automated liquid handling stations’. Lab on a
Chip, vol. 13(12) (2013), pp. 2337–2343 (cit. on pp. 5, 20, 37, 38, 59, 60, 68, 78).
107. Mellott, M. B., Searcy, K., and Pishko, M. V. ‘Release of protein from highly cross-
linked hydrogels of poly (ethylene glycol) diacrylate fabricated by UV polymerization’.
Biomaterials, vol. 22(9) (2001), pp. 929–941 (cit. on pp. 10, 36, 78, 96, 101, 103,
105).
108. Quick, D. J. and Anseth, K. S. ‘DNA delivery from photocrosslinked PEG hydrogels:
encapsulation efficiency, release profiles, and DNA quality’. Journal of Controlled
Release, vol. 96(2) (2004), pp. 341–351 (cit. on pp. 10, 36).
123. Ramakrishna, S., Mayer, J., Wintermantel, E., and Leong, K. W. ‘Biomedical
applications of polymer-composite materials: a review’. Composites science and
technology, vol. 61(9) (2001), pp. 1189–1224 (cit. on p. 36).
124. Baroli, B. ‘Photopolymerization of biomaterials: issues and potentialities in drug
delivery, tissue engineering, and cell encapsulation applications’. Journal of Chemical
Technology and Biotechnology, vol. 81(4) (2006), pp. 491–499 (cit. on pp. 36, 37).
125. Fisher, J. P., Dean, D., and Mikos, A. G. ‘Photocrosslinking characteristics and
mechanical properties of diethyl fumarate/poly (propylene fumarate) biomaterials’.
Biomaterials, vol. 23(22) (2002), pp. 4333–4343 (cit. on p. 36).
126. Davis, K. A., Burdick, J. A., and Anseth, K. S. ‘Photoinitiated crosslinked degradable
copolymer networks for tissue engineering applications’. Biomaterials, vol. 24(14)
(2003), pp. 2485–2495 (cit. on p. 36).
127. Anseth, K., Goodner, M., Reil, M., Kannurpatti, A., Newman, S., and Bowman, C.
‘The influence of comonomer composition on dimethacrylate resin properties for
dental composites’. Journal of dental research, vol. 75(8) (1996), pp. 1607–1612
(cit. on p. 36).
128. Lu, M., Lan, H., Wang, F., and Wang, Y. ‘A novel cell encapsulation method
using photosensitive poly (allylamine alpha-cyanocinnamylideneacetate)’. Journal of
microencapsulation, vol. 17(2) (2000), pp. 245–251 (cit. on p. 36).
129. Quek, C.-H., Li, J., Sun, T., Chan, M. L. H., Mao, H.-Q., Gan, L. M., Leong, K. W.,
and Yu, H. ‘Photo-crosslinkable microcapsules formed by polyelectrolyte copolymer
51
5.2 Photoinitiated Miniemulsion Polymerization in Microfluidic Chips
and modified collagen for rat hepatocyte encapsulation’. Biomaterials, vol. 25(17)
(2004), pp. 3531–3540 (cit. on p. 36).
130. Gobin, A. S. and West, J. L. ‘Effects of epidermal growth factor on fibroblast
migration through biomimetic hydrogels’. Biotechnology progress, vol. 19(6) (2003),
pp. 1781–1785 (cit. on p. 36).
131. Yokoyama, S., Nakahama, T., Miki, H., and Mashiko, S. ‘Fabrication of three-
dimensional microstructure in optical-gain medium using two-photon-induced pho-
topolymerization technique’. Thin Solid Films, vol. 438 (2003), pp. 452–456 (cit. on
p. 36).
132. Arcaute, K., Mann, B. K., and Wicker, R. B. ‘Stereolithography of three-dimensional
bioactive poly (ethylene glycol) constructs with encapsulated cells’. Annals of biomed-
ical engineering, vol. 34(9) (2006), pp. 1429–1441 (cit. on p. 36).
133. Pierre, S. J., Thies, J. C., Dureault, A., Cameron, N. R., Hest, J. C. van, Carette,
N., Michon, T., and Weberskirch, R. ‘Covalent enzyme immobilization onto pho-
topolymerized highly porous monoliths’. Advanced Materials, vol. 18(14) (2006),
pp. 1822–1826 (cit. on p. 36).
134. Li, L., Zhao, N., and Liu, S. ‘Versatile surface biofunctionalization of poly (ethylene
terephthalate) by interpenetrating polymerization of a butynyl monomer followed
by “Click Chemistry”’. Polymer, vol. 53(1) (2012), pp. 67–78 (cit. on p. 36).
135. Chemtob, A., Kunstler, B., Croutxé-Barghorn, C., and Fouchard, S. ‘Photoinduced
miniemulsion polymerization’. Colloid and Polymer Science, vol. 288(5) (2010),
pp. 579–587 (cit. on p. 36).
136. Daniloska, V., Tomovska, R., and Asua, J. M. ‘Hybrid miniemulsion photopoly-
merization in a continuous tubular reactor—A way to expand the characteristics of
polyurethane/acrylics’. Chemical Engineering Journal, vol. 184 (2012), pp. 308–314
(cit. on pp. 36, 37).
137. Landfester, K. ‘Miniemulsion polymerization and the structure of polymer and
hybrid nanoparticles’. Angewandte Chemie International Edition, vol. 48(25) (2009),
pp. 4488–4507 (cit. on p. 36).
138. Antonietti, M. and Landfester, K. ‘Polyreactions in miniemulsions’. Progress in
Polymer Science, vol. 27(4) (2002), pp. 689–757 (cit. on p. 36).
139. Jasinski, F., Lobry, E., Chemtob, A., Croutxé-Barghorn, C., and Criqui, A. ‘Pho-
topolymerizable monomer miniemulsions: why does droplet size matter?’ Macro-
molecular Chemistry and Physics, vol. 214(15) (2013), pp. 1669–1676 (cit. on p. 36).
140. Penconi, M., Lobry, E., Jasinski, F., Chemtob, A., Croutxé-Barghorn, C., Criqui, A.,
Braun, A. M., and Oliveros, E. ‘The use of chemical actinometry for the evaluation
of the light absorption efficiency in scattering photopolymerizable miniemulsions’.
52
5.2 Photoinitiated Miniemulsion Polymerization in Microfluidic Chips
Photochemical & Photobiological Sciences, vol. 14(2) (2015), pp. 308–319 (cit. on
p. 36).
141. Patel, H., Raval, D., Madamwar, D., and Patel, S. ‘Polymeric prodrug: Synthesis,
release study and antimicrobial property of poly (styrene-co-maleic anhydride)-bound
acriflavine’. Macromolecular Materials and Engineering, vol. 263(1) (1998), pp. 25–30
(cit. on p. 37).
142. Montgomery, D. C., Peck, E. A., and Vining, G. G. Introduction to linear regression
analysis. John Wiley & Sons, 2012 (cit. on p. 37).
143. Malkoch, M., Thibault, R. J., Drockenmuller, E., Messerschmidt, M., Voit, B.,
Russell, T. P., and Hawker, C. J. ‘Orthogonal approaches to the simultaneous and
cascade functionalization of macromolecules using click chemistry’. Journal of the
American Chemical Society, vol. 127(42) (2005), pp. 14942–14949 (cit. on p. 38).
144. Decker, C., Zahouily, K., Decker, D., Nguyen, T., and Viet, T. ‘Performance analysis
of acylphosphine oxides in photoinitiated polymerization’. Polymer, vol. 42(18)
(2001), pp. 7551–7560 (cit. on p. 38).
145. Laurino, P., Hernandez, H. F., Bräuer, J., Krüger, K., Grützmacher, H., Tauer, K.,
and Seeberger, P. H. ‘Snowballing radical generation leads to ultrahigh molecu-
lar weight polymers’. Macromolecular rapid communications, vol. 33(20) (2012),
pp. 1770–1774 (cit. on p. 38).
146. Lobry, E., Jasinski, F., Penconi, M., Chemtob, A., Ley, C., Croutxé-Barghorn, C.,
Oliveros, E., Braun, A. M., and Criqui, A. ‘Absorption and scattering in concen-
trated monomer miniemulsions: static and dynamic investigations’. Macromolecular
Chemistry and Physics, vol. 215(12) (2014), pp. 1201–1211 (cit. on p. 44).
147. Hoijemberg, P. A., Chemtob, A., Croutxé-Barghorn, C., Poly, J., and Braun, A. M.
‘Radical photopolymerization in miniemulsions. Fundamental investigations and
technical development’. Macromolecules, vol. 44(22) (2011), pp. 8727–8738 (cit. on
p. 45).
148. Tomovska, R., Cal, J. C. de la, and Asua, J. M. ‘Miniemulsion photo-copolymerization
of styrene/butyl acrylate in a continuous tubular reactor’. Industrial & Engineering
Chemistry Research, vol. 53(18) (2013), pp. 7313–7320 (cit. on p. 45).
149. Decker, C. ‘Kinetic study and new applications of UV radiation curing’. Macromolec-
ular Rapid Communications, vol. 23(18) (2002), pp. 1067–1093 (cit. on p. 46).
150. Yousif, E. and Haddad, R. ‘Photodegradation and photostabilization of polymers,
especially polystyrene: review’. SpringerPlus, vol. 2(1) (2013), p. 398 (cit. on p. 46).
151. Bottino, F. A., Cinquegrani, A. R., Di Pasquale, G., Leonardi, L., and Pollicino, A.
‘Chemical modifications, mechanical properties and surface photo-oxidation of films
of polystyrene (PS)’. Polymer testing, vol. 23(4) (2004), pp. 405–411 (cit. on p. 47).
53
5.2 Photoinitiated Miniemulsion Polymerization in Microfluidic Chips
152. Gardette, J.-L., Mailhot, B., and Lemaire, J. ‘Photooxidation mechanisms of styrenic
polymers’. Polymer degradation and stability, vol. 48(3) (1995), pp. 457–470 (cit. on
p. 47).
153. Kaczmarek, H., Kamińska, A., Świątek, M., and Sanyal, S. ‘Photoinitiated degrada-
tion of polystyrene in the presence of low-molecular organic compounds’. European
polymer journal, vol. 36(6) (2000), pp. 1167–1173 (cit. on p. 47).
154. Kwant, P. ‘Kinetics of styrene polymerization at ultrahigh conversion’. Journal of
Polymer Science: Polymer Chemistry Edition, vol. 17(10) (1979), pp. 3397–3410
(cit. on p. 47).
54

5.3 Fully Automated Method for Fluorescence in situ Hybridization for Biofilm Analysis
Silla H. Hansen1*, Carsten P. Radtke2*, Eva Krolitzki2, Susanne Krause3, Tobias Kabbeck3,
Michael Wagner4, Johannes Gescher3, Jürgen Hubbuch2 and Christof M. Niemeyer1
1Institute for Biological Interfaces 1, Karlsruhe Institute of Technology (KIT), 76344
Eggenstein-Leopoldshafen, Germany
2Institute of Engineering in Life Sciences, Section IV: Biomolecular Separation Engineering,
Karlsruhe Institute of Technology (KIT), 76131 Karlsruhe, Germany
3Institute for Applied Biosciences, Department of Applied Biology, Karlsruhe Institute of
Technology (KIT), 76131 Karlsruhe, Germany
4Engler-Bunte-Institut, Water Chemistry and Water Technology, Karlsruhe Institute of
Technology (KIT), 76131 Karlsruhe, Germany
* These authors contributed equally to this work.
Original manuscript is edited and extended for a publication in a wider context
56
5.3 Fully Automated Method for Fluorescence in situ Hybridization for Biofilm Analysis
Abstract
Fluorescence in situ hybridization (FISH) as well as catalyzed reporter
deposition fluorescence in situ hybridization (CARD-FISH) are extremely
powerful tools for microbiological research. Unfortunately, both tech-
niques are highly time- and labour-consuming which complicates the
analysis of multiple parallel experiments. Therefore, this study describes
the development of an automated platform for FISH and CARD-FISH,
which combines a cultivation flowcell with a commercially available liq-
uid handling station to enable fully automated analysis of up to nine
biofilm flowcells in parallel. The method was was successfully applied
for the identification and quantification of mixed model organisms and
an acidophilic environmental biofilm from a pyrite mine. Owing to the
standardized dimensions and formats of the newly designed modular
platform, standard devices and equipment of the liquid handling station
could be readily implemented including a microplate reader for fluores-
cence spectroscopic analysis of the labeled biofilms. This allowed us
to establish a semi-quantitative read out of the fluorescence hybridiza-
tion signals. The automated procedure enabled parallelization and high
reproducibility of the analysis of fluidic cultivation systems.
Keywords: FISH; CARD-FISH; biofilm; microfluidics; high-throughput experimentation
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Introduction
Biofilms are one of the most abundant form of microbial life in our ecosystems. This
extremely robust class of living systems affects various areas of human life. On the one hand,
biofilms are causing severe problems, like biofouling or hardly treatable infections [155].
On the other hand they are nowadays known to be essential for human health [156] and
their potential for industrial processes is far from being exploited[157]. In the past decades,
biofilm research was mainly focused on single species model systems, such as Pseudomonas
and Bacillus species as well as various E. coli strains [155, 158]. However, to fully understand
and effectively take advantage of biofilms, studies of multi-species biofilms are inevitable
and therefore there is a growing interest in complex microbial communities [159, 160].
Multispecies biofilms are prevalent in nature and the study of spatially-dependent cell
organization in biofilm development plays an important role in elucidating interspecies
interactions in these systems [160]. To meet the requirements of modern biofilm research,
novel tools are necessary to enable investigations in a highly parallel fashion with high
throughput. To study biofilms in vitro, flowcells are often more favourable than static
plate based methods because the hydrodynamic conditions in flowcells do much better
resemble the natural environment of the majority of biofilms. This holds particularly true
for fluidic shear forces, which strongly influence the microbial communities’ behaviour [161,
162]. While there are several assays available for the parallel screening of the static growth
of biofilms [163–165], to date only very few approaches have been reported which are
suitable for the parallel screening of biofilms cultured in flowcells [62, 63, 166, 167]. For
example, Benoit et al. [166] have used the commercially available Bio-Flux system for
parallel viability screening of flow biofilms. This device enables the cultivation of up to 96
biofilms in microfluidic channels. More recently the same system was used to study biofilm
formation and host-pathogen interactions of pathogenic E. coli [167]. As a drawback of this
device, researchers are limited to the available channel geometries and an automated fluid
exchange is not provided. Furthermore these studies have been restricted to single-species
biofilms. To the best of our knowledge, no method is currently available for comparative
screening studies of multispecies flow biofilms with high throughput. Flowcells have been
combined with imaging techniques like confocal laser scanning microscopy (CLSM) to
study the spatial structure and bacterial organisation under culturing conditions [168].
While this requires the expression of recombinant fluorescent proteins, end-point analyses
can be achieved by fluorescence in situ hybridization (FISH), which is nowadays an
established tool for the identification of single species within complex native microbial
communities [169, 170]. Typically, ribosomal RNA (rRNA)–targeting oligonucleotide
probes with specificities ranging from the species level to the level of phyla are used to
identify single microbial cells. The so-called “catalysed reporter deposition fluorescence in
situ hybridization (CARD-FISH)” provides a higher sensitivity than regular FISH because
the catalytic signal amplification step with horseradish peroxidase (HRP) enables reliable
detection of cells with low cellular ribosome content [171]. However, common drawbacks
of the FISH methods stem from the time consuming and work-intensive procedures and
the limited number of probes that can be used in a single experiment. As an approach to
overcome the latter problem, flow-through systems have been tested for semi-automated
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FISH protocols in the chromosomal analysis of eukaryotic cells [172]. However, they either
require highly sophisticated fluidic chips to achieve semi-automation [~tai2013, 173] or
they cannot avoid numerous manual handling steps [174–176]. For example, an automated
procedure for quantitative cell characterization by FISH has recently been proposed [172],
but its practical implementation remains to be demonstrated. Here we report on the
development of an interface for the handling of biofilm flowcells and the implementation of
a fully automated FISH procedure including analysis by fluorescence spectroscopy taking
advantage of commercially available and widely established liquid handling stations (LHS).
Our system is based on the platform proposed by Waldbaur et al. [79]. The dimensions,
contact points and connections are compatible with standard microtiter plate equipment,
such as thermocycler, shaker and plate readers, and offer full flexibility in the choice of
the flowcells’ geometry. As a proof of concept, we demonstrate the fully automated FISH
analysis of single- and mixed-species biofilms of Escherichia coli and Bacillus subtilis grown
in up to nine independent flow chambers with constant medium supply. Moreover, to
demonstrate the scope of our system, we implemented the complex and sensitive CARD-
FISH procedure, often used for reliable identification of slow growing species in complex
natural biofilms. An acidophilic consortium derived from a former pyrite mine [177] was
cultivated in the flowcell and automated CARD-FISH was conducted to screen for members
from the groups of Archaea and Bacteria.
Materials and Methods
General workflow
Biofilms were cultivated under flow in the newly developed cultivation chips. The chips
were tightly connected to the tubing via standard sterile cannulas. Since this connection
is reversible, after cultivation the flowcells could easily be disconnected from the silicone
tubing and reconnected to the chip-to-LHS interface described below. Fluorescence in
situ hybridization was then carried out fully automated on a LHS type Tecan Freedom
Evo 200 (Tecan, Switzerland) controlled by Evoware 2.5 (Tecan). Besides the custom
made flowcells, cartridges and a modified holder only commercially available accessories
were used for the procedure. The stained biofilms were automatically transferred to the
integrated microplate reader for fluorescence analysis. Subsequently, the biofilm structure
was examined manually by epifluorescence microscopy (cf. figure 5.13).
Flowcell fabrication and chip-to-LHS interface
The channel of the flowcell for biofilm cultivation was 3 mm wide, 1 mm high and 54 mm
long giving a channel volume of 162 𝜇L. The width was chosen in accordance with the lateral
resolution and minimal spot size for fluorescence measurements of the Tecan microplate
reader (Infinite M200 pro Tecan, Switzerland). The outer dimensions of the chips were
26x76 mm according to the standard format of microscope slides, to enable examination
of the chips with all standard microscopes. The replication master used for molding of
the flowcell was milled in brass with a computerized numerical control (CNC) machine.
Cannulas (Sterican, B. Braun Melsungen AG, Germany), were inserted through horizontal
holes in the mold before pouring the PDMS prepolymer (Sylgard 184, Dow Corning, USA)
to serve as placeholders for the later connection channel. The PDMS was cured at 60°C
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for at least 3h. The PDMS chip was bonded to a cover glass after activating both parts for
two minutes with oxygen-plasma (2 minutes, 20 sccm, 300 W, Plasma Flecto 10, Plasma
technology, Germany). The use of a cover glass for sealing the channel structure enabled
microscopic observations through the bottom of the chip. Standard cannulas were inserted
in the preformed connection channel to link the chip to the silicone tubing (figure 5.13). The
chip-to-LHS interface consisted of the flowcells, the inlet and outlet structures, connecting
cannulas and the three-part cartridge. One cartridge can hold up to three cultivation chips
for automated handling on the LHS (Fig. 1). The PDMS structures for inlet and outlet
were produced by solution casting of PDMS. The replication masters for this process as
well as the flowcell cartridges were produced by 3D-printing (Sculpteo, France). During
the casting process, as described for the fabrication of the flowcell, blunt cannulas inserted
through horizontal holes served as placeholders for the later connection channels between
flowcells and the respective structure. The flowcells were connected to these structures via
standard stainless steel capillaries (Sterican, B. Braun Melsungen AG, Germany). The
pipetting needles of the LHS could enter in the cone shaped connector ports of the inlet
structure to establish the leak-free but reversible connection between the pipetting needles
and the fluidic chip (Fig. 1). The design of the PDMS inlet structure was adopted from the
“microfluidics-on-liquid handling station” (𝜇F-on-LHS) concept introduced by Waldbaur
et al. [79]. The outlet structure was designed suitable for storage of up to 800 𝜇L liquid in
each cavity. The accumulated liquid could be removed from the cavities by the pipetting
needles. The fully assembled fluidic system (injection structure, up to three flowcells,
outlet structure) was placed in the carrier to allow for automated transfer by the robotic
manipulator arm (RoMa) of the LHS. The cartridge system comprised of the bottom
plate with positioning recesses, a cover with access holes for the pipetting needles and a
removable lid to enable optical analysis (Fig. 1). The cover provided light protection and
prevented lifting of the fluidic system from the bottom plate.
Biofilm cultivation in flowcells
Prior to assembly, all parts were sterilized by UV-radiation for 1.5 h, subsequently the parts
were connected under sterile conditions. The whole system was flushed with 70 % isopropyl
alcohol and filled with lysogeny broth medium (LB) (5 g/l yeast extract, 10 g/l tryptone,5 g/l
NaCl) with a multichannel syringe pump (KDS Multi syringe infusion/withdrawal pump
series 230, KD Scientific, USA). E. coli DH5𝛼 and B. subtilis DSM1088 were cultured in
LB medium. The system was equilibrated with the LB medium overnight. For inoculation,
overnight cultures (LB, 37°C) of both species were diluted to an optical density of 0.1 at
600 nm (OD600). For mixed species biofilms the overnight cultures were adjusted to an
OD600 of 0.2 and subsequently mixed in a ratio of 1:1. The cultivation channels were
inoculated by injecting 300 𝜇L of the diluted precultures. The system was incubated
without flow for one hour to allow initial attachment of the microorganisms. Subsequently,
the biofilms were cultivated at 37°C for 12 h with a constant flowrate of 50 𝜇L/min. The
acidophilic consortium was inoculated with a suspension of the native biofilm which was
collected from the abandoned pyrite mine “Drei Kronen und Ehrt” in the Harz Mountains
in Germany [177, 178] and stored at -80°C until usage . The biofilm was cultivated with an
adopted Picrophilus medium (FeSO4 90 mM, 0.128 g/l yeast extract, 1.51 mM (NH4)2SO4,
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MgSO4 2 mM, CaCl 1.7 mM, Wolfe’s mineral elixir, vitamin solution, [pH 2.5]) [179] at
room temperature under constant medium flow for four weeks (10 𝜇L/min)
Automated Fluorescence in situ hybridization
For automated execution of the FISH protocol, the Tecan Freedom Evo 200 (Tecan, Switzer-
land) was equipped with two temperature control systems (F25-MC, Julabo, Germany)
with coupled microplate/eppendorf tube carrier and a custom made modification for a
microplate carrier which prevented the cartridge from lifting when the pipetting needles
were retracted. One temperature control system was constantly cooled to 4°C and used
for storage of heat-sensitive reagents (hybridization buffer, DAPI solution), the second
temperature control system was initially cooled to 4°C for the fixation step of the FISH-
assay and afterwards heated to 48°C for hybridization. Temperature adjustments and all
other process steps were controlled by the Evoware software. Figure 1 displays a detailed
scheme of the LHS deck. The automated FISH procedure followed the protocol from
Pernthaler [171]. All reagents were injected to the channels by the LHS with a flowrate of
50 𝜇L/min.
Fixation and permeabilization of flow biofilms Flow biofilms were fixed by purging the
channel with 660 𝜇L of 4 % formaldehyde in LB medium and incubation for 60 minutes at
4°C. Subsequently, the biofilms were washed with 660 𝜇L phosphate buffered saline (PBS)
(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO2, 1.76 mM KH2PO2, [pH 7.6]). Cells were
then further permeabilized with 0.1 M HCl (660 𝜇L) for 10 minutes at room temperature.
Afterwards, the channels were purged with 242 𝜇L ultrapure water (ISO 3696).
Hybridization B. subtilis was visualized by hybridization with Alexa Fluor 488 labeled
LGC354B probe (5´-3´ [A488]- CGGAAGATTCCCTACTGC) (Sigma-Aldrich, USA).
E. coli was stained with Alexa Fluor 546 labeled Ent probe (5´-3´ [A546]- CCCC-
CWCTTTGGTCTTGC) (Sigma-Aldrich, USA). The hybridization buffer (0.9 M NaCl, 20
mM Tris-HCL [pH 8.0], 0.01 % SDS, 35 % formamide) containing 0.5 pmol/𝜇L of both
probes was stored on deck at 4°C until usage. An amount of 400 𝜇L was injected into the
channel. Hybridization was carried out at 46°C for 90 minutes.
Washing The excess probe was removed by purging the channel with 660 𝜇L of preheated
washing buffer (70 mM NaCl, 20 mM TrisHCl [pH 8.0], 5 mM EDTA, 0.01 % SDS) followed
by another incubation at 46°C for 15 minutes. Subsequently the biofilms were washed a
second time with 440 𝜇L of saline and sodium citrate buffer (SSC) (150 mM NaCl, 15
mM trisodium citrate, [pH 7.0]), incubated again for 15 minutes at room temperature and
finally rinsed with ultrapure water (440 𝜇L).
DAPI staining and embedding The biofilms were counterstained with 4’,6-diamidin-2-
phenylindole (DAPI) as follows. A solution of 1 𝜇g/mL DAPI (440 𝜇L) was injected into
the channel, the biofilms were then incubated for 5 minutes at room temperature and
washed with ultrapure water and ethanol (440 𝜇L each). Finally the channels were filled
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with 300 𝜇L of citifluor AF 3 (Citifluor, Great Britain) which provided protection against
bleaching.
CARD-FISH
The procedure for permeabilization and hybridization for CARD-FISH was similar as
described for FISH, besides the hybridization temperature which was set to 48°C. Bacteria
were visualized with the HRP-labeled EUB 338-I probe (5´-3´ GCTGCCTCCCGTAG-
GAGT), archaea with HRP-labeled Arch 915 (5´-3´ GTGCTCCCCCGCCAATTCCT).
For hybridization with multiple probes, the hybridization and amplification (including
all washing steps) was carried out separately for each probe. Excess probe and tyramide
conjugate were removed and the remaining HRP was inhibited with 0.1 M hydrochloric
acid.
Washing step I The channel was washed with 660 𝜇L of preheated washing buffer (70 mM
NaCl, 20 mM TrisHCl [pH 8.0], 5 mM EDTA, 0.01 % SDS), followed by 15 minutes
incubation at 48°C. After incubation, the channel was washed a second time with 440 𝜇L
washing buffer and subsequently rinsed with 440 𝜇L 1x SSC and incubated again for 15
minutes at room temperature.
Signal amplification The channel was filled with 400 𝜇L of freshly prepared amplification
mix (2 M NaCl, 0.2x PBS, 2.5 M dextran sulphate, 0.1 % blocking agent, 1 𝜇g/mL tyramide
conjugate, 15 ppm H2O2). Tyramide signal amplification was carried out for 20 minutes
at 37°C. Bacteria were visualized in red (Alexa 546), Archaea in green (Alexa 488).
Washing step II In the second washing step the remaining amplification mix was removed
by purging the channel with 660 𝜇L 1 x SSC (pH 6). Subsequently, the chip was incubated
at room temperature (total time, including purging and incubation, 30 minutes). The
channel was then rinsed with 660 𝜇L ultrapure water.
Fluorescence analysis in multiplate reader
The fluorescence of the stained biofilms was measured with the on-deck microplate reader
Tecan Infinite M200 pro (Tecan, Switzerland). The detachable lid of the carrier system was
opened by the RoMa and a predefined measurement protocol was executed automatically.
A modified protocol was used for the imaging of 13 measuring points in each chip uniformly
distributed along the flow path (Fig. 1). The excitation wavelengths for detection of the
probes were 490 nm and 556 nm for Alexa 488 and Alexa 546, respectively. The emission
was determined at 530 nm and 588 nm for Alexa 488 and Alexa 546, respectively. The
gain was set to 150 and 50 flashes were applied per measurement. DAPI was excited at
358 nm, emission was detected at 461 nm. For DAPI the gain was set to 80 and 25 flashes
were used per measurement. For each individual chip the background values for the 13
measurement points were recorded beforehand and subtracted from the raw signal. The
mean value of all 13 measurement points yielded the signal of one cultivation channel which
was then normalized to the mean background value of the respective chip. The average
signal and the standard deviation of three parallel cultivated chips were determined (Fig.
62
5.3 Fully Automated Method for Fluorescence in situ Hybridization for Biofilm Analysis
3). The average signal and the standard deviation of three parallel cultivated chips were
determined.
Microscopic analysis
Fluorescence microscope images were taken to confirm successful staining of the cells
and to observe the structure of the single and mixed species biofilms. An inverted
fluorescence microscope (ApoTome, Zeiss, Germany), a digital camera (AxioCam MRm,
Zeiss, Germany) and the AxioVision Rel. 4.7 software were used to obtain images of the
stained biofilms. Exposure times were kept constant for examination of various biofilms. For
the overview pictures nine sequential micrographs were recorded separately and composed
afterwards [180].
Optical coherence tomography (OCT)
Briefly, OCT is an interferometric imaging modality capable of visualizing biofilms com-
pletely [181, 182]. In this study a GANYMEDE-II spectral domain OCT was applied
(Thorlabs GmbH, Dachau, Germany). It acquires three-dimensional structural datasets at
the mesoscale (mm-range) with high lateral (≤ 12 𝜇m/pixel) and axial (≤ 3.1 𝜇m/pixel)
resolution at high speed, in situ, and without any sample treatment directly inside the
cultivation device. Thus, the biofilm structure after each step of the automated FISH
procedure was acquired and stored in a three-dimensional dataset. These datasets were
analysed using ImageJ [183]. After cropping the datasets to the flow channel of the mi-
crofluidic device and binarization using Otsu’s method [184] a topographic representation
of the bulk-biofilm interface was calculated.
Results
Automated flow through FISH protocol development and parallelization
Different procedures were initially tested to identify suitable conditions for the flow-through
FISH protocol. The objective was to handle as many flowcells in parallel as possible by
maintaining identical incubation times for all individual flowcells. With a nested procedure
it was possible to handle up to nine chips in parallel on three individual cartridges (Fig.
5.13 1/2/3) without major differences in incubation times. In general, we found that the
introduction of air into the microfluidic system must be strictly avoided to preclude high
shear forces arising from bubbles traveling through the cultivation channel. Therefore,
drying steps were excluded to avoid biofilm ablation and were compensated by a continuous
flow of reagents. For the flowcells used in the present study, three channel volumes (CV)
of liquid were necessary for complete liquid replacement. The whole procedure for nine
biofilm flowcells took 10 hours and could be carried out completely automated overnight.
Biofilm cultivation in flowcells and fluorescence in situ hybridization
The selected model bacteria representing a gram-positive and gram-negative bacterium
formed thick biofilms after cultivation in the flowcells at 37°C with LB medium for 12 h.
The permeabilization of the biofilm with 0.1 M hydrochloric acid was sufficient for the
used model bacteria. The chosen FISH probes showed the anticipated specificity for B.
subtilis and E. coli. Although the hybridization signal of B. subtilis was weaker than that of
E. coli, it was well suited for both manual microscopic analysis (Fig. 5.14) and automated
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Figure 5.13: Workflow of automated FISH labeling of biofilms cultivated in flowcells. E.
coli and B. subtilis biofilms were grown in a PDMS/glass hybrid cultivation flowcell. The
PDMS channel structure was sealed with a coverglass to enable microscopic examination of
the biofilms. The flowcell was connected to the tubing via standard cannulas. A medium flow
of 50 𝜇L/min was applied with a syringe pump. The various steps of FISH labeling procedure
were carried out fully automated with up to nine flowcells in parallel on a liquid handling
station (LHS). The center shows a photograph and a schematic representation of the working
deck equipped with the various stations necessary for the FISH procedure. The fluorescence
signal of the labeled cells in the channel was measured with the on-deck microplate reader on
the LHS. Afterwards, the results were additionally confirmed by epifluorescence microscopy.
An exploded view of the newly developed interface is shown on the right. One cartridge hosts
up to three chips which are connected to the inlet and outlet structures via stainless steel
capillaries. The pipetting needles form a tight but reversible connection to the inlet structure.
The scheme below shows the cultivation flowcell with the 13 measurement points for automated
fluorescence analysis in the microplate reader indicated as circles.
fluorescence analysis with the microplate reader (Fig. 5.15). The former allowed observing
the biofilm structure on different length scales. Figure 5.14 shows a number of fluorescence
micrographs with magnifications ranging from 50-fold displaying the whole channel width
to 1000-fold resolving the single cells of the biofilm structure. The E. coli D5𝛼 strain
formed mainly flat films (Fig. 5.14 B) whereas B. subtilis was also able to form filamentous
streamers (Fig. 5.14 A). In the co-cultivation this behaviour seemed not to be altered
significantly (Fig. 5.14 C). With higher magnification a cloudy structure in the E. coli
biofilms could be observed, which hampered the visualization of individual cells in some
areas (Fig. 5.14 E/H). In contrary, B. subtilis created a dense mesh of individual cells. In
mixed biofilms E. coli cells seemed to spread all over the Bacillus mesh (Fig. 5.14 B/C/F)
and only the streamer parts of the biofilm appeared to be dominated by B. subtilis cells.
Fluorescence analysis in the microplate reader
The E. coli and B. subtilis cultures could be reliably identified by an automated fluorescence
measurement following the hybridization protocol. A standard microplate reader integrated
64
5.3 Fully Automated Method for Fluorescence in situ Hybridization for Biofilm Analysis
Figure 5.14: Epifluorescence micrograph of B. subtilis (A, D, G), E. coli (B, E, H) and mix
species (C, F, I) biofilms. B. subtilis and E. coli were hybridized with probes LGC354B-A488
(colored in green) and Ent-A546 (red), respectively. Each of images A-C is a composition
of nine micrographs which were recorded sequentially and composed afterwards [180]. As a
consequence, the entire channel width is depicted in the images giving an overview of the
macroscopic structure of the flowcell biofilms. E. coli was forming a flat biofilm particularly at
the walls of the flow cell, whereas B. subtilis grew in filamentous streamers. In the mixed species
biofilms the individual structures seemed not to be strongly affected by co-cultivation. (D)
Detailed view of a B. subtilis biofilm. The Bacillus cells formed a dense network structure. (G)
The biofilm structure could be resolved at the single cell level with the 1000-fold magnification.
(E) Cloudy E. coli biofilm in 200-fold magnification. Larger particles sometimes stuck in the
biofilms interfering with the photometric fluorescence measurement (B and E). (F) Mixed
species biofilm with Bacillus cells forming a dense mesh and E. coli cells growing inside the
network. (I) Close up of the mixed species biofilm clearly demonstrating a successful one-step
double hybridization of the gram positive B. subtilis and the gram negative E. coli in a mixed
species biofilm.
on the LHS was used for the analysis. More distant excitation and emission wavelengths
were used to compensate for the distorting effect of light scattering by the PDMS. Figure
5.15 depicts the results of the fluorescence measurement of nine flowcells, which were
cultivated and stained in parallel. The chips were inoculated with E. coli, B. subtilis or a
co-culture of both organisms. The detected variations of the hybridization signals between
three flowcells were comparable for all cultures. The signals from the gram-negative E. coli
were about five-fold higher than those obtained from the gram-positive B. subtilis cultures
although signals from unspecific DAPI stain were comparable for both.
Optical coherence tomography (OCT)
To proof that the structural integrity of the biofilms during the automated FISH procedure
we monitored the mesoscopic structure of the developing biofilms (E. coli, B. subtilis,
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Figure 5.15: Mean fluorescence values of three parallel cultivated biofilms normalized to
the respective mean background value. For each flowcell the signal was averaged over the 13
measurement points. Error bars reflect the deviation between three cultivation flowcells. The
excitation wavelengths for detection of the dyes were 490 nm, 556 nm and 358 nm for Alexa
488, Alexa 546 and DAPI, respectively. The emission was determined at 530 nm, 588 nm, and
461 nm for Alexa 488, Alexa 546 and DAPI, respectively. Note that the E. coli and B. subtilis
cultures could be reliably identified by the automated fluorescence measurements.
E. coli + B. subtilis) by means of optical coherence tomography (OCT) during the entire
experiment. Figure 5.16 shows the subsequent OCT images during automated FISH
procedure as well as an example of an OCT image in conjunction to the FISH images
itself. Especially for the mixed species biofilm there where a lot of planktonic cells visible
before the protocol was started (green, lose parts), which were washed out in the fixation
step. Subsequently there was no obvious association between biomass loss and one specific
step, rather than a continuous slight erosion of biofilm throughout the whole procedure.
Due to partly strong reflexion effects on the glass bottom of the cultivation channel a
quantification of the biofilm was difficult.
CARD-FISH
Slowly growing archaea and bacteria from an acidophilic native biofilm were successfully
cultivated over long periods of up to four weeks in the microfluidic channels and visualized
with an automated CARD-FISH procedure for flowcell biofilms. The complex protocol took
approx. 10 hours for one cartridge with three flowcells and could be conducted overnight in a
fully automated manner. Figure 5.17 shows an epifluorescence micrograph of stained archaea
cells in green and neighbouring bacteria cells in red with 1000-fold magnification. The
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Figure 5.16: (a)/(b)/(c) Topographic representation (6.7 mm x 3 mm, height = 100 𝜇m
(red colored)) of the 3D structure of mixed species (a), E. coli (b) and B. subtilis (c) biofilms
captured by means of OCT during automated FISH procedure. For each biofilm images were
acquired right before FISH was conducted, after fixation, permeabilization, hybridization
and washing. Slight biofilm detachment was observed throughout the whole procedure. But
altogether the structural integrity could be preserved for all three model biofilms. (d) Epi-
fluorescence micrograph of mix species biofilm. Biofilm features visualized by OCT are easily
recognizable by epi-fluorescence microscopy after FISH.
bacterial activity induced the formation of insoluble minerals, probably Fe(III) species which
result from the oxidation of Fe(II) in the medium by chemolithoautotrophic microorganisms.
Discussion
Fluorescence in situ hybridization (FISH) is an established, widely used and powerful tool
for the identification of single cells or the analysis of complex microbial consortia [171, 185].
For conventional FISH staining as well as the more sensitive catalysed reporter deposition
fluorescence in situ hybridization (CARD-FISH) various slightly different methods have
been reported depending on the target species [171]. They all have in common the numerous
labour-intensive and time consuming steps which make the FISH method a complex process
for routine analysis. This is especially true for all CARD-FISH protocols. This study
describes the development of a platform for the fully automated handling of flowcells for
biofilm cultivation and established methods for FISH of up to nine flowcells in parallel as
well as CARD-FISH of up to three flowcells in parallel. Thus, one person can analyse nine
biofilm samples in parallel with high reproducibility and a hands-on-time of approximately
only 1.5 hours. Full automation of the FISH method in a flow-through format required
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Figure 5.17: Catalysed reporter deposition fluorescence in situ hybridization (CARD-FISH)
image of a cultivation flowcell, inoculated with native biofilm and cultivated for four weeks.
Archaea (ARCH 915) are visualized in green (Alexa 488), bacteria (EUB 338-I) in red (Alexa
546) and DAPI blue.
an automated manner of liquid replacement. The here described solution is characterized
by its minimal design using a standard robotic pipetting platform instead of a previously
suggested complex valving system, which usually provides a limited number of available
supply lines [173]. The small dead volume of the here adopted 𝜇F-on-LHS platform [79]
reduces loss of expensive reagents because the required reagent volumes only depend on
channel volume and geometry. With this set-up, it was possible to successfully hybridize
oligonucleotide probes with a mixed-species biofilm consisting of E. coli and B. subtilis cells.
Fixation with formaldehyde combined with 0.1 M hydrochloric acid treatment for 10 minutes
was well suited for the permeabilization of both cell types. However, quantitative results
of the photometric fluorescence measurements obtained with the microplate reader should
be handled with caution because the signals are affected by many different factors such
as light scattering by the PDMS, traces of lint or dirt inside the channels, brightness and
photostability of the various fluorophores as well as a lack of suitable calibration standards.
Nevertheless, this simple and very fast method allowed for unequivocal assignment of
the different organisms building up the biofilms. Furthermore, the results provided first
indications for hybridization efficiencies and composition of the mixed species biofilms.
The unspecific DAPI staining resulted in a 1.25-fold higher signal for the Bacillus biofilms,
while with the fluorescently labeled hybridization probes it was about 6-fold lower than
those observed for E. coli, thereby indicating a lower labeling efficacy for B. subtilis. The
latter can most likely be attributed to limited permeabilization of the gram-positive cell
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wall by the hydrochloric acid treatment. Therefore, further optimization of the automated
FISH-protocol will concern, in particular, optimization of the cell wall permeabilization
of gram-positive cells. In general, the permeabilization step has been identified as crucial
for successful FISH of mixed species biofilms [186]. This step has to reach an optimal
compromise between sufficient permeabilization of rather rigid cells and the integrity of
more sensitive cell-types. Since enzymatic methods like lysozyme treatment, as suggested
by Thurnheer et al. [186], are less robust and very sensitive to exact timing, we believe that
careful optimization of the hydrochloric acid treatment with respect to incubation time and
concentration will be suitable to attain higher labeling efficiencies. Microscopic investigation
of FISH stained biofilms enables a detailed analysis of the microbial community especially
with regard to spatial organisation on the cellular level without the need of genetically
modified strains. Therefore, the presented method is particularly suitable for analysis of
environmental or complex technologically relevant biofilms [160, 185]. For the used model
community, the biofilm structure could be visualized on different length scales and different
taxa could be specifically identified. The drawback of the method, a limitation all FISH
experiments have in common, is the number of available fluorescent colors . The intensity of
the FISH signal strongly depends on the cellular ribosome content, which, on the one hand,
can be a beneficial for determination of cellular activity [187]. On the other hand, small or
slowly growing microorganisms cannot be easily detected by conventional FISH [171, 185].
In the present study, an acidophilic consortium with chemolithoautotrophic organisms as
primary producers was cultivated in the flowcell system for very long time periods of up to
four weeks without any sign of contaminations . The consortium was subsequently screened
for members from the domains of Bacteria and Archaea by automated CARD-FISH. This
successful demonstration of long-term cultivation and automated high-sensitivity analysis
complements the application spectrum of our automation platform to the characterization
of all kinds of extremophilic and/or oligotrophic biofilms. There are a number of review
studies proposing fluidic or microfluidic structures as a promising tool to target new
questions in microbiology [188, 189] and particularly in biofilm research [190]. While the
number of parallel cultivations is primarily limited to the number of available pumps
and valves, the subsequent analytical methods require a lot of manual work and, hence,
this becomes the bottleneck of throughput in experimentation. In the present study
we introduced a system which is suitable for automated handling of microfluidic chips
independent of the channel geometries. The system could be easily adopted to smaller
flowcell geometries and up to eight channels per cartridge could be operated. Accordingly,
a total of [175] flow biofilms could be readily analysed in parallel with our newly established
procedure. To conclude, we developed a platform for the automated handling of fluidic
biofilm cultivation chips. We established the procedures for automated execution of FISH
and CARD-FISH analyses of flowcell biofilms on this platform and successfully applied
the method to a mixed species biofilm with a gram-positive as well as a gram-negative
member. Furthermore, the hybridized biofilms could be analysed by means of a microplate
reader and epifluorescence microscopy. In addition to the applications shown in the present
study, our platform could be used for various analytical assays in biofilm research. For
instance, Hennig et al. developed a method for the functional analysis of immune cells
by combining microfluidic chips for cell immobilization with an automated microscopic
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read-out [191]. Pernthaler et al. [192] provided a system for the automated counting of
double-stained microbial cells to determine the relative abundance of specific microbial
taxa in marine picoplankton after FISH. Following these examples, a next step for widening
the scope of the here presented platform would concern the implementation of automated
microscopy, which could be easily achieved due to the standard dimensions and formats of
our cultivation chips.
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Abstract
BACKGROUND: 3D printing and bioprinting in particular are emerging
technologies in the field of biotechnology. The developments of bioprinters
and applications lie mostly in the highly observed working fields of tissue
engineering and regenerative medicine. Until now only little attention
has been paid to the application of 3D bioprinting for the investigation
of hydrogel - liquid phase interactions in biotechnological applications.
This can mostly be attributed to the need for complex and expensive
equipment.
RESULTS: In this work, an entry-level bioprinter on the base of a com-
mercially available Fused-Filament-Fabrication 3D printer and an easy
to handle user interface was designed. This newly developed bioprinter
allowed the structuring of bioinks and hydrogels in microwell plates and
even complex models were printed. The applicability of the presented
printer setup in the field of biotechnology was shown by the encapsulation
of 𝛽-galactosidase (EC 3.2.1.23) in poly(ethylene glycol) diacrylate based
hydrogels. Subsequently, an automated screening of the biocatalytic
conversion of the substrate ONPG by the encapsulated enzyme was
executed on a liquid handling station. Under varied pH conditions in the
surrounding liquid phase highest substrate turnover rates were detected
at pH 3 and pH 5 which is in good accordance with previously reported
pH optima of 𝛽-galactosidase.
CONCLUSION: This approach shows an easy access to 3D bioprinting in
the field of biotechnology and the implementation of 3D printed hydrogels
in high-throughput experimentation.
Keywords: 3D bioprinting; hydrogels; encapsulated enzymes; high-throughput screening
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Introduction
Printing in three dimensions is one of the most aspiring technologies in various industrial
and scientific sectors. In many industrial fields 3D printing is already an established
technology for rapid prototyping or product manufacturing. Whenever new and more
effective shapes need to be developed, 3D printing provides an unrivalled fast and cheap
manufacturing technique.[84, 193] In biotechnological research at present, 3D printing
is mainly used for the manufacturing of molds for microfluidic devices [79, 194] or the
direct printing of the devices itself [49, 195, 196]. Furthermore, 3D printing technologies
are applied for tailor-made fabrication of labware [12, 87, 197] and opens simple and fast
access for new scientific approaches [89, 198, 199]. However, most attention is certainly
paid to the upcoming field of bioprinting. The concept of bioprinting is commonly defined
as the construction of three dimensional structures of biological or biocompatible materials.
Bioprinting is considered as key technology in the field of biofabrication for tissue engi-
neering (TE) and regenerative medicine.[200] Thus many researchers focus on adapting
techniques and materials for this intended purpose.[100, 201] In TE the use of hydrogels as
scaffold material to generate cell-friendly environments is a well-established method. [102,
202–204] Bioprinting techniques are applied in the preparation of scaffolds with subsequent
cell seeding [205–207], for development of medical applications [208], personalized drug
screening [209] and the engineering of tumor [210], skin [211] and organ models [212].
Further functionalities can be implemented by the combination of 3D printed hydrogels and
conducting polymers, which led to bionic approaches.[213] Yet, 3D printing of hydrogels
is not only of interest in the context of tissue engineering and regenerative medicine but
also other sectors in the biotechnological spectrum profit from this technology including
’green bioprinting’ [15] and printing of bacterial cells [16]. Further versatile hydrogel
printing applications can be developed as hydrogels are already in use for different kind of
experimental approaches. For example, the entrapment of biopharmaceutical proteins in
hydrogel structures is part of investigations in a new methodology of drug release.[110, 214,
215] Furthermore, the encapsulation or even immobilization of enzymes in and on hydrogels
is of huge interest as reusable matrix in biocatalysis or analytical applications.[109] Func-
tional biological composite materials can be incorporated in microreactors and microfluidic
devices [216–218], biosensors [219, 220] or as beads in diverse applications [221, 222].
For these and other applications the move towards three dimensional structures could open
new possibilities in industry and academics. In particular, the interaction of the hydrogel
and the encapsulated protein with the surrounding liquid phase is a crucial issue in regards
to unwanted leaching, controlled release and penetration of other molecules [107, 111]. To
investigate the multitude of variable parameters in hydrogel or liquid phase experimental
approaches in established automated high-throughput instrumentations provide a promising
concept.
The vast majority of commercially available bioprinters, which are capable of printing
hydrogels, are designed for the application in tissue engineering. To address the challenges
of cell printing applications, they provide sterile environments and cell-friendly printing
conditions which makes them expensive, complex and difficult to access. To lower the hurdle
for scientists to establish 3D printing technologies in their laboratories entry-level solutions
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with a user-friendly interface are required. To date, only a few studies are available that
provide a possibility for a more easy entry to bioprinting by the modification of commercially
available non-bioprinters.[106, 223, 224] These studies present printers specially adapted
for the application in the field of TE. The particular focus of these works was establishing
cell-friendly printing conditions and the preservation of the viability of the printed cells.
But further applications in other biotechnological fields have hardly been investigated
so far. By transferring the tools and methods developed for tissue engineering to other
biotechnological applications, promising opportunities could arise. For example, the imple-
mentation of the ’mold and fill’ strategy [225] enables the three dimensional structuring of
low viscosity bioinks, which are preferred for applications in microfluidic devices [216, 217]
or for coating procedures [226, 227]. What is currently missing are a range of entry-level
3D bioprinters for simple hydrogel printing in biotechnological applications, which fulfill
the demands of respective laboratory environments, are operated in ambient conditions
and are open and easy to access for researchers. The here presented study introduces
a combinatorial approach for the implementation of 3D printed hydrogels in automated
high-throughput experimentation on liquid handling stations (LHS) adapting printing
strategies known from tissue engineering. For this purpose we created the Biomaker, a
modified low-cost commercially available fused filament fabrication (FFF) printer with
full and easy access via G-code. The Biomaker is equipped with a custom-made syringe
extrusion unit that allowed the deposition of hydrogels on various printing substrates
including multiwell plates. These hydrogel-loaded plates could be readily implemented in
automated processes on well-established liquid handling stations. As a proof of principle
we applied the presented combination of bioprinting and automated high-throughput
experimentation to encapsulate 𝛽-galactosidase (EC 3.2.1.23) in poly(ethylene glycol)
diacrylate based hydrogels with a mold and fill printing process. The use of sacrificial
ink as a 3D printed mold could circumvent the inherent issues generating 3D structures
of low viscosity bioinks. Subsequent to the printing procedure, the activity of the encap-
sulated enzyme is determined by the automated execution of a screening assay. Various
concentrations of 2-Nitrophenyl 𝛽-D-galactopyranoside as substrate and three different pH
values of the surrounding buffer are tested. The method could be particularly suitable for
the investigation of the influence of varying parameters in a design of experiments approach.
Experimental
Modification of an Ultimaker Original+ for bioprinting
A commercially available 3D printer (Ultimaker Original+, Ultimaker, The Netherlands)
was equipped with a custom-made syringe extruder. The wooden body of the printer was
replaced with laser cut acrylic glass parts (Formulor, Germany) by modifying the open
use design laser files which are shared online (https://github.com/Ultimaker/Ultimaker-
Original-Plus). The syringe extruder was inspired by the work of Marry Bassa and Jelle
Boomstra (http://www.thingiverse.com/thing:31210). It was mounted on the print head,
which preserved the possibility of fused filament fabrication of various materials. The CAD
files for the construction of the extrusion unit were created using Solid Edge (ST7, Siemens
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PLM Software, USA). The extrusion unit consists of a housing, a NEMA 17 stepper motor
with threaded rod (Thingibox, Spain), two linear bearings and rods (Thingibox, Spain)
leading extrusion movements, printed connectors between the threaded rod and the plunger
and a printed cartridge for the syringe. The installed stepper motor is identical in construc-
tion with the provided motors of the Ultimaker which enables the control of the extrusion
unit by the Ultimaker main board. The rotation of the motor drives the movement of the
syringe plunger for extrusion. The connector between the rod and the cartridge stabilized
syringe allowed the implementation of withdrawal commands. According to the Ultimaker
specifications (see https://ultimaker.com/en/products/ultimaker-original/specifications),
the positioning accuracy is 12.5 µm in X- and Y-direction and 5µm in Z-direction. The
print head travels with a velocity up to 300 mm/s, which corresponds to the potential
maximum velocity during extrusion. The actual print speed and extrusion rate to be set
for a proper and precise printing result are strongly dependent on the characteristics of
the printing material and the dispensing tip geometry (length and inner diameter).[228]
Furthermore, the printing platform of the Biomaker can be heated up to 100°C if necessary
for the printing process. The commands for the printer were provided as a G-code file. For
creation of G-code files a user interface (UI) consisting of multiple Excel sheets (V15.0,
Microsoft, USA) was created. This UI allowed to specify various printing conditions and
parameters like the kind of printing substrate (multiwell plates, microscope slides, petri
dishes), the number of printed structures (up to 96, depending on chosen printing substrate),
the shape of the structures from a selection of predefined geometries (circle or square) and
the number of layers. Other entries in this UI affect the crucial printing parameters like
printing speed and extrusion rate which have to be adopted for a change in material or
size of the dispensing tip. From this entered data a G-code file is generated and send to
the printer by the open source software Pronterface (part of printrun, licensed under GNU
General Public License, version 3). More complex structures in the STL file format could
be printed with the use of the slicing and printing software Cura (V2.1, Ultimaker, The
Netherlands). Modified filament classes which control the printing parameters have been
created to enable Cura controlled extrusion of hydrogels.
Printing and polymerization process for the 𝛽-galactosidase encapsulation
For the sacrificial ink a solution of 30 %(w/w) Kolliphor P 407 (Sigma-Aldrich, USA)
in ultrapure water (Purelab Ultra, Elga Labwater, GB) was prepared. To achieve a
homogeneous solution, the mixture was stirred for several hours in the refrigerator. The
sacrificial ink was then filled in 10 mL syringes (Omnifix Luer lock Solo, B. Braun, Germany)
for the use in the extrusion unit of the printer. The Poly(ethylene glycol) diacrylate (PEG-
DA) based bioinks were prepared with a ratio of 50 %(w/w) PEG-DA (average Mn 575,
Sigma-Aldrich, USA), 1 %(w/w) 2-Hydroxy-2-metylpropriophenone (HMPP, Sigma-Aldrich,
USA) as photoinitiator and ultrapure water respectively a solution of 𝛽-galactosidase from
Aspergillus oryzae (EC 3.2.1.23, Sigma-Aldrich, USA) in ultrapure water. The final amount
of encapsulated 𝛽-galactosidase in one hydrogel-loaded well was 0.4 mg. As depicted in
the process scheme in figure figure 5.18, steps A-E the printing procedure was as follows.
In each well of a costar® 48 well plate (Corning, USA) ten layers of the sacrificial ink were
printed as hollow cylinders with a diameter of 7 mm using a dispensing tip with an inner
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diameter of 0.84 mm and a length of 1 inch (Vieweg, Germany). The printing process
was executed with an extrusion velocity of 500 mm/min and an extrusion rate of 0.41
mL/min (respectively 0.82 µl per mm printing distance), with the heated platform turned
off. The gap between well rim and the printed molding structure was filled with 320 𝜇L
of the PEG-DA based bioinks and polymerized with a UV-diode (LC-L2, Hamamatsu,
Japan) at 365 nm for 20 seconds with an irradiance of 14 W/cm2 (figure 5.18, step A).
After the polymerization, the multiwell plate was transferred to a liquid handling station
(Freedom Evo 200, Tecan, Switzerland) and a cleaning protocol was executed. At lower
temperatures, the sacrificial Kolliphor ink became liquid and could be washed out. Hence,
the plate was gently shaken on a cooled shaker (4°C) and filled with ultrapure water of the
same temperature (figure 5.18, step B). The water was renewed every two minutes for a
total of ten cleaning cycles. After this automated cleaning procedure the wells were filled
with 800 𝜇L of ultrapure water and stored in the refrigerator overnight.
Sacrificial ink mold
(30 % Kolliphor)
Filling gap with bioink
(PEG-DA + PI +H2O [+ ß-galactosidase])
Polymerization of bioink
(365 nm, 20s, 14W/cm²)
Printing
Dissolving sacrificial ink
(10 cycles with cooled water at 4-C)
Filling in storage solution
(stored in water at 4-C over night)
Cleaning
Equilibration
(with respective buffer, gentle shaking for
20 min)
Providing stop solution




(ONPG to ONP and galactose)
Transferring samples to
stop solution












Figure 5.18: Schematic representation of the process steps for the execution of the case study.
Step A – Printing procedure with the production of a printed sacrificial mold. The resultant
gap was filled with bioink, followed by UV-polymerization. From this point on, the process was
executed on the liquid handling station. Step B – Removal of the sacrificial mold with cooled
water in a cleaning procedure. Step C – Preparation of polymerized and cleaned hydrogels for
the assay by equilibration. Meanwhile the stop solution was provided in a deep well plate. Step
D – The execution of the enzymatic assay was started with the filling of the hydrogel-loaded
wells with ONPG solution. Samples were drawn and transferred to the provided stop solution.
Step E – The samples were transferred to a UV microplate and the absorption is measured at
410 nm. The gained data leads to the determination of reaction rates.
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Automated preparation and execution of enzyme assay
For the execution of the case study, the enzyme 𝛽-galactosidase was chosen as model
enzyme because of the colorimetric activity assay with the small substrate ONPG which is
transformed to ONP. The enzyme assay was executed according to previously published
protocols [229, 230], slightly adapted for kinetic investigations on the liquid handling station.
As buffer system a 25 mM multicomponent buffer (after Kroener and Hubbuch [231]) was
applied consisting of MOPSO (3-Morpholino-2-hydroxypropanesulfonic acid, AppliChem,
Germany) and L-(-)-Malic acid (Sigma-Aldrich, USA). The buffer was split in three portions
with the pH set to 3, 5 and 7 by titration using 4 M sodium hydroxide solution (NaOH,
Merck, USA). The five-point calibrated pH-meter HI-3220 (Hanna Instruments, USA)
with a SenTix R 62 pH electrode (Xylem Inc., USA) was used for the adjustment of the
pH. For the enzyme assay the substrate 2-Nitrophenyl 𝛽-D-galactopyranoside (ONPG,
Sigma-Aldrich, USA) was dissolved in different concentrations in the pH-variants of the
mentioned multicomponent buffer. To quantify the turnover of the substrate, a calibration
with 2-Nitrophenol (ONP, Sigma-Aldrich, USA) was performed. The stop solution was
prepared by dissolving 4 M sodium carbonate (Sigma-Aldrich, USA) in ultrapure water.
For each substrate concentration two multiwell plates with hydrogels were prepared, one
with and one without 𝛽-galactosidase to execute and blank the activity assay. To investigate
the stability of the encapsulated enzyme in a dry and moist storing condition, one pair
of plates (with and without 𝛽-galactosidase) was dried at 37°C and one pair of plates
was filled with ultrapure water. These plates were stored in the refrigerator at 4°C for
30 days until the execution of the enzyme assay. The enzyme assay was performed fully
automated on the LHS. The storage solution was removed prior to an equilibration step.
The hydrogel cylinders in the wells were filled with the buffer of the same pH as the
assay would be executed and gently shaken for 20 min to equilibrate (figure 5.18, step C).
Meanwhile, 300 𝜇L of stop solution were provided for each sample in a deep well plate
(VWR, Germany). The dried hydrogels were re-hydrated with ultrapure water before the
equilibration. Subsequently, the liquid was discarded and the wells were filled with ONPG
solution of defined concentration and pH (figure 5.18, step D). For every sampling point
and every pH a duplicate was prepared. The hydrolysis of ONPG to ONP and galactose
was monitored over a time span of 16 minutes by retrieving liquid samples every two
minutes. The samples were transferred to the deep well plate with provided stop solution.
The use of the alkaline stop solution tautomerized the produced ONP which gave it the
yellow color detectable at 410 nm, also for the samples of lower pH.40 Subsequently, the
samples were transferred to a 96 well UV-microplate (Greiner Bio-One, Germany) and
the absorption at 410 nm was measured in the integrated spectrophotometer (infinite®
M200 pro, Tecan, Germany) to obtain the substrate turnover (figure 5.18, step E). The
turnover rate of the encapsulated 𝛽-galactosidase was determined for eight different ONPG
concentrations in the range from 0.5 to 60 𝜇mol/mL at three different pH values (3, 5 and
7) on a tempered shaker at 37°C.
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Results and discussion
Printer modification and printing process
A 3D printer for bioprinting applications in the field of biotechnology should be easy
to implement in present biological laboratory environments and therefore has to fulfil
common biotechnological lab standards. Furthermore a low price-tag and the possibility
for uncomplicated adaptations and refinements in soft- and hardware are highly preferable.
This need for simple and entry-level 3D printers for bioink printing in the field of biotechnol-
ogy was addressed by the modification of a commercially available fused filament fabrication
printer as could be seen in figure 5.19A. The open-source pedigree of the Ultimaker original+
printer allowed the well-functioning transformation into a bioprinter. The mounting of the
extrusion unit (see figure 5.19B) on the print head also reduced the actual dead volume
which would have been occurred by an external installation and a tubing connection to the
print head. The first prototype parts for the extrusion unit were printed by the printer itself
using PLA. In a progressed stage the housing parts of the extrusion unit and the original
wooden parts of the printer were replaced by acrylic glass cuttings. The implementation of
an equivalent stepper motor for the extrusion unit simplified the operation and the control
by means of G-code files. With the help of simple positioning tools for the determination
of the starting point of the print and with known geometrical parameters of the multiwell
plate and its wells, the printing pattern for up to 96 wells at once or individually could
be set up. For the use of automated generated G-Code files from the slicer and printing
software Cura the predefined filament classes were adapted for bioink application.
The replacement of the wooden housing parts fulfilled the requirements for the integration
of the printer in the bio lab working environment. The acrylic glass parts conforming to lab
safety standards and are easy to clean. Through the ability to withdraw the plunger after
the completion of a print a proper outcome of the structures and the tidy and leak-free
travel of the print head between the printing spots were ensured. Providing a fixation
of the syringe in the cartridge on the extrusion unit together with the linear guidance
minimized the influence of occurring leverage effects while extruding. This resulted in
a good position precision for the entire printing process which could not been achieved
without the constructive optimization. The presented setup could print inks with a viscosity
up to 5000 Pa*s (measured at a shear rate of 0.1 s−1) which sufficiently covers the usual
viscosity range of extruded bioinks. [232, 233] The opportunities for manipulating the
G-code by the various variables entered in the UI allowed a fast adaption on changed
printing substrate geometries, inks or nozzle types. The created filament classes for various
bioinks enabled the print of complex structures like scaffolds as used in tissue engineering
or even challenging models like body parts (shown in figure 5.20) by importing files in the
STL-format into Cura. Although the biomarker is not intended to be employed for tissue
engineering, this feature could serve well for the production of preliminary research objects,
proof of concept studies and definitely as demonstration system for educational purposes.
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Figure 5.19: Photographs of the Biomaker and the extrusion unit. (A) Overview of the
modified printer named Biomaker with the extrusion unit mounted on the printhead (1), a
template for the positioning of the multiwell plate (2) and the acrylic glass body which replaces
the original wooden body. The “ulticontroller” (4) can be used for direct control of the printing
process. (B) Close-up view of the extrusion unit. The syringe is fixated in a cartridge (1) on
the extruder. The additional printed parts (2) enclose the plunger of the syringe and enabled
retraction movements. Together with the cartridge, the linear bearings and rods (3) allowed
the precise printing position. The extrusion was executed by the movement of the stepper
motor (4).
Automated execution of enzyme assay with encapsulated 𝛽-galactosidase
In the field of biotechnology, the interactions between liquid phases of various compositions
and hydrogels with incorporated biologically active components is of great interest. For this
investigative challenge of manifold combinations, automated high-throughput screenings
are a promising and already established strategy. Such screening approaches facilitate the
preparatory hydrogel research especially for applications which are difficult to automate or
to parallelize and will profit from uncomplicated preliminary tests.
To demonstrate the applicability of the developed bioprinter in the field of biotechnology,
a screening study for optimal process parameters of hydrogel encapsulated 𝛽-galactosidase
was conducted. The enzyme containing, UV-curable bioink which is usually not printable
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A B
Figure 5.20: Photographs of printed models generated from STL files, both models were
printed with a dispensing tip of 0.41 mm inner diameter (A) Scaffold printed with 30 %(w/w)
Kolliphor (B) model of a human ear (after: http://www.thingiverse.com/thing:105808) printed
with Nivea Soft Creme.
in three dimensions by extrusion-based systems, was 3D structured by a two-step printing
process using a sacrificial ink (see figure 5.18, step A). By producing these structures in
multiwell plates, a LHS based high-throughput screening of the hydrogel-enzyme composite
and its interaction with the liquid surrounding was enabled without changing the original
composition of the bioink. Hence, the transferability to the later applications in microflu-
idics or coatings was preserved. The easy setup and control of the printing process and the
precise deposition of the sacrificial ink in the multiwell plate allowed the manufacturing of
hollow hydrogel cylinders with a good positioning accuracy of the sacrificial structures. The
resulting polymerized hydrogel cylinders were approximately 8 mm in height, had a wall
thickness of approximately 1.6 mm and kept their shape over the entire experimental period
of 30 days. The activity of the encapsulated 𝛽-galactosidase was determined by monitoring
the production of the yellow-colored ONP, which was detected by absorption measurements
at 410 nm. The calculated values of produced ONP were plotted over time to determine the
turnover rate by the initial slope of the data points. An example of the turnover kinetics
for an ONPG concentration of 40 𝜇mol/mL for all three pH values is shown in figure
5.21A. The determined turnover rates were 0.199 𝜇mol/min for pH 3, 0.201 𝜇mol/min for
pH 5 and 0.117 𝜇mol/min for pH 7. Except for one outlier the shown standard deviations
were ranged between 0.05 % and 8 % which indicates a satisfactory reproducibility in the
measured duplicates. This emphasizes the good precision of the printer which results in the
production of hydrogel cylinders of consistent quality. The established turnover rates from
the multiple experiments were then merged to plot the dependency of the turnover on the
substrate concentration as depicted in figure 5.21B. For each pH, the gained data points
fit perfectly in the expected scheme of a typical Michaelis-Menten saturation curve of an
enzyme reaction. The reaction rates at pH 7 were always smaller than the rates at pH 5
and pH 3, which showed a performance comparable to each other. These obtained findings
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matched well the pH optimum of the ONPG conversion of 𝛽-galactosidase from Aspergillus
oryzae which is reported to be in the range of pH 4-5. [234–236] From the measured kinetics
also the enzymatic parameters Km and vmax could be calculated which permit a compar-






















































Figure 5.21: Representation of the reaction rate determination and the resulting Michaelis-
Menten plot. (A) The initial slope of the measured production of ONP over the observed time
span corresponds to the reaction rate of the encapsulated enzyme for the present condition.
In the shown example, an initial ONPG concentration of 40 𝜇mol/mL at pH 3, 5 and 7
was examined. (B) The calculated reaction rates were plotted over the respective ONPG
concentration which leads to a typical Michaelis-Menten saturation curve for all examined pH
values.
The used PEG-DA based hydrogel could also preserve between 60-65 % of the activity
of the encapsulated enzyme over a period of 30 days regarding the reaction rates measured
after the overnight storage as 100 % for each pH individually. This could be determined
for dry as well as for moist storing conditions (see figure 5.22). The enzyme assay for this
investigation was executed with an ONPG concentration of 10 𝜇mol/mL. The observed
influence on the activity of stored hydrogel-encapsulated enzyme could be beneficial for
the use as storage matrix in biocatalytic applications.
To check if the observed substrate conversion was triggered by the encapsulated 𝛽-
galactosidase or by unintentionally released enzyme, hydrogels were equilibrated with
buffer instead of incubating with ONPG solution. The gained samples were then ex-
amined on their potential enzyme activity with ONPG solution. The turnover of the
substrate was observed at 410 nm in the spectrophotometer but no significant activity
could be determined. Likewise, the storage solution from the overnight and the 30 days
storage as well as the water which was used to rehydrate the dried hydrogels were ex-
amined by the same procedure. In all tested samples low activity was detected, slightly
increasing with the contact time of water and hydrogel but was insignificantly small in all
cases in terms of the activities detected within the actual assay of the encapsulated enzymes.
The described case study was successfully executed to encapsulate the enzyme 𝛽-galactosidase
in hollow cylinder shaped, PEG-DA based hydrogels in 48 well plates. The washing out of
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Figure 5.22: Comparison of the enzyme activity after different storage conditions. The assay
was executed with 10 𝜇mol/mL ONPG. Storing the hydrogels up to 30 days in moist or dry
conditions preserved up to 65 % of the activity determined after one night of moist storage.
the sacrificial ink with ultrapure water under cooled conditions and the execution of the
enzyme assay in hydrogel-loaded wells could be successfully implemented in an automated
screening process on the liquid handling station (see process scheme in figure 5.18, steps A
and B). This included the scheduling and performance of the hydrogel equilibration (figure
5.18, step C), the providing of the stop solution and the ONPG solution as well as the
sampling and measurement of the gained samples (figure 5.18, steps D and E).
Conclusion
The presented study established the combination of an entry-level bioprinter for the
production of 3D hydrogel structures followed by the automated execution of the hydrogel
– liquid phase interaction investigation in multiwell plates on a liquid handling station.
The Biomaker is easy to operate through a user friendly interface, is ready to implement
in biological laboratory environments and offers a very good price-performance ratio. The
suitability of the printer for an application in the field of biotechnology was shown by
the encapsulation of 𝛽-galactosidase in poly(ethylene glycol) diacrylate based hydrogels.
The two-step printing process (’mold-and-fill’) was adapted from tissue engineering for
the production of hollow hydrogel cylinders from low viscous bioinks in multiwell plates.
This allowed the subsequent execution of an enzymatic activity assay on an automated
liquid handling station. The enzymatic turnover of various substrate concentrations was
monitored which resulted in the typical Michaelis-Menten curves for the three tested pH
values of the surrounding liquid phase.
The introduced setup is suggested to open new possibilities for the biotechnological research
and as a highly promising educational tool. It facilitates the access to 3D bioprinting with
an easy to handle user interface and an open source environment for the simple adaption
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to following demands without compromising equipment dedicated for the delicate working
field of cell applications. It can be employed to screen bioink components, their influence on
the resulting hydrogel and on the interaction with liquid phases of different compositions.
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5.5 Assessment of hydrogels using a combination of 3D printing and high-throughput screening
Abstract
Synthetic hydrogels provide an effective and convenient way to administer
high molecular weight protein drugs. However, the release kinetics of
these proteins from hydrogels depend on the highly complex physical and
chemical properties of the hydrogel, the surrounding solution conditions
and the protein itself. The objective of this work was the development of
an rapid and cost-effective tool for the investigation of the influences of
these variables on occurring interactions. The fulfilment and realization
of this aim was successfully achieved by a combination of hydrogel 3D
printing and high-throughput screening techniques. In a case study, the
lysozyme uptake and release profiles of hydrogel structures with different
compositions (poly(ethylene glycol) diacrylate and acrylic acid) under
the influence of varying surrounding buffer conditions was investigated.
In comparison with literature data, it was shown that the approach
presented here leads to verisimilar data for the used materials and thus
constitutes a helpful tool for the development of hydrogel based drug
delivery systems.
Keywords: 3D printing; photopolymerization; controlled drug delivery; protein uptake and
release
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Introduction
Advances in medical technology and the pharmaceutical sector have created a better
understanding of the root cause of a variety of diseases in recent years. Biopharmaceuticals
based on recombinant proteins, such as monoclonal antibodies or therapeutic enzymes,
promise highly effective therapies with minimal side effects due to their high selectivity for
certain cells or metabolic pathways in the human body. Moreover, recombinant proteins can
treat diseases resulting from insufficient or deficient production of endogenous proteins [237].
The increasing use of pharmaceutical proteins has created a need for new methods of
controlled administration of these compounds [107]. In this context, polymeric carrier
systems arouse the interest of academia and industry for the controlled spatial and temporal
release of biotherapeutics [238, 239]. For use in the clinical field, these polymers must
meet the requirements of biocompatibility and immunological acceptance while integrating
elements of responsive behavior to give a well-defined reaction to external conditions [238].
Proteins are found in human tissues mainly in aqueous environments. In order to mimic
this natural environment and thus to preserve the native protein conformation, hydrophilic
polymers are suitable to administer pharmaceutical proteins. These polymers are capable
of absorbing large amounts of water or biological fluids and can be interlinked to three-
dimensional networks. Therefore those hydrophilic networks are often referred to as
hydrogels. The presence of chemical and/or physical crosslinks renders hydrogels insoluble
in water after network formation. [240]
Hydrogels are already used as a matrix for the oral administration of small molecule
drugs [241]. Also, hydrogel based formulations present a promising approach for the oral
administration of protein drugs since the molecule is protected from harsh conditions and
degradation by endogenous enzymes in the gastrointestinal tract [107]. Thus, for example,
considerable efforts for the development and clinical testing of oral delivery forms for insulin
have been made [242–244]. Further, hydrogels may be applied directly to a wound or
implanted near the site of action. This approach results in a depot formulation from which
the drug slowly elutes and thus maintains a high local concentration in the surrounding
tissues over an extended period of time [245].
The network structure and the thermodynamic nature of all compounds involved determine
the protein release profile of these networks [246]. The molecular weight and content of the
polymer as well as the addition of crosslinking agents determine the density of crosslinks in
the gel matrix and thus the mesh size [107]. The mesh size of the swollen network affects
the physical properties of the gel, such as mechanical strength, degradation and diffusion of
captured molecules [237]. By the addition of ionizable or hydrophobic hydrogel monomers,
additional interactions of the proteins with the polymer network can be promoted [107].
On the protein side, mainly the molecular weight, the composition of the amino acids and
thus the distribution of charged and hydrophobic residues on the surface of the protein as
well as the three-dimensional structure of the protein affect the release properties from the
hydrogel [107]. The interaction based uptake and release of biomolecules is determined by
the ratio of the interaction between the hydrogel and the protein as well as the protein
and the surrounding solution [238].
There are many theoretical approaches to describe network structure, mesh size, swelling
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behavior and mass transport of biomolecules in hydrogels [240]. The high number of
variables, however, makes a comprehensive mechanistic understanding of protein-hydrogel
interaction difficult. Furthermore, the theoretical predictability of the uptake and release
profiles is aggravated by the multiplicity of combinable proteins and hydrogel materials [247].
A sound experimental data base is essential for theoretical knowledge building of the various
interactions occurring between the hydrogels, proteins and the liquid environment. In
this context, high-throughput screenings (HTS) may help to understand the complexity
affecting the drug delivery result [248]. HTS offer an accurate, rapid, and cost-saving
method to study hydrogel-protein interactions and the influence of surrounding solution
conditions while covering a high number of potential process parameters at the same
time. The standard HTS-format in biotechnology are multi-well plates, which are handled
by highly automated pipetting stations [24, 35, 36, 249]. For hydrogels, however, a fast
and reproducible method to crosslink precursor solutions into a HTS-compatible shape is
still missing. 3D printing offers the herefore needed outstanding possibility to polymerize
precursor solutions to any shape [250]. In case of 3D bioprinting, the printing materials,
or bioinks, are composed of biocompatible matrix materials such as hydrogels or their
precursors, additives and biological components.
This study aims to implement three dimensional hydrogel structures into multi-well
plates for the investigation of hydrogel-protein interactions on liquid-handling stations.
Therefore, hollow hydrogel cylinders fitting into standard 48-well plates were produced using
3D bioprinting. This shape provides a large surface to volume ratio for the observation
of transport phenomena while ensuring a non-destructive operation of the automated
pipetting tips. Lysozyme from chicken egg white was used as a model protein to study
the drug uptake and release behavior from poly(ethylene glycol) diacrylate (PEG-DA)
based hydrogels. PEG-DA was photochemically crosslinked using a DLP (digital light
processing) based stereolithography system. Two approaches for the incorporation of
proteins in hydrogels are compared. In the first approach, the hydrogel was printed without
protein and subsequently loaded with protein (PostFabLoading). This approach increases
the probability of preserving the biological activity of the protein, reduces, however, the
maximum utilization of the protein due to partitioning limitations [251]. In order to
maximize the protein uptake different polymer contents and pH values as well as the
addition of the co-monomer acrylic acid (AA) were investigated. For the second approach,
the protein was part of the bioink and consequently present during the polymerization
process (PrintLoading). This apporach may result in activity loss due to potential reactions
with the hydrogel polymer, resulting radicals or the energy input necessary for crosslinking.
After hydrogel formation and protein loading, the release was examined under different
solution conditions (pH and ionic strength). In order to ensure protein integrity after the
release, an activity assay was performed.
Materials and Methods
All solutions were prepared with ultra-pure water (0.55 𝜇S/cm) obtained from a PURELAB
Ultra water purification system (ELGA Labwater, Germany). The 25 mM multicomponent
buffer with a linear buffering range from pH 3 to pH 9 consisted of the buffer sub-
stances AMPSO (2-hydroxy-3-[(1-hydroxy-2-methylpropan-2-yl)amino]propane-1-sulfonic
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acid) (Sigma-Aldrich), TAPSO (3-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]amino]-
2-hydroxypropane-1-sulfonic acid)(Sigma-Aldrich), MES 1-hydrate (2-morpholinoethane-
sulfonic acid) (AppliChem), sodium acetate trihydrate (Sigma-Aldrich, USA) and formic
acid (Merck Millipore). The buffer recipe is summarized in Table 5.2.
Table 5.2: Composition of 25 mM multicomponent buffer with a linear buffering range from
pH 3 to pH 9 calculated according to [231]. The used buffer substances are displayed with the
corresponding pKa value and molarity.
Buffer component pKa-value [-] molarity [mM]
AMPSO 9.14 42.44
TAPSO 7.64 33.90
MES 1-hydrate 6.10 38.03
Sodium acetate trihydrate 4.76 27.56
Formic acid 3.75 37.43
Potassium chloride (KCl) and di-potassium hydrogen phosphate (K2HPO4) for the
size exclusion chromatography running buffer were purchased from VWR. Dulbecco’s
Phosphate buffered saline (PBS) (ThermoFisher Scientific) and sodium chloride (Merck
Millipore) were used for protein release studies. pH adjustment of all buffers within a range
of ± 0.05 units was performed using a five-point calibrated pH-meter HI-3220 (Hanna
Instruments, USA) with a SenTix® 62 pH electrode (Xylem Inc., USA). For pH correction
hydrochloric acid and sodium hydroxide were obtained from Merck (Germany). All buffers
were filtered using a 0.2 𝜇m cellulose-acetate filter (Sartorius, Germany) and degassed for
chromatographic purposes.
Poly(ethylene glycol) diacrylate (PEG-DA, average MW 575), 2,2-Dimethoxy-2-phenylaceto-
phenone (DMPA) and acrylic acid for bioink preparation were obtained from Sigma-Aldrich.
Protein solutions were prepared using chicken egg-white lysozyme (subsequently referred
to as lysozyme) from Hampton Research.
3D printing of PEG-DA based hydrogels
Preparation of bioinks The used mass concentrations of all components are summarized in
Table 5.3 for all studied bioinks. To prevent premature polymerization, all ink components
were weighed in and stored in lightproof centrifuge tubes (50 ml Tube Cellstar®, Greiner
Bio-One). The ink was mixed on an overhead shaker for at least 24 hours to ensure
complete dissolution of the photoinitiator.
3D fabrication of hydrogels A commercially available B9Creator DLP 3D printer (version
1.2, B9Creations) equipped with an modified projector (D912HD, vivitek) as light source
was used to polymerize the bioinks. The CAD model of the hollow cylinder was created in
Solid Edge ST7 (Siemens PLM Software) and exported as a stereolithography file (.stl)
into the 3D printer software (B9Creator). The hollow cylinders have an outer diameter
of 9.45 mm, a wall thickness of 0.82 mm and a height of 7 mm. This results in a total
volume of the hollow cylinder of 155.6 mm3 before being swollen in water. The model was
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Table 5.3: Composition of bioinks. The percentage of a component %(w/w) refers to the total






acrylic acid DMPA lysozyme
stock
solution
PEG-DA50 50 49 - 1 -
PEG-DA75 75 24 - 1 -
PEG-DA90 90 9 - 1 -
PEG-DA75AA7.5 75 16.5 7.5 1 -
PEG-DA75AA15 75 9 15 1 -
PEG-DA75Lys1.55 75 - - 1 9.6
sliced to layers of 200 𝜇m thickness and the configuration of the printer was set to an x, y
resolution of 30 𝜇m. Before printing, calibration of the build table and automatic focusing
of the projector was performed. Depending on the ink composition printer settings were
adjusted in order to achieve complete polymerization and 3D objects free from defects.
The applied settings for the different bioinks are summarized in Table 5.4.









PEG-DA50 25 1 1 20 1
PEG-DA75 20 1 1 15 1
PEG-DA90 20 1 1 15 1
PEG-DA75AA7.5 20 1 1 30 1
PEG-DA75AA15 28 1 1 50 1
PEG-DA75Lys1.55 11 1 2 12 1
Except the changes stated here, the bioinks were printed with the default settings for
the commercial ink B9R-1-Red from B9Creations. Since a complete filling of the tank with
bioink was too material-consuming, the ink was gradually applied manually. The necessary
time for ink application was achieved by setting the post-release delay to 10 seconds. Four
cylinders were produced simultaneously in one printing run.
The irradiation by the projector led to a clouding of the silicone layer which is built-in to
prevent adhesion of the printed structure to the resin vat. This effect was amplified by
increasing the content of AA in the bioinks. Therefore, the silicone layer was exchanged
at regular intervals according to the specification of B9Creations using Elastosil® RT 601
(Wacker Chemie).
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Determination of protein uptake and release by 3D printed hydrogel cylinders
Loading of hydrogels with protein For PrintLoading, the protein is present during the
printing process. The fabrication of the protein containing hydrogel cylinders is already
described in section 5.5. The amount of lysozyme that was entrapped within the hydrogel
was determined by assuming the same weight percent of lysozyme in the precursor solution
to be also present in the polymerized hydrogel.
To perform the PostFabLoading of the printed hydrogel cylinders, a lysozyme solution of
40 mg/ml was prepared using the 25 mM multicomponent buffer of respective pH. Protein
concentration measurements were conducted using a NanoDrop2000c UV-Vis spectropho-
tometer (Thermo Fisher Scientific) and an extinction coefficient of 𝜀 1%280 𝑛𝑚,𝑙𝑦𝑠𝑜𝑧𝑦𝑚𝑒 =
22.00 [252]. The 3D-printed cylinders were stored in ultra-pure water for at least 24 h
in order to deplete unpolymerized bioink components. For the uptake experiments, the
cylinders were drained, patted dry and placed in the wells of a 48-well plate (48 Well Cell
Culter Cluster, Costar®). Using a fully automated pipetting station Freedom EVO® 200
(Tecan) the cylinders were equilibrated for 30 min in 400 𝜇l multicomponent buffer of
the respective pH. After equilibration, 300 𝜇l of the buffer were withdrawn and replaced
by the 40 mg/ml protein solution yielding a concentration of 30 mg/ml for the uptake
experiments. During incubation, the 48-well plates were covered to avoid evaporation
and shaken at 200 rpm on a Te-Shake orbital mixer (Tecan). After 0, 2, 4, 6, 8, 10 and
12 hours, the supernatant was removed from a triplet of cylinders of equal composition and
examined by analytical size exclusion chromatography (SEC) for the remaining protein
concentration. For all experiments carried out, only one measurement value is generated
from the supernatant of each hydrogel cylinder of a 48-well plate. Thus, the multiple
determination of a data point as well as the different time steps within a protein uptake
series result from different cylinders.
The chromatography runs were performed using a Dionex UltiMate® 3000 liquid chromatog-
raphy system (ThermoFisher Scientific) equipped with a HPG-3400RS pump, a WPS-
3000TFCanalytical autosampler, a TCC3000RS column thermostat and a DAD3000RS
detector. As stationary phase, an Acquity UPLC® BEH200 SEC 1.7 𝜇m (4.6 x 30mm)
column (Waters) was used. Analysis was performed at a flow rate of 0.2 ml/min using a
200 mM K2HPO4 buffer at pH 7 containing 250 mM KCl. The injection volume was set to
20 𝜇l using double loop overfill.
Protein release from hydrogels Protein release was studied using the 25 mM multicom-
ponent buffer at three different pH values (3, 7 and 9) and under the influence of three
different sodium chloride concentrations (0 M, 0.15 M and 0.5 M). Furthermore, the protein
release under physiological conditions was tested using phosphate buffered saline (PBS).
To study the protein release from the loaded hydrogels, cylinders were incubated for 12 h
with protein solution for PostFabLoading as described in section 5.5. After incubation,
the protein solution was withdrawn and the hydrogels were washed with 1 ml ultra-pure
water by single-time uptake and dispensing with a pipette. The PrintLoaded cylinders
were rinsed with ultra-pure water for 10 s after the printing process.
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For the protein release studies, 500 𝜇l of the release buffer to be screened was added to
each cylinder. During incubation, the 48-well plates was shaken at 200 rpm. Kinetics were
recorded using a NanoDrop2000c UV-Vis spectrophotometer and an extinction coefficient
of 𝜀 1%280 𝑛𝑚,𝑙𝑦𝑠𝑜𝑧𝑦𝑚𝑒 = 22.00. For each time point, 3 𝜇l of sample were withdrawn and
analyzed. The multiple determination of a data point within one protein release series
results from three independent cylinders.
In order to evaluate biological integrity after the fabrication process, the released protein
was analyzed for residual activity using Micrococcus lysodeikticus based activity assay
according to [253]. This method was slight modified by measuring the activities only at a
protein concentration of 0.3 mg/ml. The slope of the absorption at 450 nm over time was
used as activity and related to the activity of reference sample containing native lysozyme
at pH 7. Moreover, samples were analyzed by analytical SEC in order to monitor the
formation of aggregates (c.f. section 5.5).
Results and discussion
PEG-DA based hydrogels were fabricated by photopolymerization with a DLP based
stereolithography system using DMPA as a photoinitiator. DMPA photofragments to
highly reactive methyl radicals, which initiate photopolymerization by attacking the carbon-
carbon double (C=C) bonds present in the acrylate groups of PEG-DA and acrylic acid [107,
254]. This radical photopolymerization leads to linear chain growth as well as to branched
and crosslinked structures forming a three-dimensional network [254]. The two components
PEG-DA and acrylic acid absorb water in an aqueous environment and thus create an ideal
environment to incorporate biomolecules in this three-dimensional network. In this study,
two methods to introduce the biomolecule into the hydrogels are investigated. Firstly, the
hydrogel is polymerized and subsequently incubated in concentrated drug solutions (post-
fabrication equilibrium partitioning = PostFabLoading) [251] and secondly, the protein
is present in the bioink during the polymerization (PrintLoading) [107]. The hydrogels
loaded in both ways are tested for their release behavior and the residual activity of the
incorporated protein.
3D printing of PEG-DA based hydrogels
The presented setup with the B9Creator and the modified projector was well suited to
produce hydrogel structures from all prepared ink compositions. With the UV filter removed
from the projector the emission spectra and the irradiance was adequate to polymerize
hydrogel layers of 200 𝜇m and hollow cylinders could be build up. To ensure a proper
print result, the applied printing parameters (c.f. Table 5.4) had to be adapted for the
varying bioink formulations (c.f. Table 5.3). The aim of the adaptions was the production
of hydrogel structures with a minimum of reject and waste. Furthermore, the duration
of light exposure was optimized in regard to print result, total print time, and in the
specific case preventing inadequate irradiation of the protein. Adjusting the suitable print
settings as well as the application of the ink were the most crucial steps for a successful
printing procedure. Insufficient exposure settings for the attaching layer concluded in poor
attachment and the occurring of polymerized parts in the applied ink (see Fig. 5.23A).
Also incomplete structures were developing when the freshly printed layer had no contact
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Figure 5.23: Photographs of printed hydrogel structures from PEG-DA75 (A-C) and PEG-
DA75Lys1.55 (D). Underexposure led to insufficient adherence of the hydrogel at the build
platform (A). Unbalanced ink application and air bubbles resulted in partially defective
structures (B) . Flawless hollow hydrogel cylinders as they have been used in the presented
study (C). PrintLoading cylinders with noticeable turbidity due to incorporated protein (D).
to the already consisting layer. In the later printing process, air bubbles or the lack of
applied ink could disrupt the resulting hydrogel structure as shown in Fig. 5.23B. It is in
the nature of this printing technique, that unintended absence of polymerizeable material
during the printing process inevitably causes malformations in the resulting structure.
Nonetheless, commensurate ink application in combination with the adapted printing
parameters (c.f. Table 5.4) resulted in a high repeatability in the production of flawless
hydrogel cylinders for the further use in this study (see Fig. 5.23C). An increasing amount
of PEG-DA in the bioink resulted in shorter exposure times needed for good printing
outcomes. This need for lower energy input at the given layer height can be explained
by the concentration dependent amount of possible crosslinking sites [255]. To generate
flawless hydrogel structures from bioinks containing 75 % PEG-DA and additional acrylic
acid an increase in the exposure time was required compared to bioinks without acrylic
acid. The reaction rate of this copolymerization seems to be slowed down with increasing
percentage of acrylic acid. Different reactivities of PEG-DA and acrylic acid can be used as
an explanation for this shift. The applied exposure times could be reduced for the bioink
PEG-DA75Lys1.55. This was influenced by the noticeable turbidity (see Fig. 5.23D), which
was already visible before the polymerization and probably occurred due to precipitated
lysozyme in this ink. The turbidity increased the absorbance of luminous energy which
resulted in a faster polymerization process.
Protein uptake during post-fabrication equilibrium partitioning
Post-fabrication equilibrium partitioning (PostFabLoading) of lysozyme to PEG-DA
based hydrogels was studied using the bioinks PEG-DA50, PEG-DA75, PEG-DA90, PEG-
DA75AA7.5 and PEG-DA75AA15. The protein uptake was determined by measuring the
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lysozyme concentration in the supernatant of incubated hydrogel cylinders at regular time
intervals by analytical SEC. The amount of loaded protein was calculated by the difference
between the amount of protein in the protein stock solution and in the supernatant. The
relative protein uptake was defined by Eq. 5.4, where 𝑚𝑙𝑜𝑎𝑑𝑒𝑑 and 𝑚𝑠𝑡𝑜𝑐𝑘 are the mass of
the loaded protein and the mass of the total protein in the stock solution, respectively.
𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑢𝑝𝑡𝑎𝑘𝑒 = 𝑚𝑙𝑜𝑎𝑑𝑒𝑑
𝑚𝑠𝑡𝑜𝑐𝑘
· 100% (5.4)
In Fig. 5.24, the relative protein uptake is displayed for different bioink compositions and
loading conditions. The error bars indicate the standard deviation of a triple determination
from the supernatant of three independent hydrogel cylinders. In Fig. 5.24A, the influence
of PEG-DA mass fraction in the bioink on the relative protein uptake at pH 7 is shown.
Over a time of 12 hours, the hydrogels with an initial PEG-DA mass fraction of 50 %
exhibit the highest uptake of up to 40 % of the initial applied protein mass. The course of
the protein uptake curve for the hydrogels with 75 % and 90 % PEG-DA are very similar
and achieve a maximum of approximately 20 % in the studied 12 h. These observations are
consistent with the work of Zhang and coworkers [256] who describe that a higher PEG-DA
concentration leads to a more compact hydrogel structure with higher crosslinking density.
A higher crosslinking density restricts the swelling of the hydrogel and results in a reduced
meshsize which in turn hinders protein diffusion into and out of the hydrogel. For all three
curves, the increase in protein uptake is highest during the first 6 h and almost reaches
a plateau value after 10 h. The plateau value reflects the maximal protein absorption
capacity of the hydrogel, which is denoted as protein uptake at saturation [257]. Zaho et
al. [257] have observed similar results for the uptake of lysozyme by glycerol diglycidylether
crosslinked oxidized starch microgels. They found a absorption time of 4 h to be sufficient
for the microgel to reach saturation during protein absorption.
In Fig. 5.24B it is demonstrated, how the relative protein uptake of PEG-DA based
hydrogels can be increased by addition of the co-monomer acrylic acid. Firstly, it can be seen
that the protein uptake rises more steeply in the first 4 h than without acrylic acid. This
indicates that lysozyme absorbes with higher affinity to hydrogels containing acrylic acid.
This observation can be explained by the introduction of an ionic character to the hydrogel
by the addition of acrylic acid [107]. At pH 7, acrylic acid is negatively charged due to its
pKa of 4.25 [258] while the net charge of lysozyme is positive (pI=11.3 [259]). Therefore,
electrostatic interactions occur between protein and ionized acrylic acid. Secondly, the
protein uptake at saturation increases approximately linearly with increasing mass fraction
of acrylic acid. This linear increase can be explained by the introduction of exactly one
negative charge per molecule acrylic acid into the hydrogel. Doubling the acrylic acid
content therefore leads to a doubling of the binding sites for the protein. An unlimited
increase in the acrylic acid content is, however, not possible, because the molecule has only
one free double bond and thus weakens the network structure of the hydrogel.
In Fig. 5.24C, the effect of the solution pH on the protein uptake is shown for the bioink
PEG-DA75AA15 containing 75 % PEG-DA and 15 % acrylic acid. When comparing the
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Figure 5.24: PostFabLoading of PEG-DA based hydrogels with lysozyme: Relative protein
uptake of hydrogels with varying mass fraction of PEG-DA at pH 7 (A), with 75 % PEG-DA
and varying mass fraction of the co-monomer acrylic acid at pH 7 (B) and different loading pH
values for 75 % PEG-DA and 15 % acrylic acid (C)
three pH values, the lowest protein uptake is achieved at pH 5. The curves of pH 7 and
pH 9 are identical within the error bars. Since pH 7 and pH 9 are more than two pH-steps
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higher than the pKa-value of acrylic acid, a complete deprotonation of all acid groups can
be assumed for both pH values. According to the calculation of the protein charge with
H + + [260], the net charge of lysozyme is +8 at pH 7 and pH 9. These assumptions
apply to the identical protein uptake curves at pH 7 and pH 9. In contrast, pH 5 is very
close to the pKa-value of the acrylic acid. Since the pKa-value indicates the pH-value at
which 50 % of the acid groups are deprotonated, it is possible that not all acid groups are
deprotonated at pH 5. This would result in a reduced number of negative charges available
to the protein for the interactions, and thus can explain the lower protein uptake.
Protein release from loaded hydrogels
To study the release profiles for the protein-loaded hydrogels, the hollow cylinders were
incubated in different release buffers for 150 min. During this period, samples were regularly
taken and the contained protein was quantified by means of absorption measurements. The
resulting release profiles are displayed in Fig. 5.25 for 0 M and 0.15 M NaCl in the release
buffer.
In all experiments, PBS behaves as the multicomponent buffer at pH 7 containing 0.15 M
sodium chloride. In Fig. 5.25A-D, the lysozyme release profiles for hydrogel cylinders
consisting of 75 % PEG-DA and 0 % AA (in the bioink) are displayed. These hydrogels
are uncharged since they are formed exclusively by crosslinking uncharged PEG-DA chains.
For the two loading methods PostFabLoading (Fig. 5.25A and B) and PrintLoading
(Fig. 5.25C and D), neither the pH of the surrounding solution nor the salt concentration
has any influence on the release profile. The transport of the protein therefore appears
to be driven exclusively by diffusive processes. When comparing PostFabLoading and
PrintLoading for a given solution condition, it is noticeable that the maximum protein
released is higher for PrintLoaded hydrogels. This difference can not be attributed to
different concentration gradients since hydrogel cylinders of both loading methods contain
the same amount of protein after the loading process. The most probable cause for
the difference in the maximum protein release between PostFabLoaded and PrintLoaded
hydrogels is an unequal swelling state at the beginning of the release experiments. Hydrogel
water content will affect the release profile because water in the matrix is the medium
through which proteins will diffuse [107]. The PostFabLoaded hydrogels are already
completely swollen due to their storage, equilibrium and protein loading and have thus
reached their equilibrium water content (EWC) [107]. In contrast, the PrintLoaded
hydrogels were only washed for 10 s in ultra-pure water immediately after printing to
reduce uncontrolled protein release during the washing process. The addition of buffer
during the release experiments induced the swelling process and thus led to an increasing
mesh size during the release process. An increased gel mesh size allows more protein to
diffuse out of the hydrogel [256]. The generally low release rates indicate the existence of
intermolecular interactions such as hydrogen bonds or Van-der-Waals forces which appear
to be stronger between lysozyme and PEG-DA than between lysozyme and the surrounding
solution. In case of PrintLoaded hydrogels, covalent binding of the protein to the gel is also
possible by free radical addition or Michael addition between lysine residues and acrylate
groups of the polymer [107, 261]. Since being present during the printing process, the
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Figure 5.25: Relative protein release under the influence of 0 M NaCl in the release buffer
(PostFabLoaded hydrogels from 75 % PEG-DA (A), PrintLoaded hydrogels from 75 % PEG-DA
(C) and PostFabLoaded hydrogels from 75 % PEG-DA and 15 % AA (E)) and under the
influence of 0.15 M NaCl in the release buffer (PostFabLoaded hydrogels from 75 % PEG-DA
(B), PrintLoaded hydrogels from 75 % PEG-DA (D) and PostFabLoaded hydrogels from 75 %
PEG-DA and 15 % AA (F))
protein may additionally be enclosed inaccessibly in closed or too narrow pores.
In Fig. 5.25E and F, lysozyme release profiles from hydrogels containing 75 % PEG-DA
106
5.5 Assessment of hydrogels using a combination of 3D printing and high-throughput screening
and 15 % AA are shown. Comparing Fig. 5.25E and F with Fig. 5.25A and B, it can be
seen that the release of lysozyme from acrylic acid containing hydrogels is slower than
from acrylic acid-free hydrogels. These observations suggest an affinity based mechanism
of release, as is was already discussed for the protein uptake experiments. For 0 M sodium
chloride in the release buffer (Fig. 5.25E), a clear dependency of the protein release on
the pH value of the surrounding solution can be seen. At pH 3, the maximum protein
release is 10 fold greater than at pH 7 and pH 9. Since pH 3 is below the pKa of acrylic
acid, the acid groups in the hydrogel are protonated and thus uncharged. Due to the pH
change of pH 7 during the loading to pH 3 during release, the protein which was absorbed
via electrostatic attraction is released. These results are in accordance with the work of
Zhang and coworkers [256], who have described a fast initial burst release of proteins at
pH 2.0 due to a squeezing mechanism. Since there are no electrostatic attractions between
hydrogel and lysozyme at pH 3, the addition of salt ions (compare Fig. 5.25F) also has
no significant effect on the release. At pH 7 and pH 9, the acid groups of acrylic acid,
however, are deprotonated and thus negatively charged. Since lysozyme has a net charge
of +8 (calculated with H ++ [260]) at both pH 7 and pH 9, the protein is equally retained
in the hydrogel by means of electrostatic interactions. When salt is added (compare
Fig. 5.25F), the salt ions compete with the proteins for the charges of the hydrogel and
displace the proteins. This effect has been discussed by various authors including Brooks
and Cramer [262] in the context of ion exchange chromatography.
Activity examination of the released lysozyme
Following the release studies, the gained samples were examined regarding their residual
enzyme activity compared to native lysozyme. In Fig. 5.26, the determined relative activity
of all samples is shown. The way of carrying out the assay could have led to partially
pronounced standard deviations. Therefore, we defined a relative activity of 100 % ± 10 %
as unimpaired preservation of activity. It can be seen, that the buffer conditions of the
release procedure also had an influence on the activity of the released lysozyme in the
diluted assay conditions. For the lysozyme released from PostFabLoading PEG-DA75 a
slightly positive effect can be seen for the presence of NaCl in the release buffer but no
reliable statement can be made due to the standard deviations. The positive influence of
the salt could definitely be observed for the release at pH 3 PrintLoading and even more
clearly at pH 7 and pH 9 PostFabLoading PEG-DA75AA15. The salt significantly alleviated
the negative impact on the activity initiated by the loading into acrylic acid containing
hydrogels and the subsequent release with buffers at pH 7 and pH 9. The lysozyme released
in PBS showed a slightly smaller activity than the comparable multicomponent buffer
at pH 7 with 0.15 M NaCl. Comparing the two executed approaches PostFabLoading
and PrintLoading at given pH, a negative impact of the PrintLoading procedure could be
determined. This impact was strongly evident for the released lysozyme at pH 9.
In order to further investigate the reduced activity, released protein samples from Post-
FabLoaded and PrintLoaded hydrogels without acrylic acid at pH 9 and 0 M NaCl were
analyzed using analytical SEC. The results are displayed in Fig. 5.27. The protein sample
from PostFabLoading resulted in a single peak which could be attributed to a reference
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Figure 5.26: Comparison of the relative activities of released lysozyme relating to the loading
method and ink composition.
sample of native lysozyme. The protein sample from PrintLoading, however, contained
larger and smaller protein species, which eluted earlier and later than native lysozyme, re-
spectively. The loss in activity during the PrintLoading process may therefore be attributed
to the formation of precipitate and fragments of lysozyme due to the bioink composition
and effects triggered by irradiation. The turbidity of the applied bioink and resulting
hydrogels could serve as a first indication of protein aggregation during the printing process.
Conclusion
Protein uptake and release of hydrogels depends on the right combination of hydrogel
materials, protein and surrounding solution conditions. This study has demonstrated that
mechanisms and effects of protein adsorption and release by hydrogels already described in
the literature could be reproduced reliably by the presented combination of 3D printing
and high-throughput screening. Thus, a helpful tool was developed for the rapid and
cost-effective optimization of new hydrogel materials with regard to the physical, biological
and material transport requirements at the site of action. The development of oral delivery
products and implanted reservoir systems for biopharmaceutical proteins may profit from
the here presented approach. In order to further qualify this approach for high-throughput
studies, we are in the process of automating the printing procedure.
Furthermore, the results demonstrated that the direct incorporation of proteins into the
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Figure 5.27: Analytical SEC comparing released lysozyme form PostFabLoading and Print-
Loading for PEG-DA based hydrogels without acrylic acid at pH 9 and 0 M NaCl
bioinks may lead to the formation of inactive species during the printing process. The
development of suitable stabilization strategies for hydrogel based biopharmaceutical
products are therefore of the utmost interest to meet this challenge.
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The focus of this thesis was the implementation of novel tools in the high-throughput
process development. This was achieved by the adaptation of techniques from the fields
of microfluidics and bioprinting to meet the requirements of automated experimental
workflow.
The 𝜇F-on-LHS system was successfully applied in studies from different research areas.
For the absorption-based protein analysis, a microfluidic device was developed and es-
tablished. This device allows the quantitative determination of protein concentrations in
a wide concentration range. The dimensions of the device allow its implementation in
experimental procedures on liquid-handling stations (LHS) including automated filling and
handling. Additionally, the material used for the manufacturing of the chips enabled a
read-out with the integrated spectrophotometer in the UV/Vis spectrum. Up to 96 samples
on a microfluidic device can be measured with proven accuracy and repeatability. The
applicability of this tool was shown on the basis of the sample measurement of a microscale
chromatographic separation procedure. This tool especially is a significant improvement
for the measurement of highly concentrated protein solutions which have nowadays to be
analyzed as standard in biopharmaceutical processes.
Further, the beneficial use of microfluidic channels in combination with automated process
management for the investigation of complex interdependecies could be demonstrated. The
impact of various cause variables on the monomer conversion of photoinitiated miniemulsion
polymerization has been studied. The low volume needed for a single experiment allowed
the increase of information gained from one batch of miniemulsion. The screening concept
was supported by a design of experiments approach for the systematical investigation
of the different influencing factors. This strategy was shown to be a promising tool for
the characterization and optimization of photopolymerization processes. This is of great
interest for the introduction of biological material and their interactions with the produced
nanoparticles and possible toxic reaction residues.
In addition, the ability of the 𝜇F-on-LHS system to perform highly sensitive microbiological
experiments was shown. In this context, the automation of the complex fluorescence in situ
hybridization protocol was demonstrated by its implementation in a LHS procedure. The
developed concept allowed the handling of up to 9 cultivation flowcells in an interlaced pro-
cess for the reliable experimentation without further manual work. Besides the automated
execution of all protocol steps also the semi-quantitative read-out of the fluorescence signal
was accomplished. The developed platform enabled the successful hybridization of biofilms
which could be verified through microplate reader analysis and epifluorescence microscopy.
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Apart from the implementation of the FISH protocol, the feasibility of a CARD-FISH
procedure was successfully shown. Therefore, the automation of this methods contributes
to the simplification of the analysis of microbial communities in complex biofilms.
In the field of bioprinting, two different printing techniques have been investigated for
the build-up of hydrogel structures. The adaptation of these structures to the size of the
wells of a multiwell plate allowed their integration in automated screening procedures. The
structure and the incorporated biological material was investigated on interactions with
liquid surroundings of various compositions. The first approach was the conversion of a
conventional fused filament fabrication 3D-printer to an entry-level bioprinter capable of
extruding paste-like bioinks. In combination with a simple user interface for the generation
of printing command sets, an easy access to bioprinting could be presented. In a case study,
a printing method from tissue engineering research was adapted for the encapsulation of
enzymes. The preserved activity of the enzymes was subsequently tested by an automated
assay execution. The resulting substrate conversion rates have been in good accordance to
Michaelis-Menten enzyme kinetics.
Furthermore, a stereolithographic printing device was adjusted for the production of multi-
well plate compatible hydrogel structures. This approach was applied for the investigation
of the behavior of hydrogels with respect to the uptake and release of lysozyme. The influ-
ence of the variation of hydrogel and liquid surrounding composition could be determined
in a high-throughput screening. With this method, a novel strategy for the investigation of
hydrogel materials for their application in drug delivery systems was demonstrated.
The developed approaches have demonstrated excellent applicability concerning ap-
plications in preparatory procedures and actual bioprinting strategies. The presented
applications for the combination of microfluidics and liquid-handling stations are well
suited for the further integration in process development and workflows. Preliminary
studies have been deployed for the execution of self-interaction chromatography and flow-
through aqueous two phase systems to investigate protein interactions. The bioprinting
approaches demonstrate an auspicious strategy for the implementation of hydrogel 3D-
printing in automated screening procedures. Investigations on the interaction of proteins
and hydrogels in various liquid surroundings could be performed. The open source pedigree
of both applied printers provides an good starting point for further add-on components
and research tasks.
In summary, the adapted workflows highly benefit from the practicable miniaturization and
automation. Thus, the application spectrum of LHS-based experiments has been extended
by additional tools and possibilities.
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Irgacure® 819; (C): I = 75%, t = 60 s, 3.0 wt%) Irgacure® 819). Scale on
the left image: 2000 nm, on the middle and right image: 1000 nm. . . . . . 48
5.11 SEM images of the resulting polystyrene particles from experiments in the
1000 𝜇m channel with an irradiation time of 60 s and an irradiance of 100
and 17 % RMC. The concentration of the initiator varies from 0.5 wt% on
the (A) to 3.0 wt% on the (B). Scale: 1000 nm. . . . . . . . . . . . . . . . . 48
5.12 Particle size distribution of the resulting polystyrene particles from experi-
ments in the 1000 𝜇m channel with 100 % irradiance and a photoinitiator
concentration of 0.5 wt% (black squares) respectively 3.0 wt% (red squares). 49
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5.14 Epifluorescence micrograph of B. subtilis (A, D, G), E. coli (B, E, H) and
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level with the 1000-fold magnification. (E) Cloudy E. coli biofilm in 200-fold
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with the photometric fluorescence measurement (B and E). (F) Mixed
species biofilm with Bacillus cells forming a dense mesh and E. coli cells
growing inside the network. (I) Close up of the mixed species biofilm clearly
demonstrating a successful one-step double hybridization of the gram positive
B. subtilis and the gram negative E. coli in a mixed species biofilm. . . . . 65
5.15 Mean fluorescence values of three parallel cultivated biofilms normalized
to the respective mean background value. For each flowcell the signal was
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5.16 (a)/(b)/(c) Topographic representation (6.7 mm x 3 mm, height = 100
𝜇m (red colored)) of the 3D structure of mixed species (a), E. coli (b)
and B. subtilis (c) biofilms captured by means of OCT during automated
FISH procedure. For each biofilm images were acquired right before FISH
was conducted, after fixation, permeabilization, hybridization and washing.
Slight biofilm detachment was observed throughout the whole procedure.
But altogether the structural integrity could be preserved for all three
model biofilms. (d) Epi-fluorescence micrograph of mix species biofilm.
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5.17 Catalysed reporter deposition fluorescence in situ hybridization (CARD-
FISH) image of a cultivation flowcell, inoculated with native biofilm and
cultivated for four weeks. Archaea (ARCH 915) are visualized in green
(Alexa 488), bacteria (EUB 338-I) in red (Alexa 546) and DAPI blue. . . . 68
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